VAERS Reports 027L21A

VAERS 2635472

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 23.05.2023
Impfdatum: 14.09.2022
Beginn: 03.11.2022
Tage bis Beginn: 50,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Femur fracture Pulmonary embolism

Symptomtext

ACUTE PULMONARY EMBOLISM 11/10/2022 LEFT FEMUR FX INIT ACUTE PULMONARY EMBOLISM 11/10/2022 ACUTE PULMONARY EMBOLISM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2635458

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 23.05.2023
Impfdatum: 03.03.2022
Beginn: 15.02.2023
Tage bis Beginn: 349,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Angina pectoris Myocardial infarction

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE STABLE ANGINA ACUTE ST ELEVATION MI, ANTEROSEPTAL ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2633534

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: -
Alter: 85,0
Geschlecht: F
Eingang: 18.05.2023
Impfdatum: 07.05.2022
Beginn: 14.10.2022
Tage bis Beginn: 160,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Coronary artery disease Deep vein thrombosis Hypoxia Nocturnal hypoventilation Obstructive airways disorder Respiratory failure

Symptomtext

SLEEP RELATED HYPOVENTILATION DUE TO LOWER AIRWAYS OBSTRUCTION 10/13/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/14/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/14/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/2/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA HYPOXIA 10/13/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2625815

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 03.05.2023
Impfdatum: 27.11.2021
Beginn: 26.07.2022
Tage bis Beginn: 241,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Obstructive sleep apnoea syndrome

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ADULT OBSTRUCTIVE SLEEP APNEA ACUTE ST ELEVATION MI, ANTERIOR WALL ACUTE ST ELEVATION MI, INFERIOR WALL ACUTE ST ELEVATION MI, UNSPECIFIED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2591035

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: SC
Alter: 52,0
Geschlecht: F
Eingang: 03.03.2023
Impfdatum: 07.03.2022
Beginn: 13.05.2022
Tage bis Beginn: 67,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aneurysm Cardiac disorder Cerebrovascular accident

Symptomtext

Systemic: Cardiac Disorder (diagnosed by MD)-Medium, Systemic: Stroke-Medium, Additional Details: Suffered from stroke and aneurysm on May 13, 2022. Unsure of severity.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2586896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: MI
Alter: 85,0
Geschlecht: M
Eingang: 24.02.2023
Impfdatum: 26.04.2022
Beginn: 18.12.2022
Tage bis Beginn: 236,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Asthenia Blood culture positive Blood glucose increased COVID-19 Central venous catheterisation Cerebrovascular accident Condition aggravated Confusional state Diabetes mellitus inadequate control Failure to thrive Glycosylated haemoglobin increased Hyperglycaemia Insulin therapy Magnetic resonance imaging head abnormal Mental status changes Metabolic encephalopathy Pyrexia

Symptomtext

"Patient with history of COVID vaccines who admited to hospital with COVID detected PCR. Provider d/c note: ""Reason for Admission: Weakness, altered mental status, hyperglycemia 86-year-old male patient with past medical history of hypertension, diabetes mellitus, CVA, polymyalgia rheumatica on steroid, patient lives at Assisted Living Facility was brought here by EMS due to febrile, and hyperglycemia of 515, tested positive for COVID Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) treated for acute metabolic encephalopathy, improving Case was discussed with son 1/2 blood cultures positive for MRSA, being treated with IV vancomycin for now, initially thought to be contaminant, follow-up blood cultures, from 12/20 shows positive for MRSA 12/ 22 Right shoulder x-ray, MRI of the spine, requested periods of confusion, getting MRI of the brain Continued positive MRSA bacteremia 11/ 23 MRI of the brain showed small late acute/subacute left postcentral gyrus, requested neurology consultation, added aspirin to Eliquis 12/24 Improving, PICC line requested for 6 weeks course of IV vancomycin 12/25 Stable, appreciate neurology consultation for acute to subacute CVA 12/ 27 Stable PICC line done 12/27 COVID illness , positive since 12/18 with mild sepsis ( fever and tachycardia ), sepsis has resolved Acute metabolic encephalopathy likely from the combination of hyperglycemia and fever and COVID illness - admit - no evidence of desaturation but will continue to monitor pulse oximetry closely - not a candidate for Decadron or remdesivir as he is not a very high risk patient - supportive management and treatment Improving Failure to thrive, generalized weakness PT/OT evaluation SNF was recommended Poorly controlled diabetes last hemoglobin A1 c of 8.4 on 11/29 Outpatient metformin on hold, started Lantus insulin, on correction insulin"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 11,0
Labordaten: COVID Detected PCR on 12/18/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Sensorineural hearing loss (SNHL) of both ears Benign prostatic hyperplasia with urinary frequency Type II diabetes mellitus, well controlled Ischemic stroke Vertigo Cerebrovascular accident (CVA) due to occlusion of cerebral artery Oral thrush Myalgia, other site PMR (polymyalgia rheumatica) SIRS (systemic inflammatory response syndrome)
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2584867

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: FL
Alter: 91,0
Geschlecht: M
Eingang: 21.02.2023
Impfdatum: 13.04.2022
Beginn: 04.02.2023
Tage bis Beginn: 297,0
Dosis: 4
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Pneumonia SARS-CoV-2 test positive Urinary tract infection

Symptomtext

Hospitalization: 2/4/2023 - 2/8/2023 (4 days) Presentation to the ED: BILATERAL PNEUMONIA & UTI. COVID + date: 2/4/23. Treatment: steroids Discharge to: HOSPICE - EXPIRED 2/9/23. 038K20A 1/29/2021 023M20A 2/26/2021 047C21A 11/4/2021 027L21A 4/13/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PAF, HTN, CVA, UTI, BPH, ANXIETY
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558568

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: WI
Alter: 77,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 26.05.2022
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death on 12/16/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: centrilobular emphysema; OSC: COVID-19; dementia; DM2; dysphagia; HLD; malignant neoplasm of prostate
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2465606

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: KY
Alter: 80,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 05.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 14,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray abnormal Death Pneumonia

Symptomtext

HAD COVID 1/22/22. ADMITTD 3-22-22 THRU 3-28-22 MEDICAL CENTER AND WAS COVID NEGATIVE AT PER PCR ON 3-22-22. HE WAS ADMITTED FROM NURSING HOME WITH PNEUMONIA AND INITALLY ON 100 PERCENT nrb BUT WEANED TO 6 LITERS N/C. hIS CXR WAS NOW CLEAN WITH NO PNEUMONIA. AND WAS TRANSFERRED TO A DIFFERENT NURSING HOME WHERE DECEASD ON 4-19-22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CORONARY ARTERIOSCLEROSIS, CHF, COPD, PAROXYSMAL AFIB
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2425305

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: MI
Alter: 89,0
Geschlecht: F
Eingang: 31.08.2022
Impfdatum: 05.05.2022
Beginn: 26.08.2022
Tage bis Beginn: 113,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Condition aggravated Debridement Decubitus ulcer Enterococcal infection Failure to thrive Infected skin ulcer Pathogen resistance SARS-CoV-2 test positive Sepsis Septic shock Staphylococcal bacteraemia Staphylococcal infection Wound

Symptomtext

Provider d/c note: "89 YO female with history of sacral decubitus ulcer stage IV, dementia, dm 2, recent prolonged hospitalization due to septic shock from infected sacral decubitus ulcer presented from a residential facility due to concern for weakness. She was found to be COVID positive as well. She was subsequently admitted for management of failure to thrive and sepsis due to sacral wound ulcer and action. During her hospitalization stay, patient started on vancomycin and Zosyn. Surgical team consulted and perform bedside debridement of sacral wound ulcer. It was noted that the sacral wound is extensive. Surgeon who performed debridement shared that prognosis is likely grave. Her hospitalization is further complicated by vancomycin resistant Enterococcus faecium and Staphylococcus epidermis bacteremia with likely sources in her urine and sacral ulcer. Antibiotics transition to ampicillin, cefepime and Flagyl. Due to poor overall prognosis, patient was transitioned to hospice after discussion with patient's son who is also POA. He chose for his mother to go back to the residential facility under hospice care. Abx disccontinued and patient transfer back to residential facility. "

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: 4,0
Labordaten: COVID detected PCR on 08/26/22
Aktuelle Erkrankungen: -
Vorgeschichte: Type 2 diabetes mellitus with kidney complication, without long-term current use of insulin Hyperlipidemia (Chronic) Essential hypertension (Chronic) COPD (chronic obstructive pulmonary disease) (presumed) (Chronic) 3/11/2013 Osteoporosis of multiple sites 9/27/2017 Chronic diastolic congestive heart failure (HCC) 1/20/2018 Failure to thrive 40 lb weight loss Panlobular emphysema Dementia without behavioral disturbance
Andere Medikamente: -
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2403004

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 05.08.2022
Impfdatum: 09.05.2022
Beginn: 01.08.2022
Tage bis Beginn: 84,0
Dosis: 3
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aspiration pleural cavity Asthenia COVID-19 Cardiac failure Cough Cytology abnormal Death Decreased appetite Fall Hypervolaemia Hypoxia Impaired quality of life Non-small cell lung cancer stage IV Pneumonia Pulmonary hilum mass Respiratory failure SARS-CoV-2 test positive Salivary gland neoplasm

Symptomtext

Patient with 3 COVID vaccines who admitted with positive COVID test. Hypoxic during stay. Patient died on 08/01/22. Provider d/c note: "81 YO F with hx CAD, PAF on eliquis, TAVR, who presented with facial swelling x1 day, 1 month of increasing generalized weakness and falls, poor appetite, and 1-2 weeks of cough (diagnosed with COVID on 7/17) was found to have parotid/right tonsillar/left hilar mass in setting of symptomatic COVID with hypoxic respiratory failure. Thoracentesis performed demonstrated exudative fluid with cytology preliminary showing NSCLC. EBUS recommended; however, cancelled due to increasing oxygen requirements without overt clear etiology. Thought of latter due to post obstructive pneumonia complicated by fluid overload in setting of HFpEF. Given suspected stage IV cancer with worsening quality of life, patient and family elected to transition to comfort measures, and patient passed at 6:41 this morning. "

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Reported positive home antigen test on 07/17/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Mesenteric ischemia Coronary artery disease involving native coronary artery of native heart without angina pectoris HTN (hypertension) PVD (peripheral vascular disease) Chronic sialoadenitis 3/20/2014 Stenosis of right carotid artery 1/12/2017 Claudication, class III 4/6/2017 Nicotine dependence, cigarettes, uncomplicated 2/8/2020 Mass of hilum
Andere Medikamente: Pacerone Norvasc Eliquis Aspirin Lasix Toprol XL Multivitamin Protonix Crestor
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2373786

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: MO
Alter: 75,0
Geschlecht: F
Eingang: 19.07.2022
Impfdatum: 15.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Blood test Chest X-ray Computerised tomogram pelvis Computerised tomogram thorax Deep vein thrombosis Dyspnoea Echocardiogram Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

Gradually noticed breathlessness in normal activities, worsening over a period of weeks until very serious in early when I sought help by going to ER on July 7. I was immediately given blood test, chest x-ray, chest CT and diagnosed with multiple pulmonary emboli in both lungs. I was admitted to the hospital where a sonogram showed deep vein thrombosis in right leg.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: CT scan, lungs; Sonogram, legs, Echocardiogram, CT scan pelvis, between July 7-15.
Aktuelle Erkrankungen: -
Vorgeschichte: Osteo arthritis Acid reflux Hypertension
Andere Medikamente: Levothroxine Sodium 112mcg Omeprazole 40 mg Amlodipine-Olmesartan 5-20 mg Meloxicam 7.5 mg All 1x daily
Allergien: Sulfa drugs, avocado, canteloupe
Vorherige Impfungen: -

VAERS 2321494

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: TX
Alter: 30,0
Geschlecht: M
Eingang: 16.06.2022
Impfdatum: 21.02.2022
Beginn: 01.02.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: OT / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature COVID-19 Death Erythema Fall Hypoaesthesia SARS-CoV-2 test Swelling face

Symptomtext

passed away; he fell down 3 times but like in slow motion, he fell on the floor with his face down; face was more swollen; face started changing colors, it became burgundy, blue, and kind of red; his legs and arms were going numb; tested twice for COVID and the results came back as positive; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (passed away) and COVID-19 (tested twice for COVID and the results came back as positive) in a 30-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy to antibiotic and Diabetes (Ongoing up until death) since 2021. Concomitant products included INSULIN GLARGINE (LANTUS) for Diabetes. On 21-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. In February 2022, the patient experienced COVID-19 (tested twice for COVID and the results came back as positive) (seriousness criterion death) and HYPOAESTHESIA (his legs and arms were going numb). On 21-Feb-2022, the patient experienced SWELLING FACE (face was more swollen) and ERYTHEMA (face started changing colors, it became burgundy, blue, and kind of red). On 25-Feb-2022, the patient experienced FALL (he fell down 3 times but like in slow motion, he fell on the floor with his face down). The patient died on 26-Feb-2022. The cause of death was not reported. An autopsy was not performed. At the time of death, SWELLING FACE (face was more swollen), FALL (he fell down 3 times but like in slow motion, he fell on the floor with his face down), HYPOAESTHESIA (his legs and arms were going numb) and ERYTHEMA (face started changing colors, it became burgundy, blue, and kind of red) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 35-36 35F-36F. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive. No treatment drug was provided by reporter. It was reported that for an unknown concomitant medication description was given as Antidepressant. Company Comment: This spontaneous case concerns a 30-year-old male patient, with relevant medical history of Allergy to antibiotic and Diabetes, who experienced the unexpected serious event of Death, the unexpected AESI of COVID-19. The events Swelling Face, Hypoesthesia, and Erythema, occurred approximately 1 day after receiving the first dose of mRNA-1273 Vaccine. The patient suddenly experienced Fall 4 days later that led to an emergency call to paramedics. However, upon evaluation of vital signs, the patient was reported to have suffered a fatal event. The cause of death was not reported. An autopsy was not performed due to the positive SARS-CoV-2 test. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 30-year-old male patient, with relevant medical history of Allergy to antibiotic and Diabetes, who experienced the unexpected serious event of Death, the unexpected AESI of COVID-19. The events Swelling Face, Hypoesthesia, and Erythema, occurred approximately 1 day after receiving the first dose of mRNA-1273 Vaccine. The patient suddenly experienced Fall 4 days later that led to an emergency call to paramedics. However, upon evaluation of vital signs, the patient was reported to have suffered a fatal event. The cause of death was not reported. An autopsy was not performed due to the positive SARS-CoV-2 test. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: Body temperature; Result Unstructured Data: 35F-36F; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Allergy to antibiotic; Diabetes (Ongoing up until death)
Vorgeschichte: -
Andere Medikamente: LANTUS
Allergien: -
Vorherige Impfungen: -

VAERS 2184362

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

kritisch

Staat: KY
Alter: 85,0
Geschlecht: M
Eingang: 17.03.2022
Impfdatum: 16.03.2022
Beginn: 17.03.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Vaccination given at 02:52PM on 3/16/2022. No distress noted or voiced by patient. Tolerated well. Vital signs stable. Patient died at 5:00AM on 3/17/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: COVID-19 illness 1/14/2022 was hospitalized and admitted to facility on 2/16/2022.
Vorgeschichte: CHF, Sleep apnea, morbid obesity, Type 2 DM, Chronic kidney disease, hypertension, hypothyroidism, GERD, iron deficiency, hyperlipidemia, nonrheumatic mitral and aortic valve insufficiency, chronic respiratory failure with hypoxia and hypercapnea.
Andere Medikamente: Lispro insulin, levothyroxine, warfarin, remeron, furosemide, glipizide, senna, metoprolol, pantoprazole, ferrous sulfate, aspirin, cetirizine.
Allergien: Medication allergy list: amlodipine, clonidine, felodipine, fosinopril, sulfa antibiotics, PCN, streptomycin, lisinopril, HCTZ
Vorherige Impfungen: -

VAERS 2472017

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: NY
Alter: 32,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 01.04.2022
Beginn: 08.08.2022
Tage bis Beginn: 129,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Exposure during pregnancy Eye movement disorder Facial paralysis Hemiplegia Laboratory test normal Pain in extremity SARS-CoV-2 test negative

Symptomtext

I had a sore arm for a couple of days after the vaccine. I was 7 months pregnant at the time of the vaccine and I was due in June. I had to go to the emergency room on 08/08/2022 because I woke up with left side paralysis on my face. At the emergency room they ordered blood work, tested for COVID-19, checked if I was having a stroke and checked if I had any feeling or moved in the left side of my face. I had difficulty closing my left eye and my smile was not correct. I was prescribed an antiviral medicine and a steroid and sent home. As of today, I am improving with closing my eye but it's still not correct.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: COVID-19 test was negative; Stroke was negative; blood work was within normal range.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Prenatal Vitamins; Omeprazole
Allergien: None
Vorherige Impfungen: -

VAERS 2427598

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: MI
Alter: 84,0
Geschlecht: M
Eingang: 02.09.2022
Impfdatum: 11.04.2022
Beginn: 26.08.2022
Tage bis Beginn: 137,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Cardiac amyloidosis Cardiogenic shock Central venous catheterisation Condition aggravated Dizziness Dyspnoea Dyspnoea exertional Feeling abnormal Heart rate increased Magnetic resonance imaging heart Oedema peripheral Scan

Symptomtext

Admission Date: 8/26/2022 Discharge Date: 08/31/2022 Presenting Problem: Cardiogenic shock (HCC) HOSPITAL COURSE: Patient is an 84 year old male with PMH of chronic diastolic heart failure, cardiac amyloid TTR, persistent Afib on ASA only 2/2 hx rectal bleeding, CAD s/p CABG and LAA excision 3/2021, pulmonary sarcoidosis, hypertension, hyperlipidemia, orthostatic hypotension, OSA on CPAP, CKD 3b, thoracic aortic aneurysm, and venous insufficiency. He was hospitalized July 2022 with SOB and LE edema, ultimately diagnosed with cardiac amyloid based on CMR and PYP scan. He does have hx of Afib but has LAA ligation and with hx of GIB, he was not discharged on DOAC. He was discharged with torsemide, BB, spiro and since been started on tafamidis in the clinic. Patient saw Dr. as follow up on 8/25 and reported feeling miserable for the last month; DOE, SOB, lightheaded, dizzy. He was scheduled for urgent RHC to assess hemodynamics. RHC on 8/26 showed low filling pressures but cardiogenic shock (RA 8, PA 50/14/24, W 14, FCI 1.2, wt 94.7 kg) and he was subsequently admitted for optimization. He was started on milrinone 0.2. He remained in Afib with elevated HRs, but given exteremly low FCI, his BB dose was reduced and then discontinued. Typically digoxin is contraindicated in patients with amyloid, but discussed with AHF providers, some clinical success with low dose digoxin so he was started on digoxin. Also, given Afib and amyloidosis, it was recommended that he start OAC; he was started on low dose eliquis 2.5mg bid. If rectal bleeding recurs, can discuss stopping OAC again. Prior to discharge, RUE PICC line was placed for home milrinone. Palliative care saw patient this admission, patient aware of condition and prognosis long term, and would like Hospice to call him next week to set up an informational meeting once patient is home. Patient stable for discharge on IV milrinone at 0.2 mcg/kg/min on 8/31/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiogenic shock
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic diastolic heart failure (HCC) COVID Pulmonary sarcoidosis (HCC) Coronary artery disease involving coronary bypass graft of native heart without angina pectoris Dyslipidemia Stage 3b chronic kidney disease (HCC) Cardiac amyloidosis (HCC) Persistent atrial fibrillation (HCC) OSA on CPAP Other chest pain Cardiogenic shock (HCC) Multiple comorbid conditions Counseling regarding advance care planning and goals of care
Andere Medikamente: acetaminophen (TYLENOL) 650 MG suppository Albuterol Sulfate, sensor, (PROAIR DIGIHALER) 108 (90 Base) MCG/ACT AEPB apixaban (ELIQUIS) 2.5 MG tablet apixaban (ELIQUIS) 2.5 MG tablet atorvastatin (LIPITOR) 40 MG tablet atorvastatin (LIPITOR)
Allergien: AdhesiveRash MorphineRash
Vorherige Impfungen: -

VAERS 2309870

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: PA
Alter: 52,0
Geschlecht: F
Eingang: 04.06.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Burning sensation Condition aggravated Dizziness Fatigue Feeling abnormal Headache Seizure

Symptomtext

Patient began feeling a burning from the Inside out like she was on fire around 6pm on 5/25/22. Then she was light headed and had a headache. At about 10:30pm, she started to have seizures. Pt already had a seizure disorder. She felt tired and drained the next day. No treatment was done. She did talk to Dr. on 6/3/22. The dr said to not get another booster until she speak with him. She didn't have these reactions to the first two.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2633943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: FL
Alter: 19,0
Geschlecht: M
Eingang: 02.06.2022
Impfdatum: 27.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Dyspnoea Headache Pericarditis

Symptomtext

Chest pain, shortness of breath headache, developed into pericarditis treated with non-steroidal oral medication X 5 days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: exam, vitals 4/27/22 4/29/22
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2243678

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: MA
Alter: 67,0
Geschlecht: F
Eingang: 20.04.2022
Impfdatum: 13.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Injection site pain Seizure

Symptomtext

Site: Pain at Injection Site-Mild, Systemic: seizure-Mild, Systemic: Seizure-Mild, Additional Details: she called on april 17, stating she had no history of seizures and had a seizure the day following her 2nd booster of moderna and went to the hospital she is home recovering now

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2225950

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: NJ
Alter: 79,0
Geschlecht: F
Eingang: 11.04.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: ID / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Chest X-ray Computerised tomogram head Head injury Pruritus Syncope Urticaria

Symptomtext

As per vaccine recipient: Became itchy during night of 04/07/2022. Woke up with hives. 04/08/2022: Consulted with cardiologist as had previous appointment. Prescribed steroid. Upon returned home, took steroid. Vomiting and diarrhea immediately after taking. Approx. 30 mins following, fainted and hit head. Called 911 and taken to hospital. CXR, Ct Scan. Given IV steroid. 04/10/2022: Released from hospital. Continuing on steroid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 2,0
Labordaten: As per vaccine recipient: CXR, Ct Scan head. Was not sure of additional tests.
Aktuelle Erkrankungen: -
Vorgeschichte: Low white blood cell count x 50 years High Blood Pressure Atrial fibrillation resolved with ablation ( 2007)
Andere Medikamente: Pravastatin, Metoprolol, baby aspirin x 2
Allergien: Vancomycin, Keflex
Vorherige Impfungen: -

VAERS 2207121

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: OH
Alter: 65,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 27.03.2022
Beginn: 28.03.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Chest X-ray normal Computerised tomogram normal Contusion Dizziness Electrocardiogram normal Eye injury Fall Head injury Headache Syncope

Symptomtext

I felt dizzy and sat down on a stool. I was in the company of someone. I was told I then fainted. I hit my head on a wood piece of equipment and the floor. I went to the ER. They did a CT head and cervical scan, chest x ray, EEG and blood work. I received a tetanus shot. Everything was ok. I needed glue on one of the cuts. My eye and forehead have cuts and bruises. I continue to have a headache 2 days later.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: CT head and cervical scan, chest x ray, EKG and blood work all normal 3/28/22 Vasovagal syncope
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Alendronate
Allergien: none
Vorherige Impfungen: -

VAERS 2198876

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: NY
Alter: 51,0
Geschlecht: F
Eingang: 25.03.2022
Impfdatum: 24.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dysphagia Head injury Loss of consciousness Migraine Nausea Pain Pyrexia Tremor

Symptomtext

Woke up at 1am very nauseous, had a fever, chills and was shaking really bad. Could barely swallow. I got up to get a drink and passed out on the floor hitting my head. When I came to went into my bed shaking and the next day had a migraine and my whole body was sore.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Nothing yet, just happened yesterday
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Synthroid 112, and Lexapro 10mg
Allergien: None
Vorherige Impfungen: -

VAERS 2178290

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: NJ
Alter: 66,0
Geschlecht: M
Eingang: 14.03.2022
Impfdatum: 21.02.2022
Beginn: 21.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Dehydration Diarrhoea Dizziness Loss of consciousness Pyrexia Stool analysis Vomiting

Symptomtext

I had chills, fever, diarrhea, and vomiting the evening of vaccine. I felt dizzy and kind of faint. 2 to 3 days later I passed out twice. Wife called ambulance. They checked my vitals and check with my doctor. Next day I went in to see my doctor. My doctors checked my vitals, and I was given IV due to dehydration. I began to feel better after giving IV.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Stool Sample
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Telmisartan 80 mg, Bystolic 20 mg, Chlorthalidone, Travopost, Vitamin D, Preservation, Apple Cider Vinegar
Allergien: None
Vorherige Impfungen: -

VAERS 2126423

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: CA
Alter: 19,0
Geschlecht: F
Eingang: 19.02.2022
Impfdatum: 16.02.2022
Beginn: 16.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure

Symptomtext

Systemic: Seizure-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2122776

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: SC
Alter: 24,0
Geschlecht: M
Eingang: 18.02.2022
Impfdatum: 17.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Flushing Hyperhidrosis Paraesthesia Seizure Visual impairment

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Seizure-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Visual Changes/Disturbances-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2110847

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: KY
Alter: 20,0
Geschlecht: F
Eingang: 14.02.2022
Impfdatum: 10.02.2022
Beginn: 11.02.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Contusion Disturbance in attention Dyspnoea Ear pain Emotional disorder Face injury Fatigue Fear Headache Joint injury Loss of consciousness Malaise Nausea Ocular discomfort Pain Pain in extremity Tremor

Symptomtext

Friday, the day after, I woke up at 6:00am experiencing severe head pain, eye pressure, ear ache, full body ache, fatigue, sore arm. Applied cold wash cloth to forehead for about thirty minutes, took a Tylenol, and eat some yogurt at about 7:45 am. Went to class, felt okay, pain was not severe due to pain medication. Then, at 9:50am I started feeling un-well, shortness of breath, loss of concentration, nausea. Then, blacked-out, hit the floor face-down, bruised knee, broke glasses. Unsure of how long I was out...not long though. Woke up shaking, was lucid after and able to answer questions, scared and emotional. Ambulance called, examined by EMTs, spent the rest of the day in bed at dorm, head and body pain continued throughout Friday treated with ibuprofen. Saturday, woke up feeling good, minimal pain, minor headache...feel good now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: No tests. Check up at Health Services Monday Morning at 7:40am.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2109382

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: CA
Alter: 20,0
Geschlecht: M
Eingang: 12.02.2022
Impfdatum: 12.02.2022
Beginn: 12.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Pallor

Symptomtext

Pt was asked to sit for 15 minutes to observes, after about 5 minutes of sitting down pt walked to the cashier to get the drink and he passed out for about 30 seconds.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Pt's temp was measured at the time of vaccination was 98.5F, his blood pressure was measured after passing out was 101; 80 ; 76 pt was pale, alert and thirsty. pt reported that this is his second time passed out when he had the vaccine. Pt reported that he first passed out with the first vaccine on 09/15/2021
Aktuelle Erkrankungen: asthma
Vorgeschichte: asthma
Andere Medikamente: no taking any OTC
Allergien: NKA
Vorherige Impfungen: had the first pass out on his first vaccine also on 09/15/2021

VAERS 1374282

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

schwer

Staat: CA
Alter: 23,0
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: 21.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aneurysm Arthralgia Fatigue Feeling cold Neck pain Pain in extremity Swelling Thrombosis Vaccination complication

Symptomtext

The vaccine is affecting young people; My son felt like he had an aneurysm in his neck/He had pain in the large artery on the right side of his neck like a myocardial inflammation or something; The right side of his neck, between the shoulder and neck, on the inside, he felt swelling, pressure pain, dull pain that comes and goes; On Tuesday, on the right side of his neck, between the shoulder and neck, on the inside, he felt swelling, pressure pain, dull pain that comes and goes; shoulder pain; On Saturday night he was feeling tired and cold; feeling cold; On Saturday his legs were very heavy and had pain, like he had blood clots or thrombosis in his veins; On Saturday his legs were very heavy and had pain; This spontaneous case was reported by a patient and describes the occurrence of THROMBOSIS (On Saturday his legs were very heavy and had pain, like he had blood clots or thrombosis in his veins) and ANEURYSM (My son felt like he had an aneurysm in his neck/He had pain in the large artery on the right side of his neck like a myocardial inflammation or something) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included BUPROPION HYDROCHLORIDE (ZYBAN) for an unknown indication. On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced THROMBOSIS (On Saturday his legs were very heavy and had pain, like he had blood clots or thrombosis in his veins) (seriousness criterion medically significant), PAIN IN EXTREMITY (On Saturday his legs were very heavy and had pain), FEELING COLD (feeling cold) and FATIGUE (On Saturday night he was feeling tired and cold). On 25-May-2021, the patient experienced ANEURYSM (My son felt like he had an aneurysm in his neck/He had pain in the large artery on the right side of his neck like a myocardial inflammation or something) (seriousness criterion medically significant), NECK PAIN (The right side of his neck, between the shoulder and neck, on the inside, he felt swelling, pressure pain, dull pain that comes and goes), SWELLING (On Tuesday, on the right side of his neck, between the shoulder and neck, on the inside, he felt swelling, pressure pain, dull pain that comes and goes) and ARTHRALGIA (shoulder pain). On an unknown date, the patient experienced VACCINATION COMPLICATION (The vaccine is affecting young people). At the time of the report, THROMBOSIS (On Saturday his legs were very heavy and had pain, like he had blood clots or thrombosis in his veins), ANEURYSM (My son felt like he had an aneurysm in his neck/He had pain in the large artery on the right side of his neck like a myocardial inflammation or something), VACCINATION COMPLICATION (The vaccine is affecting young people), PAIN IN EXTREMITY (On Saturday his legs were very heavy and had pain), NECK PAIN (The right side of his neck, between the shoulder and neck, on the inside, he felt swelling, pressure pain, dull pain that comes and goes), SWELLING (On Tuesday, on the right side of his neck, between the shoulder and neck, on the inside, he felt swelling, pressure pain, dull pain that comes and goes), FEELING COLD (feeling cold), ARTHRALGIA (shoulder pain) and FATIGUE (On Saturday night he was feeling tired and cold) outcome was unknown. No treatment information was provided. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-182543 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: ZYBAN
Allergien: -
Vorherige Impfungen: -

VAERS 2722202

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 60,0
Geschlecht: M
Eingang: 08.12.2023
Impfdatum: 01.03.2022
Beginn: 29.11.2023
Tage bis Beginn: 638,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea Lethargy Pyrexia

Symptomtext

Admit date: 11/29/2023 Discharge date: 12/03/2023 Admitting Physician: MD Attending Physician at the Time of Discharge: MD Primary Care Physician: NP Reason for Admission: SOB 61 YO male with a past medical history of severe intracranial bleed and TBI 1985, HTN, HLD, and depression that lives at AFC with complaints of lethargy, fever and dyspnea. Patient was recently diagnosed with COVID-19. Per EMS report, patient was noted to have SpO2 80% on RA and was placed on 2L nasal canula . Discharged to home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650299

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 28.06.2023
Impfdatum: 04.05.2022
Beginn: 25.06.2023
Tage bis Beginn: 417,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cardiac telemetry normal Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Full blood count Hypoxia Infection Laboratory test abnormal Leukocytosis Lymphocyte count increased Neutrophil count increased Pneumonia bacterial Positive airway pressure therapy Productive cough Respiratory disorder Respiratory viral panel

Symptomtext

Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "Patient is a 68YO female with past medical history of COPD, HTN, DM2 who presented to the hospital from AFC on 6/25/23 with worsening cough, shortness of breath, and wheezing for few days prior to admission. Patient required frequent use of her rescue inhaler which made her concerned. Patient reports multiple individuals at AFC were diagnosed with COVID-19. Symptoms upon presentation included productive cough of clear-yellow sputum and shortness of breath. She denied fever, chills, weakness, abdominal pain, N/V/D/C. Patient received DuoNebs and Solu-medrol prior to arrival in the ED by EMS. ED work-up was remarkable for hypoxia and tachycardia. Labs were notable for leukocytosis with elevated neutrophils, lymphocytes. RVP was positive for COVID-19. Patient was placed on BiPAP due to respiratory status and eventually weaned off prior to admission. Patient was admitted for presumed COPD exacerbation in the setting of COVID-19. Patient's hospitalization was unremarkable, she was initially started on Azithromycin and Rocephin for presumed underlying superimposed bacterial pneumonia. Chest XR findings were unremarkable so Rocephin was discontinued prior to discharge. Patient completed a 3-day course of Azithromycin for COPD exacerbation. Patient was also weaned down on oxygen to 0.5-1L to maintain SpO2 88-94%. Patient was on telemetry for hx of paroxysmal Afib with normal rate. Given that patient uses 2L NC SpO2 at baseline, she did not require a walk test prior to discharge. However, patient was encouraged to decrease her home O2 to none at rest and 0.5-1L with exertion. The patient's leukocyte count remained elevated, presumed reactive from her current infection and COPD exacerbation; however, it was recommended that patient repeat a CBC in 1 month, and if abnormal, follow-up with Hematology. Patient was discharged back to AFC (Home) in stable condition with recommendations to continue Prednisone for 2 additional days"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: COVID detected PCR 6/25/23
Aktuelle Erkrankungen: -
Vorgeschichte: Osteoporosis Alcohol abuse, in remission Paroxysmal atrial fibrillation (Chronic) COPD (chronic obstructive pulmonary disease) (Chronic) Liver cirrhosis, alcoholic Mixed hyperlipidemia Pulmonary nodule Dementia associated with alcoholism (Chronic) Encounter for long-term (current) use of medications Type 2 diabetes mellitus with diabetic dermatitis, without long-term current use of insulin Essential hypertension Mild protein-calorie malnutrition History of alcohol dependence Cigarette nicotine dependence in remission
Andere Medikamente: -
Allergien: Bee Stings [insect Stings]
Vorherige Impfungen: -

VAERS 2650299

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 28.06.2023
Impfdatum: 04.05.2022
Beginn: 25.06.2023
Tage bis Beginn: 417,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cardiac telemetry normal Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Full blood count Hypoxia Infection Laboratory test abnormal Leukocytosis Lymphocyte count increased Neutrophil count increased Pneumonia bacterial Positive airway pressure therapy Productive cough Respiratory disorder Respiratory viral panel

Symptomtext

Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "Patient is a 68YO female with past medical history of COPD, HTN, DM2 who presented to the hospital from AFC on 6/25/23 with worsening cough, shortness of breath, and wheezing for few days prior to admission. Patient required frequent use of her rescue inhaler which made her concerned. Patient reports multiple individuals at AFC were diagnosed with COVID-19. Symptoms upon presentation included productive cough of clear-yellow sputum and shortness of breath. She denied fever, chills, weakness, abdominal pain, N/V/D/C. Patient received DuoNebs and Solu-medrol prior to arrival in the ED by EMS. ED work-up was remarkable for hypoxia and tachycardia. Labs were notable for leukocytosis with elevated neutrophils, lymphocytes. RVP was positive for COVID-19. Patient was placed on BiPAP due to respiratory status and eventually weaned off prior to admission. Patient was admitted for presumed COPD exacerbation in the setting of COVID-19. Patient's hospitalization was unremarkable, she was initially started on Azithromycin and Rocephin for presumed underlying superimposed bacterial pneumonia. Chest XR findings were unremarkable so Rocephin was discontinued prior to discharge. Patient completed a 3-day course of Azithromycin for COPD exacerbation. Patient was also weaned down on oxygen to 0.5-1L to maintain SpO2 88-94%. Patient was on telemetry for hx of paroxysmal Afib with normal rate. Given that patient uses 2L NC SpO2 at baseline, she did not require a walk test prior to discharge. However, patient was encouraged to decrease her home O2 to none at rest and 0.5-1L with exertion. The patient's leukocyte count remained elevated, presumed reactive from her current infection and COPD exacerbation; however, it was recommended that patient repeat a CBC in 1 month, and if abnormal, follow-up with Hematology. Patient was discharged back to AFC (Home) in stable condition with recommendations to continue Prednisone for 2 additional days"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: COVID detected PCR 6/25/23
Aktuelle Erkrankungen: -
Vorgeschichte: Osteoporosis Alcohol abuse, in remission Paroxysmal atrial fibrillation (Chronic) COPD (chronic obstructive pulmonary disease) (Chronic) Liver cirrhosis, alcoholic Mixed hyperlipidemia Pulmonary nodule Dementia associated with alcoholism (Chronic) Encounter for long-term (current) use of medications Type 2 diabetes mellitus with diabetic dermatitis, without long-term current use of insulin Essential hypertension Mild protein-calorie malnutrition History of alcohol dependence Cigarette nicotine dependence in remission
Andere Medikamente: -
Allergien: Bee Stings [insect Stings]
Vorherige Impfungen: -

VAERS 2650299

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 28.06.2023
Impfdatum: 04.05.2022
Beginn: 25.06.2023
Tage bis Beginn: 417,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cardiac telemetry normal Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Full blood count Hypoxia Infection Laboratory test abnormal Leukocytosis Lymphocyte count increased Neutrophil count increased Pneumonia bacterial Positive airway pressure therapy Productive cough Respiratory disorder Respiratory viral panel

Symptomtext

Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "Patient is a 68YO female with past medical history of COPD, HTN, DM2 who presented to the hospital from AFC on 6/25/23 with worsening cough, shortness of breath, and wheezing for few days prior to admission. Patient required frequent use of her rescue inhaler which made her concerned. Patient reports multiple individuals at AFC were diagnosed with COVID-19. Symptoms upon presentation included productive cough of clear-yellow sputum and shortness of breath. She denied fever, chills, weakness, abdominal pain, N/V/D/C. Patient received DuoNebs and Solu-medrol prior to arrival in the ED by EMS. ED work-up was remarkable for hypoxia and tachycardia. Labs were notable for leukocytosis with elevated neutrophils, lymphocytes. RVP was positive for COVID-19. Patient was placed on BiPAP due to respiratory status and eventually weaned off prior to admission. Patient was admitted for presumed COPD exacerbation in the setting of COVID-19. Patient's hospitalization was unremarkable, she was initially started on Azithromycin and Rocephin for presumed underlying superimposed bacterial pneumonia. Chest XR findings were unremarkable so Rocephin was discontinued prior to discharge. Patient completed a 3-day course of Azithromycin for COPD exacerbation. Patient was also weaned down on oxygen to 0.5-1L to maintain SpO2 88-94%. Patient was on telemetry for hx of paroxysmal Afib with normal rate. Given that patient uses 2L NC SpO2 at baseline, she did not require a walk test prior to discharge. However, patient was encouraged to decrease her home O2 to none at rest and 0.5-1L with exertion. The patient's leukocyte count remained elevated, presumed reactive from her current infection and COPD exacerbation; however, it was recommended that patient repeat a CBC in 1 month, and if abnormal, follow-up with Hematology. Patient was discharged back to AFC (Home) in stable condition with recommendations to continue Prednisone for 2 additional days"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: COVID detected PCR 6/25/23
Aktuelle Erkrankungen: -
Vorgeschichte: Osteoporosis Alcohol abuse, in remission Paroxysmal atrial fibrillation (Chronic) COPD (chronic obstructive pulmonary disease) (Chronic) Liver cirrhosis, alcoholic Mixed hyperlipidemia Pulmonary nodule Dementia associated with alcoholism (Chronic) Encounter for long-term (current) use of medications Type 2 diabetes mellitus with diabetic dermatitis, without long-term current use of insulin Essential hypertension Mild protein-calorie malnutrition History of alcohol dependence Cigarette nicotine dependence in remission
Andere Medikamente: -
Allergien: Bee Stings [insect Stings]
Vorherige Impfungen: -

VAERS 2640247

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: -
Alter: 90,0
Geschlecht: M
Eingang: 02.06.2023
Impfdatum: 25.04.2022
Beginn: 28.01.2023
Tage bis Beginn: 278,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Hyponatraemia Hypotension

Symptomtext

I95.9 HYPOTENSION 9/1/2022 ANEMIA I95.9 HYPOTENSION 9/1/2022 HYPONATREMIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2631043

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 12.05.2023
Impfdatum: 20.04.2022
Beginn: 11.06.2022
Tage bis Beginn: 52,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension Symptom recurrence

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION 6/19/2022 & 7/6/2022 -- RECURRENCE OF SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2631041

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 12.05.2023
Impfdatum: 20.04.2022
Beginn: 26.10.2022
Tage bis Beginn: 189,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension Symptom recurrence

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION 3/18/2023 -- RECURRENCE OF SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2631032

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 12.05.2023
Impfdatum: 20.04.2022
Beginn: 04.07.2022
Tage bis Beginn: 75,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension Symptom recurrence

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION 7/29/2022, 8/12/2022, 9/30/2022, 1/8/2023 -- RECURRENCE OF SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2609086

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: VA
Alter: 70,0
Geschlecht: F
Eingang: 04.04.2023
Impfdatum: 01.04.2022
Beginn: 02.08.2022
Tage bis Beginn: 123,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest pain Condition aggravated Echocardiogram abnormal Malaise Muscle spasms Pericardial effusion Pleural effusion

Symptomtext

I experienced COVID-19 on 08/02/2022 and was sick for a week. I had first symptoms of COVID. I saw the cardiologist who ordered an echocardiogram on 12/01/2022. The echocardiogram showed pleural effusion. It also showed pericardio effusion. I do not know what caused the pleural effusions. I had severe pain in my chest, right under my breast bone during COVID. It felt like spasms in the center of my chest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 01DEC2022 Echocardiogram - Pleural Effusion
Aktuelle Erkrankungen: None
Vorgeschichte: Pericardio Effusion; Ehlers-Danlos Syndrome; History of Thyroid Cancer
Andere Medikamente: None
Allergien: Aspirin; Bactrim; Microbarom; Iridium; Visc Eye Drops; Besivance Eye Drops; Benadryl Cream, Adhesive Tape
Vorherige Impfungen: -

VAERS 2562307

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NY
Alter: 61,0
Geschlecht: M
Eingang: 18.01.2023
Impfdatum: 20.01.2022
Beginn: 28.01.2022
Tage bis Beginn: 8,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Ageusia Alopecia Anosmia Anxiety Catatonia Chest discomfort Cognitive disorder Communication disorder Computerised tomogram Delirium Depression Disability Disturbance in attention Electroconvulsive therapy Electroencephalogram normal Erectile dysfunction Erythema Gait inability

Symptomtext

62 yr. old male ? took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax. J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff. At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days. Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax. In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety. NO prior family or personal history of mental health. 4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium. Noted as a possible drug withdrawal from previous visit. Took off controlled substances too quickly. Diagnosed with catatonia, severe depression and anxiety. 5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions. Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so. Continued therapist and psych Dr appointments to this day. 8/2022 consult with Neurological Institute. Had MRI and EEG ? both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much. Patient is currently on LTD from his job as of Sept 27/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: 60,0
Labordaten: BRAIN MRI 3/29/22 BRAIN MRI and EEG 09/2022 CAT SCANS 05/2022
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: LATEX
Vorherige Impfungen: -

VAERS 2453402

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: OH
Alter: 51,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 18.02.2022
Beginn: 06.09.2022
Tage bis Beginn: 200,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Blood creatinine increased Blood sodium decreased Blood urea increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic kidney disease Computerised tomogram thorax abnormal Cough Diarrhoea Dyspnoea Echocardiogram normal End stage renal disease Haemoglobin decreased Hyperlipidaemia Hypertension Hyponatraemia

Symptomtext

Patient is a 51 y.o. female with history of renal transplant (on immunosuppressants) and current COVID-19 infection who presented from home on 9/6/2022 with worsening dyspnea and cough, along with worsening renal function. Nephrology and ID involved with care. Fevers COVID-19 pneumonia Patient overall feeling improved, symptoms are resolving. Initially presented with worsening cough, dyspnea, fevers, diarrhea in the setting of COVID-19; tested positive 8/24 on home rapid test. Symptom onset ~8/19-8/20. CXR at COPC 9/2 suggestive of CHF, indeterminate pulmonary nodules within R lung; CXR in ED with diminished lung volumes and crowding of vasculature, faint opacity in R mid to lower lung zone; CT chest with patchy ground glass opacities likely consistent with COVID / viral pneumonitis - pt fully vaccinated and boosted x 2; had Evushield in March 2022; could not get MAB and not a candidate for Paxlovid. Monoclonal antibodies given during this hospitalization - TTE obtained, no evidence of overt volume overload -will continue isolation in the hospital and continue CDC guidelines in the outpatient setting. We discussed ongoing isolation and mask wearing in the home setting given her recent fever. - ID consulted for guidance on further infectious work-up, appreciate recommendations AKI on CKD 4 Hypovolemia, hyponatremia History of kidney transplant History of metabolic acidosis With history of membranous nephropathy. S/p deceased donor transplant 6/1999 at OSU; functioned until 2011; then s/p cadaveric kidney transplant 3/30/2016 (second transplant); 11/30/20 transplant kidney biopsy with evidence of acute on chronic rejection with transplant glomerulopathy - sCr 2.78 and Na 134 on admit 9/6; improved compared to COPC labs 9/2 which showed sCr 3.1, BUN 56 - baseline sCr ~2.1?2.3 - continue home immunosuppression regimen -Close to patient follow-up with her nephrologist in outpatient setting for recheck of renal function this upcoming week. History of nonischemic CMP Elevated troponin No evidence of overt volume overload on exam. Recovered EF; secondary to ESRD per OP notes. Ongoing care in the outpatient setting Hypertension Home beta-blocker dose increased. Pancytopenia History of anemia of CKD Hemoglobin 9.2, WBC 4.05, platelets 118 on admission 9/6. COPC labs 9/2 with Hgb 9.2, WBC 4.4, PLT 117. ESA per nephrology, started 4/2021, goal hemoglobin 10?11. Noted history of neutropenia due to higher dose Myfortic, resolved with reduction and use of steroids -Continue to follow counts in the outpatient setting Hyperlipidemia Resume statin therapy on discharge

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: history of renal transplant s/p Evusheld March 2022
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2446344

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: OH
Alter: 61,0
Geschlecht: M
Eingang: 15.09.2022
Impfdatum: 09.03.2022
Beginn: 16.06.2022
Tage bis Beginn: 99,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest pain Cough Dysphagia Fatigue Hypersomnia Impaired work ability Influenza like illness Oropharyngeal pain Pyrexia SARS-CoV-2 test positive Sudden onset of sleep

Symptomtext

I started getting a sore throat. I was at a major conference when I began having problems swallowing and my throat hurt. It just hit me like a brick. I was going to spend another night, but I decided to head home that day. I started feeling extremely run down and had a cough. I pulled off the highway at around 09:00PM to a rest stop. I happened to have some COVID-19 tests with me so I took two and they were both positive. I called my workplace to inform them of my positive results so that they could tell others who had been with me. I then continued driving home and returned home at around 11PM. I had a fever, chest pain, cough. I felt like I had the flu. I called my doctor in the morning. I am on Stelara which lowers your immune system, so my doctor arraigned for me to receive a monoclonal antibody infusion on 06/18/2022. They told me it would take around 48 hours for me to feel the effects. It took less than 24 hours for me to feel significantly better. For the next 2 days, I felt exhausted but better. I continued to feel fatigued and slept a lot for the following 5-6 weeks. I could work, but not a whole day. I would fall asleep in the middle of the day for about a month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: COVID-19 test-positive
Aktuelle Erkrankungen: -
Vorgeschichte: Psoriatic Arthritis
Andere Medikamente: Metformin; Naproxen Sodium; Atorvastatin; Amlodipine; Bystolic; Baby Aspirin; Velia; Amlodipine Desolate; Nexium; Zinc; Fish Oil; Flax Oil; Stelara
Allergien: Penicillin; Ultram; Thimerosal
Vorherige Impfungen: Flu like responses to Flu vaccines with Thimerosal

VAERS 2433434

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 24.02.2021
Beginn: 15.08.2022
Tage bis Beginn: 537,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest discomfort Dyspnoea Inflammatory marker test Malaise Pain Palpitations Productive cough Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

58y.o. female developed symptoms 3 days prior to presentation, felt unwell, developed chest pressure, fever, congestion, runny nose, body aches, productive cough, shortness of breath, mild palpitations. Initial home covid test was negative. Then repeated 2 days later, showed positive. Vaccinated and boosted. Last in July 2022. Covid 19. Patient was at high risk due to immunosuppressants post renal transplant and diabetes. She was stable, no hypoxia. Inflammatory markers were monitored. She was started Remdesivir for 3 days. All other medical issues were managed as prior to hospital stay.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 1,0
Labordaten: 8/15 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2401448

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NJ
Alter: 75,0
Geschlecht: M
Eingang: 04.08.2022
Impfdatum: 02.02.2022
Beginn: 02.07.2022
Tage bis Beginn: 150,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bone pain COVID-19 Chest discomfort Chills Dyspnoea Fatigue Feeling cold Pyrexia SARS-CoV-2 test positive

Symptomtext

On Saturday he said his bones ached all over. He had chills and was freezing. He did not have a temperature. On Sunday he tested positive for COVID-19 on July 2, 2022. His doctor prescribed Paxlovid. He also took a ZPack, Prednisone, for his lungs. Another symptom was that he was very tight chest and it was hard to get air out. He felt about the same for a week. He then took the second pack of Prednisone. As of today he is still exhausted with fatigue. We have a Pulse Ox machine and it was always normal and never ran a fever. After 5 days of Paxlovid her still tested positive. It took two weeks for him to test negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Home COVID-19 test, 02JUL2022, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD; Emphysema; Sleep Apnea; Type 2 Diabetes; Thyroid Issues
Andere Medikamente: Spiriva; Advair; Combiventrestimate; Lasix; Potassium; Mucinex; Percocet; Byetta; Losartan; Crestor; Synthroid; Jardiance; Multi Vitamin; Vitamin D; Probiotic; Vitamin C; Collagen
Allergien: N/A
Vorherige Impfungen: -

VAERS 2390964

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: IN
Alter: 68,0
Geschlecht: F
Eingang: 26.07.2022
Impfdatum: 25.04.2022
Beginn: 17.07.2022
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia Aphonia COVID-19 Decreased appetite Diarrhoea Discharge Dysphonia Dyspnoea Fatigue Headache Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I started getting symptoms of hoarseness and lost my voice. I had lots of drainage and congested. I had diarrhea and headaches. I thought it was a sinus infection. I was in another state and got back. I could not breath good, then I developed a fever. I went to my doctor and took a COVID-19 test that was positive. I was prescribed PAXLOVID for 5 days. I did feel better and was functioning. I still feel tired, fatigued, and some congestion. I did also lose my taste or smell so I lost my appetite. I am eating better today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID-19 test - positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: N/A
Allergien: None
Vorherige Impfungen: -

VAERS 2366498

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NY
Alter: 73,0
Geschlecht: M
Eingang: 12.07.2022
Impfdatum: 08.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test COVID-19 Cardiac stress test Computerised tomogram Dizziness Electrocardiogram Malaise Nausea Ventricular tachycardia

Symptomtext

I felt light headedness, some mild nausea and I had been diagnosed with ventricular tachycardia. I am also at the tale end of covid. The symptoms sometimes last for about 20 minutes some last for a couple hours. I am still experiencing these symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ventricular tachycardia
Hospital-Tage: -
Labordaten: EKG; CAT scan; Stress test; Full panel blood work
Aktuelle Erkrankungen: none
Vorgeschichte: Stage 3 renal disease
Andere Medikamente: Allipurinol
Allergien: Inseds; Seasonal allergies
Vorherige Impfungen: -

VAERS 2364437

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 11.07.2022
Impfdatum: 10.04.2022
Beginn: 29.06.2022
Tage bis Beginn: 80,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Cough Dizziness Exposure to SARS-CoV-2 Fatigue Feeling abnormal Headache Malaise Mobility decreased Nausea Oropharyngeal discomfort Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I received my second Moderna booster for COVID-19 on 4/10/2022. On the evening of 6/29/2022, I ran a fever. I sort of thought it was a hot flash, but since it lasted for 6 hours, I eventually realized that wasn't the case. On the morning of the 6/30/2022, the fever was gone, but I had a pressure headache in the back of my head. I felt off, but I didn't know if it was just because of the headache. On 7/1/2022, I started to get a ticklish sensation in the back of my throat; I thought it might be allergies and that the sensation was caused by drainage. On either 7/1/2022 or 7/2/2022, I started to feel lightheaded and nauseous. It wasn't severe, but I would just get little waves of queasiness. This lasted until 7/4/2022 or 7/5/2022. At the time of this writing, I still occasionally get that sensation if I'm exerting myself too much, but it's not nearly as bad as it was before. I developed a dry cough on 7/1/2022, and it just gradually intensified. It was so frequent that I could barely finish a sentence or catch a breath without coughing. My throat also became raw and sore as a result of the coughing. At the time of this writing, the cough continues, but it's not as severe as it was before. It's annoying, but tolerable. I took a home test for COVID-19 on 6/30/2022, and the result was negative. I took a home test every day for 9 days straight; the result was negative for 7 days in a row. However on 7/7/2022 and 7/8/2022, the result was positive. On the 7/5/2022, I had had a virtual visit with my doctor after my husband had tested positive for COVID-19. Even though I hadn't yet at that point gotten a positive test result, the doctor gave me a 5-day supply of PAXLOVID, Z-PAK, and cough syrup with codeine. The doctor decided to give me the Z-PAK, because I had developed a fever for the second time on 7/4/2022, and he was concerned that I might have developed a secondary respiratory infection. I began taking the medicine on the evening of 7/5/2022. I was still pretty sick at that point; I still had a nagging cough and extreme fatigue. However, on 7/7/2022, I began to feel that my condition was improving. On that day, I felt slightly more energetic and less fatigued. I was able to get a little bit of housework done. My cough also seemed to improve. I still have fatigue at the time of this writing, though it is gradually diminishing. Sometimes simple tasks like showering and putting in laundry will take too much out of me, and I will have to rest for a while afterwards, but my ability to get things done is slowly but surely improving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: 6/30/2022, 7/1/2022, 7/2/2022, 7/3/2022, 7/4/2022, 7/5/2022, 7/6/2022- home COVID-19 test results negative. 7/7/2022, 7/8/2022, home COVID-19 test results positive.
Aktuelle Erkrankungen: None.
Vorgeschichte: Celiac Disease; vitamin B12 Deficiency; Hypothyroidism; Hypertension.
Andere Medikamente: TIROSINT; BIEST; vitamin B12; multivitamin; vitamin D; benazepril HCTZ.
Allergien: Sulfa drugs; fluoroquinolones; penicillin; ROCEPHIN; wheat gluten; rye; barley; cross-contaminated oats.
Vorherige Impfungen: When I got my first Moderna booster for COVID-19 on 10/22/2021, I ran a fever that lasted a few days. Within the week, the lymph

VAERS 2362668

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: VT
Alter: 65,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 07.04.2022
Beginn: 19.06.2022
Tage bis Beginn: 73,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dyspnoea Malaise Myalgia Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

My symptoms began 06/19/2022. I had a low fever of around 100. I also had a nonproductive cough, muscle aches and general malaise. I tested positive with a home test on the morning of 06/21/2022. I called my doctor?s office and they called in Paxlovid. I took my first dose early afternoon of that day. My symptoms were not really bad, I had a good cough, and my fever went up to 101.3. Within 2 days I was much better, I still had the cough. I typically have long bouts of colds; I currently just have a tickle in my throat, which I feel would last for another week with my illness history. I have been able to do a few hikes that I lead without a lot of problems, slight shortness of breath and some achy muscles although these may just be within my normal range.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Home test on 06/21/2022 results are positive.
Aktuelle Erkrankungen: none
Vorgeschichte: Coronary Artery Disease; A stent put in in 2012; Chronic back pain
Andere Medikamente: Amlodipine; Losartan; Atorvastatin; Tamsulosin; Multivitamin; Iron Supplement; COQ10; Vitamin D3; Low dose aspirin; Glucosamine, MSN Joint supplement
Allergien: Seasonal environmental allergies
Vorherige Impfungen: -

VAERS 2359536

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NY
Alter: 79,0
Geschlecht: F
Eingang: 06.07.2022
Impfdatum: 02.04.2022
Beginn: 03.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered Migraine

Symptomtext

About 12 hours after my Moderna vaccination, I developed a Migraine, it was really early morning. When I get a migraine I get sick to my stomach and I take ondansetron (Zofran) for nausea and rizatriptan. The last headache in contrast to the previous 3 vaccinations, is my medications worked. The previous 3 vaccinations I also experienced migraines that were much worse and nothing worked to relieve it. I had a telehealth visit, it was a regularly scheduled visit and I spoke with my PCP about having a migraine. She told me that she had called Moderna previously (because of my previous 3 reactions) and said they hadn't included headaches or migraines in their studies but that she has gotten a lot of women who have developed migraines after Moderna vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Neurontin, Montelukast, Vitamin C, Vitamin D3, Docusate sodium
Allergien: -
Vorherige Impfungen: Previous 3 Moderna vaccinations, severe Migraines

VAERS 2357705

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: IN
Alter: 52,0
Geschlecht: F
Eingang: 05.07.2022
Impfdatum: 22.04.2022
Beginn: 23.05.2022
Tage bis Beginn: 31,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bone pain COVID-19 Chest discomfort Chills Cough Dyspnoea Eye pain Fatigue Feeling abnormal Gait disturbance Headache Hypersomnia Malaise Myalgia Ocular discomfort Pain Paranasal sinus discomfort Pyrexia

Symptomtext

On 5-20-22 i began to feel like i had a sinus infection and began mucinex, advil, gargling with salt water, and nasal saline wash. I had a negative home test for covid on 5-22. started feeling much worse: harder to breathe, coughing, sinus pressure, headache. then on 5-23-22 i started having fever and chills all night and morning on 5-24 and did a home test, which was +covid. i continued to use mucinex, advil, salt water, drinking fluids and resting. i began either throwing up or pooping out any food or water i ate. coughing got much worse and my MD refused to give me the new antiviral medication, despite me having asthma. she did prescribe me perles drops for the coughing, which helped, and a new asthma inhaler. i ached all over, every muscle and bone, and was sleeping a lot because i was so exhausted, and the other symptoms from the beginning continued. My eyes had so much pressure on them and were sore. i had trouble breathing or walking down the street a block to put in my recycling. i felt like there was something heavy sitting on my chest and it was tight. the only symptoms on the list for covid that i didnt have were the loss of taste and smell. i was sick for 3 weeks and still have a lingering cough. it wasnt until the 3rd week that i thought i might be coming out of it. (FYI: i have had both of the original moderna covid vaccines and the 2 booster vaccines.)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: negative home covid test on 5-22-22 positive home covid test on 5-24-22
Aktuelle Erkrankungen: none
Vorgeschichte: asthma, chronic pain, adhd, year round allergies, depression
Andere Medikamente: zyrtec, ritalin, advil, cymbalta, multivitamin
Allergien: lactose intolerant, vicodin
Vorherige Impfungen: -

VAERS 2341697

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: FL
Alter: 97,0
Geschlecht: F
Eingang: 29.06.2022
Impfdatum: 24.02.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Aspiration pleural cavity Asthenia Atrial fibrillation Chromaturia Condition aggravated Electrolyte imbalance Mental status changes Urinary tract infection

Symptomtext

Pt presented with altered mentalt status, dark urine and generalized weakness and electrolyte imbalance and UTI. pt was treated for afib RVR with amiodarone and lopressor. Requireda a left thoracentesis. Antibiotic used for UTI. Pt discharged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Breast Cancer, Dementia, HTN, HLD, CKD, Afib.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2336514

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: SC
Alter: 48,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 23.03.2022
Beginn: 21.06.2022
Tage bis Beginn: 90,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia COVID-19 Cough Fatigue Headache Hypersomnia Hypophagia Impaired work ability Influenza virus test negative Mobility decreased Oropharyngeal pain Pain Productive cough Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sleep disorder Sluggishness

Symptomtext

On 3/23/2022, I received my first dose of the Moderna booster for COVID-19. On 6/21/2022, I started coughing and feeling sluggish in the evening. I also developed a slight sore throat. I went to bed and woke up on 6/22/2022 with a fever of 101, coughing and with headache and severe sore throat. I called in sick to work and went back to sleep. I periodically had to wake up to take TYLENOL to break the fever and to use the toilet. The TYLENOL would help relieve the fever for a short time, but the fever would return, and I had to take more TYLENOL every 4-6 hours. I stayed in bed all day and all night. I didn't get out of bed until the morning 6/23/2022. I had a little more energy. I didn't eat much, except for a little soup and little bit of beans. I had a fever when I woke up, so I took TYLENOL and then went to urgent care. At the urgent care clinic, I was tested for strep throat, the flu, and COVID. I tested negative for strep throat and the flu, and when I got the COVID test results on 6/24/2022, they were positive. When I got home from the clinic, I camped out on the couch and then went to bed that night. I woke up coughing around 2 AM on 6/24/2022. When I got up on the morning on 6/24/2022, I got a call from urgent care telling me that I had COVID. I asked them if I was eligible to get PAXLOVID. They told me I would have to call my PCP to get a prescription. However, they did give me amoxicillin, prednisone, lidocaine, and benzonatate. I called my PCP's office and was scheduled for a virtual visit with the doctor at 11 AM that day. When we did the virtual visit, we discussed the risks and benefits of PAXLOVID. The doctor determined I would be a suitable candidate for PAXLOVID, but I would need to stop taking CRESTOR and prednisone while I was taking PAXLOVID. I got the PAXLOVID and began taking it. Within a few hours of taking it, I began to see results. I very quickly felt better. On 6/25/2022, the congestion began to loosen up and I developed a productive cough. Since then, I have continued to improve. I have been fever-free since 6/24/2022. I returned to work on 6/27/2022. At the time of this writing, I've still got a slight cough and feel weak and fatigued.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No.
Vorgeschichte: Heart failure; coronary heart disease; plantar fasciitis; cataracts in both eyes.
Andere Medikamente: Spironolactone; ZYRTEC; aspirin; TYLENOL; hair skin and nails vitamin; FARXIGA, carvedilol; lansoprazole; ZICAM; ENTRESTO; vitamin B12; PEPCID AC; LASIX; probiotic; multivitamin; CRESTOR.
Allergien: Sulfa drugs.
Vorherige Impfungen: I had body aches and fatigue for 2 days after getting my second COVID vaccine injection and my first COVID booster.

VAERS 2335782

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: KY
Alter: 21,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 25.06.2022
Beginn: 25.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Nausea Tremor

Symptomtext

Approximately 15 minutes post injection, patient complained of nausea, dizziness. Pt became very shaky BP 124/84 HR 123, RR 24 and O2 sat 97%. Pt took 2 salt tabs due to history of POTS, EMS called for evaluation. Pt taken to First Aid via stretcher for further evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: POTS Ehlers danlos syndrome Syncope
Andere Medikamente: None
Allergien: Tree nuts, flouroquinolones
Vorherige Impfungen: -

VAERS 2311744

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 027l21A

moderat

Staat: CT
Alter: 83,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 22.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 9,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Mobility decreased Pain Pain in extremity

Symptomtext

Right thigh ache. Cannot walk up stairs. Severe pain to walk up stairs. There is no strength in the right thigh to lift me to the next step.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: 06/07/2022
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Irbesartan 300mg tablets; Pravastatin 20mg tablets; low strengthen aspirin: Vitamin 3; Glucosamine (1500mg) / Chondroitin (1200mg); Centrum Men 50+. (About 04/01/2022, because of the muscle ache, I started on the following for three days
Allergien: None.
Vorherige Impfungen: -

VAERS 2292924

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: CT
Alter: 47,0
Geschlecht: F
Eingang: 24.05.2022
Impfdatum: 19.02.2022
Beginn: 18.04.2022
Tage bis Beginn: 58,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dyspnoea exertional Fatigue Nausea Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Vomiting

Symptomtext

Moderna Dose #4 half dose given. I feel I contracted Covid on 04/18/2022 when I went out of town. So, I started out with runny nose, congestion and sore throat on 04/18/2022 at like 06:30AM ET. Then I tested my self with a rapid home test on 04/18/2022 around 01:00PM ET that came out positive. I had some nausea later in the day and then I slept the rest of the day. Then the next day 04/19/2022 between 02:00AM and 11:00AM ET, I vomited water and bile approximately 8 times. I was also very fatigued and exhausted. Then I stopped the vomiting when I was able to take Zofran. After that the sore throat went away and I just had the runny nose, congestion, fatigue and I had shortness of breath with physical activity, like just going up the stairs. I stayed away from work for like 6 days. I still had shortness of breath for another week with physical activities and I was still fatigued. Currently fatigued still, and the shortness of breath has subsided. The shortness of breath continued up until about 04/30/2022 with physical activity. I am not sure the fatigue is due to Covid or my other health issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea exertional
Hospital-Tage: -
Labordaten: Home test 05/18/2022 positive.
Aktuelle Erkrankungen: No
Vorgeschichte: Ehrler's Danlos Syndrome; Lupus; osteoarthritis; fibromyalgia; occipital neuralgia; chronic headaches; hypothyroidism; fibrocystic breast changes; GERD; POTS- postural orthostatic tachycardia syndrome; eczema; asthma; anxiety; MCAS -Mast cell activation syndrome
Andere Medikamente: Levothyroxine; liothyronine; prednisone; Protonix; Belbuca; Lidoderm patch; ibuprofen; vitamin D; 5-HTP; multivitamin; magnesium glycinate; omega 3; digestive enzymes; d-ribose
Allergien: Shellfish; latex; gluten sensitivity; adhesive; yellow #5 food dye; pollen; dust; dust mites; detergents; neoprene
Vorherige Impfungen: -

VAERS 2290919

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: HI
Alter: 29,0
Geschlecht: M
Eingang: 23.05.2022
Impfdatum: 03.02.2022
Beginn: 08.03.2022
Tage bis Beginn: 33,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Chest pain Dizziness Fatigue Myalgia Palpitations

Symptomtext

Anxiety Attacks, Chest Palpation, Chest Aches, Chronic Fatigue, Heart Muscle Pain, Chest Pain, Dizziness Spells

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2281030

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: OH
Alter: 28,0
Geschlecht: F
Eingang: 17.05.2022
Impfdatum: 16.03.2022
Beginn: 11.04.2022
Tage bis Beginn: 26,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alopecia Anxiety Blood iron normal Blood thyroid stimulating hormone normal Condition aggravated Depression Full blood count normal Iron binding capacity total normal Laboratory test normal Panic attack Serum ferritin normal Suicidal ideation Thyroxine normal Weight increased

Symptomtext

extreme hair loss, weight gain, increase in anxiety/panic attacks, worsening depression & suicidal thoughts

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: labs completed 04/2022 & CBC/Ferr/Iron+TIBC/T4/TSH-- normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: anxiety, depression, ADHD, migraines
Andere Medikamente: prozac 60mg, vyvanse 50mg, propranolo ER 60mg, Junel Fe, Lunesta 2mg, MVI, B12
Allergien: NKDA, NKA
Vorherige Impfungen: -

VAERS 2266168

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: VA
Alter: 76,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 01.04.2022
Beginn: 17.04.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Fatigue Glycosylated haemoglobin increased Haemoglobin abnormal Hypoaesthesia Lethargy Nausea Paraesthesia

Symptomtext

04/17/2022 I woke up and my fingers were numb and tingling. I noticed my toes were the same way, but not as bad as my fingers. I was also nauseated. I was very tired, lethargic and fatigued. I am still fatigued and I am always tired. My fingers and toes are still numb and tingling. I went to see Doctor and she took me off all my medications and did bloodwork. She is still working with me.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Bloodwork , Hemoglobin and AC1 were a little above normal.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension Hypo cholesterol
Andere Medikamente: Triamterene Lipitor Vitamin C Zinc Multivitamin Calcium Garlic Niacin Benadryl
Allergien: Crabmeat Lisinopril
Vorherige Impfungen: -

VAERS 2259780

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: AR
Alter: 50,0
Geschlecht: F
Eingang: 30.04.2022
Impfdatum: 24.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chest pain Dyspnoea

Symptomtext

Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2245997

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NC
Alter: 67,0
Geschlecht: F
Eingang: 21.04.2022
Impfdatum: 28.03.2022
Beginn: 28.03.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Electrocardiogram Interventional procedure Palpitations

Symptomtext

A few hours after receiving the vaccine my heart started racing. Normally I could get it down by either walking around, coughing, or taking deep breaths. When I saw that wasn't working I took a beta blocker called Metoprolol Tartrate 25mg tablet. That still didn't work so I set up a video appointment with a doctor. It was going over 1 hour that my heart was racing so she told me to go to the ER. When I went to the ER they moved me to a room to try a procedure to stop my heart from racing. They got me something to blow into then they pulled my legs up to try and get blood up to my heart. That wasn't working so then they administered an adenosine injection through IV. When they checked my heart I didn't have irregular heart beats. My heart rate was between 159 and 169 BPM but it was regular. I followed up with a cardiologist on April 11, 2022. The doctor advised to continue taking the same course of beta blockers. They said if my heart starts racing more frequently then I have other procedures that can be done. Right now we will just be monitoring my heart while I'm taking the beta blockers.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Electrocardiogram
Aktuelle Erkrankungen: None
Vorgeschichte: Lupus; Super Ventricular Tachycardia; Overweight; 3 surgeries for Diverticulitis over the last year
Andere Medikamente: Methotrexate 2.5mg 4 tablets 1xweek Folic Acid 1mg 1xday Modafinil 100mg 1xday Zyrtec 10mg 1xday Calcium 600 with Vitamin D 2xday Fish Oil 1,200mg 1xday Centrum Silver for Women's 50 Plus 1xday Benlysta 200mg per ML 1xweekly
Allergien: Penicillin; Sulfa; Merthiolate; Latex
Vorherige Impfungen: When I received my first 3 covid vaccines on 1/22/2021 and 2/19/2021 and 10/15/2021 I had flu like symptoms, a slight temperatur

VAERS 2243683

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MD
Alter: 64,0
Geschlecht: F
Eingang: 20.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Heart rate increased Mobility decreased Nausea Pain in extremity Pyrexia

Symptomtext

I had fever nausea extreme fatigue and arm soreness and high heart rate. All in one day, I could hardly get out of bed. I called my PCP on the phone, the doctor had me take a few medicines. I awoke the next day, and my arm was just sore, but I felt normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Reflex sympathetic dystrophy syndrome (RSD)
Andere Medikamente: Vitamins- Calcium
Allergien: Sulfa drugs
Vorherige Impfungen: Shingles Vaccine - Left Arm- 10/2019- My arm was swollen and sore. It was painful rash and High fever and rash lasted for on wee

VAERS 2238062

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: AL
Alter: 76,0
Geschlecht: M
Eingang: 16.04.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Chills Hypertension Tachycardia Tremor

Symptomtext

Systemic: Chills-Severe, Systemic: Hypertension-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Severe

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2237444

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MA
Alter: -
Geschlecht: F
Eingang: 16.04.2022
Impfdatum: 10.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Migraine

Symptomtext

Migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Migraine (Caller reported patient has had migraine for over 30 years and this was not unusual for her.). On 10-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) had not resolved. Concomitant medications were not reported.. Treatment medications were not reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Migraine (Caller reported patient has had migraine for over 30 years and this was not unusual for her.)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2231425

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21a

moderat

Staat: CT
Alter: 74,0
Geschlecht: F
Eingang: 13.04.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Injection site bruising Injection site pain Injection site swelling Limb injury Paraesthesia

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2226583

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: PA
Alter: 59,0
Geschlecht: F
Eingang: 11.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Dizziness

Symptomtext

DIZZINESS AND CHESTPAIN WITHIN MINUTES OF MODERNA VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: PENICILLIANS
Vorherige Impfungen: -

VAERS 2225717

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NY
Alter: 83,0
Geschlecht: F
Eingang: 10.04.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling abnormal Injected limb mobility decreased Injection site pain Malaise

Symptomtext

- Run down, malaise times 2 days starting a few hours after immunization - - Resolving about 48 hours after. - arm site still tender, low mobility & hard to raise arm completely - - no redness at site of injection or fever noted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none known
Vorgeschichte: -
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2209754

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 37,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 29.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Dyspnoea Fatigue Headache Pain Pyrexia

Symptomtext

Fever of 102, severe body aches, severe fatigue, severe dizziness, severe headache, and shortness of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Na
Aktuelle Erkrankungen: Na
Vorgeschichte: Asthma
Andere Medikamente: Alburerol and vitamin D3
Allergien: Latex and amoxicillin
Vorherige Impfungen: -

VAERS 2204980

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: FL
Alter: 53,0
Geschlecht: M
Eingang: 29.03.2022
Impfdatum: 28.03.2022
Beginn: 28.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Condition aggravated Dry eye Headache Injection site pain Injection site reaction Interchange of vaccine products Musculoskeletal stiffness Poor quality sleep

Symptomtext

Soreness and stiffness in the upper left deltoid muscle, the site of the injection, starting in the early evening and continuing throughout the night; restless sleep on 3/29/2022; increased soreness and stiffness on 3/30/2022 and a mild headache throughout the day and into the evening; dry eyes on 3/30/2022 and slight feeling of being chilled in the early to mid evening until about 10 p.m. EDT; pain in upper left arm began to diminish slightly at around 9 p.m. but is still present as of the writing of this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin without iron for men, tumeric
Allergien: None
Vorherige Impfungen: Johnson & Johnson initial and booster COVID-19 vaccine administered in 2021; slight soreness of upper left arm at vaccine inject

VAERS 2200746

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: TX
Alter: 41,0
Geschlecht: F
Eingang: 27.03.2022
Impfdatum: 26.03.2022
Beginn: 26.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure decreased Chills Condition aggravated Dizziness Flushing Hyperhidrosis Skin discolouration

Symptomtext

Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Within 5 minutes of receiving first dose of Moderna vaccine, patient felt lightheaded. Upon checking, BP was <70/50, with noticeable change in color and presence of sweating. Patient was given water and protein bar immediately, and patient began to feel better. Patient remained seated for another 10 minutes and BP was rechecked; BP was 99/70. Patient states that her BP typically runs low but she is feeling much better. Patient stayed seated for another 5 minutes before leaving pharmacy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2200658

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21a

moderat

Staat: CA
Alter: 22,0
Geschlecht: F
Eingang: 26.03.2022
Impfdatum: 23.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site rash Pain Pain in extremity Paraesthesia Rash

Symptomtext

Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Rash on the injection arm (below the injection site) with a short period of shooting/tingling pain in arm. Patient had a latent reaction, started 2 days after injection. Rash is still there about but patient states a lot better than the previous day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2198419

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: PA
Alter: 26,0
Geschlecht: M
Eingang: 25.03.2022
Impfdatum: 24.03.2022
Beginn: 24.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fatigue Flushing Headache Hyperhidrosis Hypotension Lethargy

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Mild, Systemic: Hypotension-Mild, Additional Details: Patient felt the side effects for about 30 minutes and then made a full recovery.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2192359

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: SC
Alter: 73,0
Geschlecht: F
Eingang: 22.03.2022
Impfdatum: 19.03.2022
Beginn: 20.03.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

3-20-22: redness at injection site and pain in a 1" diameter circle and fever 100.1 degrees. 3-21-22: fever gone and redness circle around injection site increasing to about 2" diameter site along with an itch beginning . 3-22-22: redness and swelling and more itching at injection site for about a 4" diameter circle.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: Hypertension, Gastroesophageal Reflux Disease, Diabetes type II, hypokalemia, Peripheral neuropathy
Andere Medikamente: Metformin, Losartan, Hydrochlorothiazide, Omeprazole, Pepcid AC, Atorvastatin, Potassium Chloride, Turmeric, Mixed Vitamin B's, Flaxseed Oil, Vitamin D3, and CoQ10.
Allergien: Penecillin, Bandaid adhesive, some unknown anesthesia, pain medication or antibiotic given during a surgical Hospital stay in 2010 (had an itchy rash all over). Fluress for dying the eye yellow. Chondroitin and/or Glucosamine and Shellfish.
Vorherige Impfungen: 72 age; fever, itching swelling at injection site

VAERS 2189197

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: CA
Alter: 32,0
Geschlecht: F
Eingang: 20.03.2022
Impfdatum: 19.03.2022
Beginn: 19.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Dysphagia Dyspnoea Nausea Tachycardia Throat tightness

Symptomtext

Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Nausea-Mild, Systemic: Tachycardia-Mild, Additional Details: Upon administration of the vaccine, the patient expressed difficulty breathing, nausea and tachycardia. The pharmacy team prepared to adminsiter epinephrine and benadryl, however, upon speaking with the husband and the patient, it appeared to be more of an anxiety-related symptom. The patient refused to take benadryl due to concerns about breastfeeding. The patient stayed in the pharmacy for observation. Symptoms resolved within 30 minutes after sitting down and drinking water.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2187568

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 027L21A

moderat

Staat: NY
Alter: 47,0
Geschlecht: F
Eingang: 18.03.2022
Impfdatum: 16.03.2022
Beginn: 16.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Chest X-ray Dyspnoea Electrocardiogram Haemoglobin normal Headache Palpitations Red blood cell count normal SARS-CoV-2 test White blood cell count normal

Symptomtext

I had 1 full-term natural birth pregnancy at 17 yrs. old on 3/6/1992. My son was 51bs 4 oz. After the vaccination, I experienced headaches, shortness of breath, and intermittent heart palpatations. The heart palpitations were intense and frequent lasting over 24 hrs. I was directed by an on-call physician at Medical to go to the ER because heart palpitations is not one of the known side effects and it has not subsided. I went to hospital ER unit where they did an EKG, Chest X-Ray, Rapid Covid Test, and drew blood. Dr. stated I was experiencing a heightened reaction to the vaccine and should follow up with my cardiologist within 1 to 5 days. I am currently schedulded to see my cardiologist at 4:30 pm today. I experienced heart palpitations before when I received the initial dose but it only lasted for 3 hrs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: WBC - 8.9X10(9)/L - 3/17/22; RBC - 4.30X10^12/L - 3/17/22; Hgb - 14.0 g/dL- 3/17/22;
Aktuelle Erkrankungen: none
Vorgeschichte: Lupus, hypertension, migraines, anemia, thyroid cancer survivor
Andere Medikamente: Synthroid - 150 MCG Spironolactone - 100 MG
Allergien: none
Vorherige Impfungen: 4/12/21 Moderna - 040B21A

VAERS 2187087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: IL
Alter: 50,0
Geschlecht: M
Eingang: 18.03.2022
Impfdatum: 01.03.2022
Beginn: 01.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute chest syndrome Chest discomfort Chest pain Inflammation Lethargy Malaise Palpitations Pruritus SARS-CoV-2 test

Symptomtext

Acute chest syndrome; Patient says that he feels chest pain/Fleeting pain in his chest/Acute Pain lasting 1 minute; Lethargy; Palpitations One occurrence. Did not last long. Fleeting.; Feels very sick since receiving the vaccine; Feels like he has inflammation; Heart feels weird/chest discomfort; Experiencing itchy nipples on his chest; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE CHEST SYNDROME (Acute chest syndrome) in a 50-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 11-Mar-2021. On 01-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Mar-2022, the patient experienced MALAISE (Feels very sick since receiving the vaccine). On 04-Mar-2022, the patient experienced ACUTE CHEST SYNDROME (Acute chest syndrome) (seriousness criterion medically significant), CHEST PAIN (Patient says that he feels chest pain/Fleeting pain in his chest/Acute Pain lasting 1 minute), LETHARGY (Lethargy) and PALPITATIONS (Palpitations One occurrence. Did not last long. Fleeting.). In March 2022, the patient experienced INFLAMMATION (Feels like he has inflammation), CHEST DISCOMFORT (Heart feels weird/chest discomfort) and PRURITUS (Experiencing itchy nipples on his chest). In March 2022, PALPITATIONS (Palpitations One occurrence. Did not last long. Fleeting.) had resolved. At the time of the report, ACUTE CHEST SYNDROME (Acute chest syndrome), MALAISE (Feels very sick since receiving the vaccine), INFLAMMATION (Feels like he has inflammation), CHEST DISCOMFORT (Heart feels weird/chest discomfort), PRURITUS (Experiencing itchy nipples on his chest), CHEST PAIN (Patient says that he feels chest pain/Fleeting pain in his chest/Acute Pain lasting 1 minute) and LETHARGY (Lethargy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The concomitant medication was not reported. There was no history of Myocarditis/Pericarditis. The treatment medication was not reported. COMPANY COMMENT : This spontaneous case concerns a 50 -year-old male patient with no relevant medical history, who experienced the unexpected serious (seriousness criterion medically significant) event of acute chest syndrome, which occurred 3 days after receiving first dose of mRNA- 1273 vaccine. It is reported SARS-CoV-2 test is positive on 15-Mar-2021. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2022: Follow-up information received contains no new information.; Sender's Comments: This spontaneous case concerns a 50 -year-old male patient with no relevant medical history, who experienced the unexpected serious (seriousness criterion medically significant) event of acute chest syndrome, which occurred 3 days after receiving first dose of mRNA- 1273 vaccine. It is reported SARS-CoV-2 test is positive on 15-Mar-2021. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Test Date: 20210315; Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2179943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MI
Alter: 31,0
Geschlecht: F
Eingang: 15.03.2022
Impfdatum: 11.03.2022
Beginn: 13.03.2022
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Migraine Musculoskeletal stiffness Neck pain

Symptomtext

Stiff neck, neck pain, migraine headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: February had a cold
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 2174182

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NJ
Alter: 51,0
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 10.03.2022
Beginn: 10.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Chills Decreased appetite Headache Myalgia Nausea Pain Pyrexia

Symptomtext

Fever, 102 Nausea Loss of appetite Chills Headache Muscle pain Body aches Chest pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Advil
Allergien: Levaquin
Vorherige Impfungen: Moderna, shot 1

VAERS 2168256

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: TN
Alter: 61,0
Geschlecht: F
Eingang: 09.03.2022
Impfdatum: 06.03.2022
Beginn: 08.03.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Injection site erythema Injection site pain Joint injury Paraesthesia

Symptomtext

Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2151533

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: CT
Alter: 23,0
Geschlecht: F
Eingang: 02.03.2022
Impfdatum: 25.02.2022
Beginn: 26.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Chest discomfort Chest pain Hypoaesthesia Injection site bruising Injection site erythema Injection site pain Injection site pruritus Injection site swelling Neuralgia Pain Paraesthesia Rash Skin discolouration

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: right sided chest pain purple rash ans soreness on right ankle nerve pain over all body all subsided for the most part-Medium, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2151486

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: CA
Alter: 34,0
Geschlecht: F
Eingang: 01.03.2022
Impfdatum: 26.02.2022
Beginn: 27.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia Chest discomfort Fatigue Lymph node pain Myalgia Pain Palpitations Parosmia Pyrexia

Symptomtext

Got the 3rd covid vaccine around 1:35pm 2/26/22. Felt fine afterwards. Around midnight started experiencing side effects as follows: fever, entire body ached, joints hurt, lymph nodes under both armpits hurt (but not at the same time, also on and off), heart was racing, felt like there was pressure on my chest. Muscle aches/joint pain/racing heart/chest pressure lasted all night and went away the next day around 830am. Had on and off fever the next day and felt extremely fatigued (probably from not being able to sleep due to racing heart). Also noticed altered sense of smell (perfumes smell very smokey) 2/27 and 2/28. Sense of smell seems to be recovering 3/1. Chest feels kind of weird 3/1

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: have not sought medical attention
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: allergic to fluoride (rash around mouth)
Vorherige Impfungen: -

VAERS 2151480

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NJ
Alter: 42,0
Geschlecht: F
Eingang: 01.03.2022
Impfdatum: 25.02.2022
Beginn: 25.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angioedema Chills Condition aggravated Eye pain Hyperhidrosis Hypoaesthesia Injection site erythema Injection site induration Injection site pain Injection site reaction Injection site swelling Lymphadenopathy Migraine Muscle contracture Pain in jaw Seborrhoea Trigeminal neuralgia

Symptomtext

After first 6 hours, major Left arm stabbing pain in Deltoid. Migraine HA symptoms developed. Trigeminal neuralgia symptoms started. Left face, jaw, eye, and ear pain and numbness. After 10 hours, Left axillary lymphoid node swelling occurred, full body rigors with body sweeting, no fevers. Muscle contracting happened after 14 hours. This included upper and lower extremities and ABD. muscles. Injection site swelling continued into day 2, large erythema area developed. Hard, skin shinny, painful to touch or clothing touching area. Symptoms of muscle contracting stopped after 2 full days. Today is 3/1 and left deltoid still swollen, hard redden, shinny. Lymphoid node still swollen in axially area. Trigeminal symptoms still present. Migraine HA symptoms resolved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none. Did not seek outside medical help as i was required to get the booster shot in order to keep my job even if I recently had COVID in Jan. 2022.
Aktuelle Erkrankungen: none
Vorgeschichte: GERD, Right Trigeminal neuralgia, reynaud syndrome
Andere Medikamente: none
Allergien: Latex Tuberculin
Vorherige Impfungen: -

VAERS 2151121

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: MO
Alter: 58,0
Geschlecht: M
Eingang: 01.03.2022
Impfdatum: 27.02.2022
Beginn: 28.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest discomfort Chest pain

Symptomtext

Systemic: Chest Tightness / Heaviness / Pain-Severe

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2148777

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: OH
Alter: 35,0
Geschlecht: M
Eingang: 28.02.2022
Impfdatum: 24.02.2022
Beginn: 24.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Dizziness Dysstasia Mobility decreased Pyrexia Tremor

Symptomtext

Within 5 mins. of vaccine, became lightheaded, weak, chills and shaky. Was sent home. Called to say he made it home. 2/25/22 called to check on him; he was better, just some intermittent fevers. 2/28/22 his wife called wanting to know what to do as he has not been out of bed since Friday night, having fevers, unable to stand. Advised to call ambulance but unable to reach them since 1:15 p.m. today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: None known
Aktuelle Erkrankungen: None known
Vorgeschichte: None known
Andere Medikamente: Unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2128555

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: -
Alter: 23,0
Geschlecht: F
Eingang: 20.02.2022
Impfdatum: 16.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Lymphadenopathy Migraine Musculoskeletal stiffness Pyrexia

Symptomtext

fever , upset stomach , swollen lymph nodes in armpits , stiff neck , migraine. the migraine and stiff neck has lasted for 4 days so far. tylenol doesn?t seem to be helping

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2123878

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MD
Alter: 37,0
Geschlecht: F
Eingang: 18.02.2022
Impfdatum: 11.02.2022
Beginn: 12.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electrocardiogram normal Extrasystoles Headache Malaise Pain Palpitations Sinus rhythm

Symptomtext

strong immune response with generalized body aches, pain, headache and heart palpitations upon waking up the morning after booster shot of Moderna. self checked pulse and missed beats noted. feeling unwell with persistent missed beats on pulse checks for several days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: EKG on 2/18/2022 showing sinus rhythm with occasional ectopic ventricular beat. referral to cardiology given.
Aktuelle Erkrankungen: none
Vorgeschichte: depression anxiety polycystic ovarian syndrome endometriosis
Andere Medikamente: wellbutrin 300 mg spironolactone 50mg lo-loestrin fe multivitiamin tylenol prn for pain
Allergien: NKDA seasonal/environmental allergies
Vorherige Impfungen: -

VAERS 2121111

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: GA
Alter: 39,0
Geschlecht: F
Eingang: 17.02.2022
Impfdatum: 16.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Ear pain Injection site erythema Injection site swelling Pain Pyrexia Tachycardia Vomiting

Symptomtext

High fever (104) resistant to medications, erythema and swelling at injection site, chills, body aches, nausea and vomiting, tachycardia, left ear pain radiating to the back of head

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Fever, chills, body aches with first Covid vaccine

VAERS 2115842

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

moderat

Staat: NJ
Alter: 38,0
Geschlecht: F
Eingang: 16.02.2022
Impfdatum: 15.02.2022
Beginn: 15.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Dysphagia Dyspnoea Malaise Paraesthesia oral Swollen tongue Tachycardia Throat tightness Tremor

Symptomtext

Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Shakiness-Medium, Systemic: Tachycardia-Medium, Additional Details: pt alerted pharmacist not feeling well, feeling dizzy/faint, I ( the pharmacist) instructd pt to stay >15 minutes, lay on floor, elevate feet, provided water. patient then stated felt like tongue tingling, swelling, hard to swallow/talk, (similar reaction in past to sulfa when presented to er w/ anaphlaxis) administer 1 dose epipen 615 pm,, bp 165/134, 101 hr (620 pm,), paramedics called

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2102764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NY
Alter: 43,0
Geschlecht: F
Eingang: 10.02.2022
Impfdatum: 10.02.2022
Beginn: 10.02.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Paraesthesia Throat irritation

Symptomtext

The patient started having itchiness at the back of her throat and tingling senses on her body. No signs of rash, hives, or any swelling on facials, neck, or body. The observation continues to 2:00 pm, symptoms described above were still remaining but not elevated. Benadryl 25 mg, oral was administered at 2:10 pm. Self-monitoring for further reactions after taking medication was suggested. During those times, the patient was alert and oriented. The patient had Hx of sensitivity reactions from Moderna with itchy at the back of throat and body and received Benadryl 50 mg, oral.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2091717

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: MD
Alter: 54,0
Geschlecht: F
Eingang: 06.02.2022
Impfdatum: 05.02.2022
Beginn: 05.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dry throat Dyspnoea Headache Injection site pain Tremor

Symptomtext

Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Headache-Mild, Systemic: Shakiness-Severe, Additional Details: Patient given Moderna booster injection; did not tolerate well. C/O headache, dry throat, shakiness. Upon assessment vital signs 98.1 temp, 154/86 BP, 24 RR, 99% O2 SATS. Fingerstick # 124. No s/s of sweating, alert & oriented x3. Denied pain. Call placed to # 911. Transported to hospital via ambulance. Husband at her side, stated my wife is not immunocomprise but she and I both has diabetes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1850976

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

moderat

Staat: NY
Alter: 41,0
Geschlecht: F
Eingang: 08.11.2021
Impfdatum: 03.11.2021
Beginn: 06.11.2021
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Extra dose administered Migraine Neuralgia

Symptomtext

Booster had caused intense migraines and neuropathic pains on previous days that had appeared to have cleared up when I woke on Sat. Chest pain started at 12:30pm continued until evening. Unrelieved by stomach aid medications like Zantac, phazyme, tums, ginger, Zofran. Heart rate remained normal (no palpitations, no racing), monitored by Watch; Watch ekg showed no skipped beats. At 6:30, patients migraine became more bothersome than chest pain, treated with ?triple shot? of 1mg each of Ativan, Cogentin, and Haldol, plus 8mg Zofran. All symptoms, including chest pain, began to clear up. Fell asleep. (This happened once before in Jan or Feb that a migraine presented as chest pain so bad it sent me to ER.)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic migraine, mild autoimmune NOS, fibromyalgia, high blood pressure
Andere Medikamente: Apri, reboxetine, claritin, singulair, lyrica, topamax, flexeril, benadryl, ondansetron, emgality, botox, trazodone, melatonin, cbd,
Allergien: Coconut, levoquin, macrobid
Vorherige Impfungen: -

VAERS 2692089

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: GA
Alter: 63,0
Geschlecht: F
Eingang: 06.10.2023
Impfdatum: 04.10.2023
Beginn: 05.10.2023
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Limb discomfort Oedema peripheral

Symptomtext

The day after vaccination injection site sore. On Friday morning soreness not as bad at injection site.I noticed discomfort in armpit later upon examining underarm area and noticed visible swelling in armpit. I contacted primary care physician via portal to ask if swelling was common. No response.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Thyroid disease
Vorgeschichte: Fibromyalgia Anemia
Andere Medikamente: Estradiol 0.075 Ozempic 2 mg Pravastatin 40 mg Folic Acid 1 mg Synthroid 35 mg Krill oil Co q 10
Allergien: Latex
Vorherige Impfungen: -

VAERS 2636214

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: AZ
Alter: 81,0
Geschlecht: F
Eingang: 24.05.2023
Impfdatum: 30.03.2022
Beginn: 24.05.2023
Tage bis Beginn: 420,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram pelvis Fatigue Herpes zoster Impaired work ability Malaise Oral surgery Pain Pelvic pain Post herpetic neuralgia Renal disorder

Symptomtext

I was experiencing Extreme fatigue so I determined I would need to take some time off work beginning on 9/1/2022. I was just too tired to work, rather than being sick. The first week of September, I was feeling sick. I experienced excruciating pain down the left side of my body and was diagnosed with Shingles later that week. I experienced the symptoms until late November of 2022. Exhaustion lingers and is not decreasing as does post hermetic neuralgia to time of reporting. Early November I was diagnosed with Kidney Disease. There was continuing and recurring Pelvic Pain, CT scan on 12/20, inconclusive results. In January there was a referral to a cardiologist for a workup, clean bill of health. Oral Surgery in February, where I got Azithromycin. The azithromycin led to a persistent case of Candidiasis that is current to time of reporting. Nystatin is treating the Candidiasis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 20Dec2022 CT scan of pelvis, inconclusive results
Aktuelle Erkrankungen: NA
Vorgeschichte: COPD; Kidney Disease; Cancer survivor(endometrial); High risk of colon cancer; Traumatic Brain Injury
Andere Medikamente: Levothyroxine
Allergien: Penicillin; Sulfa; Morphine; Cipro; Dextropropoxyphene; Dilantin; Strawberries; Shellfish; Eggs; Bandage adhesives
Vorherige Impfungen: -

VAERS 2629023

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: DC
Alter: 39,0
Geschlecht: F
Eingang: 09.05.2023
Impfdatum: 11.04.2022
Beginn: 01.04.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Computerised tomogram head abnormal Diarrhoea Exposure to SARS-CoV-2 Nasal congestion Nasopharyngitis Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus congestion Sinus operation Somnolence

Symptomtext

After the second dose I was a little sleepy and had some cold like symptoms. I got a little better, and then I got COVID-19 along with everyone in my house. I had congestion, body aches, diarrhea, and a fever. This lasted for about 2 weeks. We didn't go to the doctor, but we contacted them, and they told us what to do. My nose had been stuffy since being vaccinated and having COVID-19 and I went to the doctor, and they told me that my sinuses were swollen shut and I had to have a procedure done on 4/25/23, to open them back up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: APR2022 COVID-19 - Positive; 12APR2023 CT Scan - Abnormal Sinuses
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Tylenol; Labetalol; Prenatal Vitamin; Silica; Biotin; Calcium; Vitamin D; Probiotic. Milk Thysell; Sunflower Lecithin
Allergien: Plantains; Kiwi; Grass; Milk Weed; Cats; Latex; Penicillin; Roaches
Vorherige Impfungen: I had a nasal Flu vaccine a long time ago, and I broke out in hives. It could have been a reaction to the latex tip, but we are

VAERS 2614545

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MD
Alter: 56,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 11.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Rash

Symptomtext

04/25/2022 I started to experience large round bumps on my back

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: IBS; High blood Pressure; Lichen Planus; Eczema
Andere Medikamente: Celebrex; Cetirizine; Temovate; Flonase; Prevacid; Cozaar; Paxil; Retinoic acid/ Minoxidil/ Triamcinolone; Prograf; Desyrel; Phentermine; Topamax; Vitamin D3; Vitamin B12; Vitamin B complex; Asawagandha; Estroven; Culturelle; Sudafed; Multi
Allergien: Sulfa; Apple; Oranges; Pineapple; Cat; Dog; Grass; Pollen ; Roaches; Dust mites; Seasonal allergies; Mold
Vorherige Impfungen: -

VAERS 2608444

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 70,0
Geschlecht: F
Eingang: 03.04.2023
Impfdatum: 31.03.2022
Beginn: 06.10.2022
Tage bis Beginn: 189,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Pyrexia SARS-CoV-2 test positive

Symptomtext

I had fever of one hundred one point seven, I immediately took a COVID-19 test and it was positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 06OCT2022 COVID-19 Test -Positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin B12; Vitamin D
Allergien: Shellfish; Egg
Vorherige Impfungen: -

VAERS 2531110

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: FL
Alter: 64,0
Geschlecht: F
Eingang: 14.12.2022
Impfdatum: 04.03.2022
Beginn: 05.03.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Allergy test negative Laboratory test normal Nasal congestion Sinus congestion Urticaria

Symptomtext

Within 24 hours, i was stuffed up to the point of not being able to breath at all through my nose. This lasted for over 1 week. Into the second week after the shot, my sinuses cleared and i was able to breathe once again through my nose. That has remained satisfactory. Into the third week, i started to develop hives all over my body whenever i would eat anything that i normally ate. I went to an allergist who suggested i take Zyrtec twice a day rather than once. That did not help. This persisted for 3 months before i researched Mast Cell Activation Syndrome, and began following dietary protocols for this condition. That seemed to help. It is now 9 months later, and it would seem as though the hives are finally subsiding. I've added a number of supplements to control the hives and have eliminated a lot of things from my daily diet, i.e. gluten, sugar, chocolate, alcohol, caffeine, red meat, legumes, etc. As the effects of the shot wear off, the hives seem to be disappearing as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: In 2022, I have been tested for Lupus, celiac's, and all sorts of allergens. All tests have been negative. I have never been formally evaluated for MCAS, mainly because there are no doctors in my area (and covered by my insurance) that deal with it.
Aktuelle Erkrankungen: I had developed sinus polyps that required surgical removal just 2 months prior to this shot. I'm convinced that those developed as a reaction to the first 2 Moderna shots a year earlier.
Vorgeschichte: None
Andere Medikamente: zyrtech, flonase, multi-vitamin, fish oil, D3, B-complex.
Allergien: None - was thoroughly tested for food and environmental allergens just a few months before this booster shot because i'd developed mild hives after the first 2 Moderna shots a year earlier.
Vorherige Impfungen: Moderna - when i was 63, i developed mild hives after my first 2 Moderna shots. I never thought the vaccines were the cause of

VAERS 2512785

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: IN
Alter: 68,0
Geschlecht: F
Eingang: 21.11.2022
Impfdatum: 12.05.2022
Beginn: 01.07.2022
Tage bis Beginn: 50,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash erythematous Urticaria

Symptomtext

About three or four months ago I started breaking out in red bumps which turned out to be hives. The first time it happened I was sitting outside, and they started to pop up around my elbow and as I scratched it, it started to spread down my arm. I initially thought it was a spider bite or chiggers because they just kept popping up, and there was no head. I started to rule out my environment and foods. I tried BENADRYL but it just knocked me out. I finally went to see a doctor and she gave me hydroxyzine tablets. It helped at first but then the hives started come back. I've had them on my feet, my arms, even under my toenails, my neck, my face, everywhere. My doctor doesn't know where it's from either. It's usually in the middle of the night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Previous lung cancer (partial lung and lymph nodes removed); Arthritis; COPD; Emphysema
Andere Medikamente: Theophylline; levothyroxine; CENTRUM adult over 60 multivitamin; SPRING VALLEY calcium
Allergien: N/A
Vorherige Impfungen: -

VAERS 2480426

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: GA
Alter: 70,0
Geschlecht: F
Eingang: 17.10.2022
Impfdatum: 14.04.2022
Beginn: 01.09.2022
Tage bis Beginn: 140,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain lower Diverticulitis Nausea Scan abnormal Urine analysis normal

Symptomtext

I thought I was coming down with a UTI and it kept getting worse so I went to urgent care the weekend before Sept 5th. The doctor gave me antibiotics and said if it doesn't get better go see my doctor. By the time I went to my dr. I was having lower pain in my right quadrant and was feeling nauseous. I went to the ER for a scan and was given antibiotics. I'm feeling much better and watching what I eat.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain lower
Hospital-Tage: -
Labordaten: Urinalysis normal; Scan, diverticulitis.
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; Hypothyroidism
Andere Medikamente: Hydroxyzine; montelukast; LEVOXYL
Allergien: Penicillin
Vorherige Impfungen: 1st COVID-19 vaccine I had a severe locate reaction of a big welt.

VAERS 2470126

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: DE
Alter: 53,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 31.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Pyrexia SARS-CoV-2 test negative

Symptomtext

I ran a fever every day for over 3 weeks. It cycled, with the duration eventually becoming shorter, down to an hour or so at a time, but for the first 2 weeks, it was all afternoon and evening every day. I was also very fatigued. (I spoke to my doctor's office over the phone but they did not ask me to come in for an appointment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Negative r-PCR test April 11, 2022 (and negative home test morning of March 31, 2022)
Aktuelle Erkrankungen: none
Vorgeschichte: Raynaud's, ADHD
Andere Medikamente: Prilosec, Vyvanse, Astelin, Flonase, Vitamin D, Iron
Allergien: Tylenol, Sulpha, Cipro, Clindomycin, and seasonal allergies
Vorherige Impfungen: -

VAERS 2461873

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: VA
Alter: 74,0
Geschlecht: F
Eingang: 27.09.2022
Impfdatum: 27.03.2022
Beginn: 14.09.2022
Tage bis Beginn: 171,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Nasal congestion Nasopharyngitis Pain in extremity Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a sore arm and I felt tired for a day. On 09/14/2022 I started feeling like I was getting a cold and I had a fever of 100.7. I took a home test on 09/15/2022 and it was positive for COVID-19. I contacted my doctor and was prescribed PAXLOVID and I started it on 09/15/2022. I had a rebound and felt stuffy on 09/25/2022 and I tested positive for COVID-19 on 09/26/2022. I'm currently taking SUDAFED for congestion and a sinus rinse. For my cough I am taking MUCINEX.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home test for COVID-19 was positive on 09/15/2022 and again on 09/26/2022.
Aktuelle Erkrankungen: None
Vorgeschichte: Bronchiectasis; MAC
Andere Medikamente: SYNTHROID; LIPITOR
Allergien: None
Vorherige Impfungen: -

VAERS 2444731

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: IL
Alter: 43,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 14.06.2022
Beginn: 01.09.2022
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Nasopharyngitis Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Started having a really bad cold, with fever, sore throat and congestion. Took an at home COVID-19 test and it was positive. Talked to Dr. and was prescribed PAXLOVID and told to rest. Took another home COVID-19 test on 09/10/22 and it was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 09/01/2022 home COVID-19 test - positive; on 09/10/2022 home COVID-19 test - negative.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type 1 diabetic
Andere Medikamente: N/A
Allergien: Shellfish; MOBIC; SYNTHROID
Vorherige Impfungen: -

VAERS 2444730

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 10.03.2022
Beginn: 10.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Acne Malaise Vaccination site discolouration Vaccination site pain

Symptomtext

After I got the shot, I got swallow on the site of the vaccine, the vaccine area got white, about 2 inches, and it was painful for almost three weeks, and finally got away. After that, probably about 6 weeks I started to break up with pimples on my face and my arms, for about three weeks. Everything happened in about three weeks increments. I was swearing very bad, it lasted for 10 minutes to one hour, during different times of the day. Back in November I got COVID-19 and doctors said all these symptoms could be Post COVID-19 symptoms. I went to three different doctors' and they said no to do anything. I got sick to my stomach every time I ate, about 10 minutes before my meals.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Two Stems; Pace Maker; MS; Diabetes; Arthritis; High Blood Pressure
Andere Medikamente: Tizanidine; Multi Vitamin; Tylenol; B Complex; Metformin; Glipizide; Aspirin; Allopurinol; Lisinopril HZT
Allergien: Morphine; Seasonal Allergies; green Dine; Entex; Green Colors Medications; Celebrex; Bentyl
Vorherige Impfungen: -

VAERS 2440992

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 10.03.2022
Beginn: 30.06.2022
Tage bis Beginn: 112,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had my vaccination 03/10/2022. On 06/30/2022 I started to experience body aches. I did an at home COVID-19 test early on 07/01/2022 and it was positive. I then started to have sniffles and 103 temperature with a mild cough on 07/01/2022. I started the Plaxovid on 07/02/2022 I had mild cough and sniffles with a sustained low grade fever for five to seven days. I haven't fully recovered as it has been slow.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: 07/01/2022 COVID-19 Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; Rheumatoid Arthritis
Andere Medikamente: N/A
Allergien: Penicillin; Amoxicillin; Latex
Vorherige Impfungen: -

VAERS 2418475

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: TX
Alter: 70,0
Geschlecht: M
Eingang: 23.08.2022
Impfdatum: 30.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema multiforme Pruritus Urticaria

Symptomtext

intense pruritis accompanied by an urticarial rash and erythema multiforme over the trunk and extremities lasting 6 hours and treated with chlorpheniramine 4 mg q4h and loratadine 10 mg tid and topical 0.8% lidocaine gel. Afebrile. Duration of treatment approximately 12 hours. (Photos of rash are available with date and time stamp).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Psoriatic Spondyloarthropathy
Andere Medikamente: Pravastatin, Biotin, Niacin, Loratadine, Celecoxib, Folic Acid
Allergien: Penicillin, Sulfa, Ilotycin, Phenacetin, Novocaine
Vorherige Impfungen: -

VAERS 2401634

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NJ
Alter: 76,0
Geschlecht: F
Eingang: 04.08.2022
Impfdatum: 02.02.2022
Beginn: 02.07.2022
Tage bis Beginn: 150,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Cough Fatigue Hypersomnia Malaise Rhinorrhoea SARS-CoV-2 test positive Sinus headache

Symptomtext

I tested positive for COVID-19 on July 2, 2022. My symptoms began on June 26, 2022 but I thought it was a sinus infection. I had energy and was not fatigued. I had nasal drainage and coughing and a sinus headache. After I tested positive I did feel very fatigued on July 3rd. I slept about 17 hours a day for at least 2 weeks. I didn't have any energy to do anything I wanted to do. The next time I tested myself was about July 10th and I tested negative. After that I was still fatigued but beginning to feel more energetic. As of today I have mild fatigue but I feel like I am on my way to recovery.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home COVID-19 test, 02JUL2022, positive; home COVID-19 test, 10JUL2022, negative.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetic
Andere Medikamente: FARXIGA; glimepiride; GLUMETZA; ramipril; HCTZ; atorvastatin; baby aspirin; vitamin B + C; vitamin D; coQ10; AREDS2; collagen; ALIGN probiotic
Allergien: Stinging insects
Vorherige Impfungen: -

VAERS 2396346

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 64,0
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 28.04.2022
Beginn: 17.07.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise Paranasal sinus discomfort SARS-CoV-2 test positive Sinusitis

Symptomtext

I suspected I was getting a sinus infection and we were coming home from a trip and I thought oh shoot I was coming back from my mother's memorial service and on Tuesday on the 19th I was not waiting any longer my face felt like it wanted to explode from the pressure from my sinuses and I was coughing. I didn't have fever or chills just what felt like a sinus infection. On the morning of the 20th I got up and was going to make an appointment and took a home test and before I could get on the phone with the physician's office it came up positive. They asked me how long I had tested positive and it was 2 minutes and they set up a telehealth appointment and on that appointment she prescribed PAXLOVID. I feel fine now and was only sick for 5 days. I had zero pressure in my face the next day after starting PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 home test positive- 7/20/22
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Allery medication; iron; multivitamin; D3 vitamin; CITRACAL; vitamin C; CARDIZEM CD; potassium; metoprolol succinate ER; vitamin B12; FLONASE
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2393218

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: PA
Alter: 73,0
Geschlecht: M
Eingang: 27.07.2022
Impfdatum: 25.04.2022
Beginn: 21.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Rhinorrhoea SARS-CoV-2 test positive Sneezing Vaccine breakthrough infection

Symptomtext

Break through Covid 19 case on July 21, 2022, symptoms were sneezing, runny nose, cough, mild fatigue. Had a video appointment with my doctor 8am July 22nd and was prescribed Paxlovid. Took first dose at 5PM on July 22 and 2nd at 1AM on July 23, have continued twice a day, last dose 9PM July 26. Symptoms have improved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Took and at home BinaxNOW test morning of July 21, 2022 which was positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; HX pulmonary embolism; Left and right knee replacements; elevated cholesterol
Andere Medikamente: Atenolol; Losartin; Rosuvastatin; Vitamin C; Vitamin D
Allergien: Penicillins; Simvastatin; Amlodipine; Nifedipine; Chlorthalidone
Vorherige Impfungen: Fatigue for one day after all doses of vaccine which were 02/05/2021, 03/05/2021, 11/10/2021, 04/25/2022.

VAERS 2379176

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: IN
Alter: 65,0
Geschlecht: F
Eingang: 22.07.2022
Impfdatum: 02.04.2022
Beginn: 02.07.2022
Tage bis Beginn: 91,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Chills Cough Diarrhoea Facial pain Fatigue Headache Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I started getting symptoms of headache that went down the side of my face, sore throat, congestion, weakness, and fatigue. I also had serious diarrhea. About the 3rd day, I started getting fever and chills. I started coughing. I tested negative for COVID-19 with a rapid test 3 days later. Then I tested positive for COVID-19 on the 5th day. I contacted my doctor with a telehealth visit and was prescribed Molnupiravir on 7/6/2022. My symptoms did get better after 24 hours. I still have a dry cough to this day. I take Nyquil and Dayquil as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test - positive
Aktuelle Erkrankungen: None
Vorgeschichte: HTN; Seasonal Allergies
Andere Medikamente: Vitamin C; Vitamin D; Lisinopril; Atorvastatin; CoQu10
Allergien: None
Vorherige Impfungen: Shingles - 2021 High fever and sore arm

VAERS 2373921

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: TX
Alter: 68,0
Geschlecht: M
Eingang: 19.07.2022
Impfdatum: 18.04.2022
Beginn: 27.06.2022
Tage bis Beginn: 70,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Feeling cold Pain Paranasal sinus hypersecretion SARS-CoV-2 test positive

Symptomtext

04/18/2022 Vaccination 06/27/2022 I had sinus drainage, cough, body aches, chills, fatigue. COVID-19 testing x2 NEGATIVE 06/30/2022 PCR test COVID-19 POSITIVE Was prescribed Albuterol but I didn't use it much. They did also give me something for cough but I can't remember the name. I am presently feeling better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: PCR COVID-19 POSITIVE
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2372363

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NJ
Alter: 60,0
Geschlecht: M
Eingang: 18.07.2022
Impfdatum: 15.04.2022
Beginn: 17.06.2022
Tage bis Beginn: 63,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Headache Malaise Nasopharyngitis Pyrexia SARS-CoV-2 test positive

Symptomtext

COVID-19 symptoms started on evening of June 17 and day of June 18. I tested positive on June 19. I had a fever on the 19th and 20th. Symptoms included cold-like symptoms, fever, minor headache, and cough. My fever was measured at 101.4, possibly could have hit 102. Symptoms broke by the 21st. I was on Paxlovid and things got better pretty quickly. No lingering symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 Positive 06/19/22
Aktuelle Erkrankungen: None
Vorgeschichte: Type 2 Diabetes; Hypertension
Andere Medikamente: Trulicity; Metformin; Atorvastatin; Jardiance; Lisinopril; Vitamin D; CoQ10; Allegra
Allergien: Dust; Ragweed
Vorherige Impfungen: -

VAERS 2372302

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NC
Alter: 49,0
Geschlecht: M
Eingang: 18.07.2022
Impfdatum: 14.04.2022
Beginn: 27.06.2022
Tage bis Beginn: 74,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Malaise Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I contracted COVID-19 on 06/27/2022 with symptoms of sore throat, cough, and fever. I was prescribed PAXLOVID on 07/02/2022. I was ill for 9 to 10 days before my symptoms began to resolve. I still have a lingering cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 rapid home test was positive on 07/02/2022.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Type 2 Diabetes
Andere Medikamente: Rosuvastatin; carvedilol; metformin; amlodipine; losartan; OZEMPIC
Allergien: Lisinopril
Vorherige Impfungen: -

VAERS 2369216

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: KS
Alter: 76,0
Geschlecht: F
Eingang: 14.07.2022
Impfdatum: 13.04.2022
Beginn: 03.07.2022
Tage bis Beginn: 81,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Ear pain Headache Nasopharyngitis Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Speech disorder Throat tightness

Symptomtext

On 7/3/2022 My throat became very tight and it became very hard to talk. I believe I ran a fever of 100.5 for about two days. I also had a nasty head cold develop as well. I also had an ear ache that came along with non-severe headaches. The fever was gone and I felt pretty good by 07/13/2022, however, I still had a deep cough and a lot of congestion. I also had been taking Mucinex since the beginning as well. I reached out to my PCP office and the told me to stay well hydrated and contact them again if symptoms persisted or became worse. The nurse I did talk to said that the shots are doing their job and keeping me from getting very sick.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: Self At Home COVID-19 Test: Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Atrial Fibrillation; Asthma
Andere Medikamente: Eliquis; Zytalazam; Flovent; Multivitamin; Vitamin D; Calcium
Allergien: Sulfa Drugs; Codeine
Vorherige Impfungen: -

VAERS 2364396

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NJ
Alter: 54,0
Geschlecht: M
Eingang: 11.07.2022
Impfdatum: 07.01.2021
Beginn: 04.07.2022
Tage bis Beginn: 543,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

Tested COVID positive with minor symptoms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID home test X2
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Atorvastatin Zyrtec
Allergien: None
Vorherige Impfungen: -

VAERS 2362749

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 69,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 07.04.2022
Beginn: 24.06.2022
Tage bis Beginn: 78,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Decreased appetite Nasopharyngitis Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Weight decreased

Symptomtext

06/24/2022 I had a sore throat and a runny nose. The next day, I had congestion and started coughing. I assumed it was a cold. On the third day I tested positive for COVID at an Urgent Care. The doctor advised me that I needed to stay away from people for five days or 10 days recommended by the CDC. The doctor listened to my lungs and said they were not that bad, so she did not think it was advisable to prescribe an antiviral. I lost 10 pounds because I was not very hungry. Other than that, it just seemed like a cold. I took over the counter medicine for cough and congestion and finally cleared up. I stayed away from people for 10 days after the onset of symptoms. I isolated from my wife. I fully recovered and am back to normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: COVID test, positive
Aktuelle Erkrankungen: None
Vorgeschichte: Pre diabetic; High cholesterol
Andere Medikamente: Januvia ;Jardiance; Lipitor
Allergien: None
Vorherige Impfungen: -

VAERS 2361014

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: TX
Alter: 52,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 06.04.2022
Beginn: 05.07.2022
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Oropharyngeal pain Pain Pyrexia Respiratory tract congestion

Symptomtext

On Tuesday I felt a lot of congestions, body aches, fever, chills and soar throat . I deceived I needed to go to the Urgent care . I was there for 2 hours but today I am getting an Infusion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Infusion.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Iodine; Latex; Codeine
Vorherige Impfungen: -

VAERS 2359638

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: TX
Alter: 75,0
Geschlecht: F
Eingang: 06.07.2022
Impfdatum: 05.04.2022
Beginn: 26.06.2022
Tage bis Beginn: 82,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Headache Pain SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the vaccine but I tested positive for COVID-19 06/28/2022. I started feeling systems on 06/26/2022. I felt achy all over, headache and I was coughing. I took ZYRTEC and TYLENOL for my symptoms prior to testing positive. I had a telehealth visit with my doctor and they prescribed PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: I took the home test for COVID-19 on 06/27 which ways negative. Tested again on 06/28 and it was positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Colon cancer survivor diagnosed in 2011.
Andere Medikamente: I take two blood pressure medications; two eyedrop medications.
Allergien: None
Vorherige Impfungen: -

VAERS 2357808

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: FL
Alter: 62,0
Geschlecht: F
Eingang: 05.07.2022
Impfdatum: 03.04.2022
Beginn: 20.06.2022
Tage bis Beginn: 78,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

Became and tested positive for Covid on June 20, 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Home Covid tests positive 06/20 thru 06/27 and positive again on 07/02/2022 after symptoms returned.
Aktuelle Erkrankungen: High Blood Pressure
Vorgeschichte: High Blood Pressure
Andere Medikamente: Trileptal, Oxcarbazepine, Losartan, Triamterene, Bisoprolol, Rosuvastatin, Meloxicam
Allergien: Hydrochlorathiazide
Vorherige Impfungen: -

VAERS 2347577

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 01.07.2022
Impfdatum: 31.03.2022
Beginn: 31.05.2022
Tage bis Beginn: 61,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Malaise Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I started getting symptoms of runny nose. I tested because I had a friend to test positive 3 days prior. I took 2 at home COVID-19 test that was positive. My symptoms progressed to a sore throat and a cough. I called my doctor and was prescribed PAXLOVID for 5 days. My symptoms lasted for approximately 6-9 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 test - positive.
Aktuelle Erkrankungen: None
Vorgeschichte: HTN (controlled)
Andere Medikamente: Multivitamin; calcium
Allergien: None
Vorherige Impfungen: Moderna 1st dose - sore arm and fatigue.

VAERS 2347512

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 63,0
Geschlecht: F
Eingang: 01.07.2022
Impfdatum: 31.03.2022
Beginn: 25.05.2022
Tage bis Beginn: 55,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the vaccine. I tested positive COVID-19 on 5/25/2022. I took a home test and I had a PCR test at the hospital I work at. I had a sore throat, headache and fatigue. I took TYLENOL to help with my symptoms. I had a telehealth visit with my provider and was prescribed PAXLOVID for my symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home test and PCR test both positive for COVID-19.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Thyroid medication
Allergien: None
Vorherige Impfungen: -

VAERS 2344923

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: DE
Alter: 72,0
Geschlecht: F
Eingang: 30.06.2022
Impfdatum: 30.03.2022
Beginn: 23.06.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Exposure to SARS-CoV-2 Fatigue Feeling abnormal Nasal congestion Respiratory tract congestion SARS-CoV-2 test negative SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

I started with congestion and post nasal drip. I also had a cough and fatigue. It got worse on Friday, My husband had COVID-19 already so I tested 3 times on Monday June 20th and the 21st and both were negative. On that Wednesday we went to a walk in Clinic and had a PCR on June 22nd which was negative. I took another test on Friday the 24th which also was negative. On the 25th in the morning, I took another test and it was positive. By Saturday I felt really lousy and had a fever of 99. I took Tylenol, Cough medicine and an inhaler that I had been prescribed from a previous illness. I still have nasal congestion but the cough is very sporadic and I no longer have fever. The fatigue has lessened but I am still recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19-June 20th-Negative, June 21st, 2022, June 24th, 2022-Negative, June 25th, 2022-Positive COVID-19 PCR-Negative-June 22nd, 2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arthritis Ulcerative Colitis
Andere Medikamente: Vitamin D3; Osteo bi-flex Amlodipine; Mesalamine; Melatonin;
Allergien: Bactrim
Vorherige Impfungen: -

VAERS 2336526

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: GA
Alter: 93,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Muscular weakness Myalgia Pain in extremity

Symptomtext

Patient states her arm began getting sore the night of the vaccine and has continued to be sore still today. She has muscle weakness and pain in the right deltoid where the vaccine was administered. There is no sign of injury on her arm, the patient states the pain is in her muscle.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335777

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: KY
Alter: 20,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 25.06.2022
Beginn: 25.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cold sweat Dizziness Feeling cold Vision blurred

Symptomtext

Approximately 10 minutes post vaccination patient complained of feeling light headed, patient felt clamy and cold. Pt also complained of blurry vision and dizziness . BP taken 80/52 leaft arm sitting HR 92. Unable to obtain O2 sat at that time. Medical triage called.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: Pt report not eating anything since the day before, started drinking little fluids during observation. At 5:05pm EMS started IV fluids 0.9% normal saline. IV ended at 5:13pm. O2 sat 99%, HR 106 patient transported to Hospital ED via EMS.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Takes Birth Control Pills does not know the name
Allergien: No
Vorherige Impfungen: -

VAERS 2314047

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: GA
Alter: 58,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 05.03.2022
Beginn: 11.03.2022
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Breast pain Breast swelling Erythema Hyperaesthesia Nipple pain Nipple swelling Pain Sensory disturbance

Symptomtext

Beginning March 11 I began having a reaction that has affected both breasts. The areolas and nipples began to be very sensitive to the touch, experienced a "stinging" sensation and it felt as if needles were poking them when touching, they turned red and were swollen. The reaction began to subside on March 18 and finally dissipated; however, on April 10 they began again, very severe this time and continued until May 13 when they began to subside. The sensations did not completely disappear and began again on May 25 with mild sensitiviy. On June 7 the sensitiviy began to grow more severe and both have become just as sore as before. I intend to contact my physician today to inquire about a resolution - possible antidote? I cannot continue this as it is very painful!

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breast pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2305282

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 62,0
Geschlecht: M
Eingang: 01.06.2022
Impfdatum: 02.05.2022
Beginn: 28.05.2022
Tage bis Beginn: 26,0
Dosis: 4
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I've been home since May 2nd , I had some type of congestion and cough. So we were on vacation for 3 weeks, we did try to mask up the whole time because we were seeing my parents. The last week we didn't wear it on the train because of the heat wave. We did test before we went home on the 23rd that was negative. We went to a graduation. And I think I still had my cough. I was feeling tired and had a small fever and I took a test May 28th and did it twice and it was positive. I called telehealth and they gave me medications.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mass on right kidney, been there for a year and a half ( being removed )
Andere Medikamente: Blood Pressure Medication Amlodipine Vitamin D B12
Allergien: N/A
Vorherige Impfungen: Minor Reactions to the first 2 COVID-19 Vaccines

VAERS 2303505

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 14,0
Geschlecht: M
Eingang: 31.05.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pain in extremity Product administered to patient of inappropriate age

Symptomtext

Patient was given Moderna despite not being eligible for it due to his age. Patient and family report no side effects other than sore arm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2301741

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: VT
Alter: 61,0
Geschlecht: F
Eingang: 30.05.2022
Impfdatum: 19.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Histamine level Pruritus Rash Urticaria

Symptomtext

Across upper torso a little itchy; rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body; rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Across upper torso a little itchy), URTICARIA (rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body) and RASH (rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to antibiotic (cillin medications) and Hashimoto's thyroiditis. On 19-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URTICARIA (rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body). On an unknown date, the patient experienced PRURITUS (Across upper torso a little itchy) and RASH (rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; LORATADINE (CLARITINE) at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (Across upper torso a little itchy), URTICARIA (rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body) and RASH (rash and hives on ankles, feet, toes, mainly middle lower extremities, stomach, occasionally on arm/travels throughout body) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, Histamine level: more active/increased (High) more active/increased. No concomitant medications were reported. Patient's date of birth mentioned. The patient had allergy to poison ivy. She did not have seasonal allergies and had not added any new foods to diet. Moderna 2nd booster dose Lot number was reported as 027L21A or Z1A. The patient suspected hives and rash were due to vaccine in combination with having hashimotos. She experienced hives and rash had been going for weeks and saw doctor. The rash and hives happened through the day, histamines were more active at night. Treatment with Benadryl, Claritin, prednisone made that worse. The patient had not experienced a similar event in the past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: Test Date: 2022; Test Name: Histamines; Result Unstructured Data: more active/increased
Aktuelle Erkrankungen: Allergy to antibiotic (cillin medications); Hashimoto's thyroiditis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298723

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 55,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 09.04.2022
Beginn: 02.05.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chest discomfort Chills Cough Decreased appetite Fatigue Headache Illness Malaise Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sneezing Symptom recurrence

Symptomtext

I contracted COVID-19 on 05/02/2022 with symptoms of severe headache, sore throat, sneezing , congestion, fever of 101, loss of appetite, chills, and severe fatigue. I was prescribed Paxlovid on 05/02/2022 and after finishing the Paxlovid on 05/10/2022 my symptoms were resolving. On 05/14/2022 I began feeling ill again, and my initial symptoms of sneezing, congestion, chest tightness, and fatigue returned. I developed a cough two weeks after initial illness and sought care at the urgent care. I was prescribed cough medicine and an albuterol inhaler upon my second visit to the urgent care. My symptoms have resolved except for a mild cough, fatigue, congestion, and chest tightness. I still have not fully recovered as of today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 home rapid nasal swab was positive on 05/05/2022 COVID-19 rapid nasal swab was positive on 05/05/2022 COVID-19 rapid nasal swab was positive on 05/14/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension Hypothyroidism Irritable Bowel Syndrome Sleep Apnea Skin Cancers
Andere Medikamente: Losartan Levothyroxine Women's Multivitamin Vitamin D
Allergien: Intolerant to Lisinopril Intolerant to Zoloft
Vorherige Impfungen: -

VAERS 2290829

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 74,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 20.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site pain Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Injection site is red, swollen, hot, painful and itchy. At its largest, the redness covered about 3 inches in diameter and is still, as of the date of reporting about 2 inches in diameter... not quite as red but very hot, itchy and tender

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: diabetes type 2
Andere Medikamente: Metformin, Atorvastatin, L-Thyroxine, Prilosec OTC, Vitamin C, Vitamin D3, Calcium, Magnesium, Vitamin E, Evening Primrose Oil, Rhodiola, baby aspirin, Mult-vitamin, Iron, MSM, Glucosamine, Chondroitin Sulfate, Advil
Allergien: iodine dye
Vorherige Impfungen: -

VAERS 2290361

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CT
Alter: 56,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 18.02.2022
Beginn: 03.05.2022
Tage bis Beginn: 74,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Respiratory tract congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

I started getting symptoms of scratchy throat, headache, fatigue, and congestion. I had a positive COVID-19 test from an in home test and at a testing facility. I contacted my doctor and was prescribed a Mon Lupardiar. This seemed to help. My symptoms lasted 2 days. Day 9, I tested negative. Then On day 17, I took another test and it was positive again. Then 8 days later I took another test which was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test
Aktuelle Erkrankungen: N/A
Vorgeschichte: Ulcerative Colitis
Andere Medikamente: Remicade, Crestor, COQ-10, Vitamin D3, Milk Thistle, Vitamin B12, Melatonin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2290357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 20,0
Geschlecht: M
Eingang: 23.05.2022
Impfdatum: 17.02.2022
Beginn: 09.03.2022
Tage bis Beginn: 20,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test normal Oropharyngeal pain Secretion discharge Tonsillar haemorrhage Tonsillitis Upper respiratory tract infection

Symptomtext

March 9, started experiencing upper respiratory infections with heavy green mucus and sore throat. Was diagnosed with tonsillitis and I have been having multiple flare ups. Went to ENT and have been on multiple rounds of antibiotics. At one point I had severe bleeding from tonsils. I have never had tonsillitis issues prior to the 3 dose of Moderna Vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Blood work all returned normal
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 2287123

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CT
Alter: 69,0
Geschlecht: M
Eingang: 20.05.2022
Impfdatum: 12.04.2022
Beginn: 14.05.2022
Tage bis Beginn: 32,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Nasal congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

On 5/14, Saturday, I had a pretty bad cough, classic tickle in the back of my throat were I could not clear my throat. I called the doctor on Sunday and I did a home test and it came out positive before I even put the drops on it. The doctor prescribed prednisone. I had no fever, I still have my taste and smell, and I am a little tired. I have been on prednisone and I will finish up on Sunday, 5/22/2022. I took a covid-19 today, 05/20/2022 and it was positive. The cough is mostly gone, my sinuses are a little stuffy, other than that, I have good appetite, nothing else out of the ordinary.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Covid-19 home test 5/15/2022 and 5/20/2022 both positive.
Aktuelle Erkrankungen: No; I have not been sick in like 3 or 4 years
Vorgeschichte: Cardiac history; Prostate was high -1/10 of 1/12 section; we medicated and my PSA is now down
Andere Medikamente: Multivitamin; baby aspirin; finasteride; ezetimibe statins; rosuvastatin calcium; tamsulosin; lisinopril; metoprolol
Allergien: No
Vorherige Impfungen: Shingles vaccine, taken about 2 or 3 years ago, kicked my butt, each one of the vaccines knocked me down.

VAERS 2284840

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NM
Alter: 69,0
Geschlecht: F
Eingang: 19.05.2022
Impfdatum: 05.04.2022
Beginn: 11.05.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia Asthenia Bronchitis COVID-19 Chest discomfort Chills Drainage Dysphonia Exposure to SARS-CoV-2 Fatigue Head discomfort Heart rate increased Malaise Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I had my vaccine on 04/05/2022. In the evening I did not feel well so I went to bed. I had chills, slight fever. I took Tylenol and I slept it off for nearly 2 days. Just getting up and using the bathroom and hydrate. I felt weak, fatigued, and it was my worst vaccine for sure. This lingered on an extra day, longer than the others. I was exposed the first of May by my husband who tested positive for COVID on 5/8/2022. I had At-Home COVID tests, so when I knew I was exposed from him, I tested on 5/9 and it was negative. I tested on 5/11 and I was still negative when my symptoms began. I tested on 5/12 and I was still negative. 5/12/2022 I also had a vault test as a back up. I did take that test and had my son mail that out, but I do not have the results yet. I felt pretty bad at this point, so my husband made an appointment with his doctor on 5/13. I took another COVID test before this appointment and it came back positive. I knew I had to confirm with the doctor for the positive test, so I went to the clinic. From there, my daughter made a suggestion for me to go to an infusion center to get an antibody infusion. I went straight from clinic and to the infusion center. The lady at clinic prescribed the anti-viral Paxlovid and told me not to take it until I got the infusion. She suggested that I also use a nebulizer to help me keep my airways open. Prescribed a medication that was expensive and ended up using albuterol instead. Used the nebulizer for a few days to keep airways open. Also suggested Pepcid for the stomach part of the symptoms. Also another medication to help with breathing. Just took Tylenol for the aches and pains. I would consider my case to be very mild. No fever, just had a stuffy head, congestion, store throat, croaky like I had a cold, drainage and lost taste and smell. Heaviness in chest. Seemed like a severe bronchitis. My O2 never went below 90. Heart rate was elevated a little bit. Dropped a little bit one night, but honestly seemed like a mild case. My symptoms are completely gone now, other than just my taste.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 05/09/2022 - At-Home COVID Test - Negative 05/11/2022 - At-Home COVID Test - Negative 05/12/2022 - At-Home COVID Test - Negative 05/12/2022 - COVID Vault Test - Pending 05/13/2022 - At-Home COVID Test - Positive 05/13/2022 - Antigen COVID Rapid Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Rheumatoid Arthritis Hx of total knee replacement in Feb 2022
Andere Medikamente: Synthroid Multivitamin - Vitamin C, Zinc, Elderberry
Allergien: Sensitivity to Naproxen products Seasonal allergies
Vorherige Impfungen: -

VAERS 2282891

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 68,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 05.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Biopsy breast Lymphadenopathy Mammogram Pyrexia Toothache

Symptomtext

In January, have severe teeth pain. I had fever. Swollen lymph under left arm pit. Breast Biopsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: Breast xray
Aktuelle Erkrankungen: No
Vorgeschichte: High Blood Pressure, Allergies
Andere Medikamente: Lisinopril, Hydrochloride, Multivitamin, Prilosec, Xanax
Allergien: Statins
Vorherige Impfungen: -

VAERS 2278444

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 75,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 01.05.2022
Beginn: 13.05.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Emotional disorder Pain Pyrexia

Symptomtext

PT COMPLAINING OF A "BAD MODERNA SHOT" PT STATES HE IS STILL IN PAIN 13 DAYS LATER FROM THE INJECTION . IT HAS BEEN VERY PAINFUL AND HE HAD FEVER FOR UNKNOW DAYS IN HIS LETTER PT STATED HE HAD FEVER AND GREAT PAIN AND HAS BEEN "EMOTIONALLY UPSET" - UNABLE TO OBTAIN MORE CLINICAL INFORMAITON TO COMPLETE FORM BECAUSE PT IS NOT ANSWERING HIS PHONE AND KEEPS CALLING PHARMACY STATING HE IS IN PAIN AND THEN HANGING UP. WE HAVE TRIED TO CONTACT HIM AND SPEAK TO HIM SEVERAL TIMES TO OBTAIN MORE INFORMATION AND DIRECT HIM IN THE RIGHT DIRECTION WITH APPROPRIATE MEDICAL CARE "IBUPROFEN OR TYLENOL"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278420

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: GA
Alter: 67,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 02.04.2022
Beginn: 08.05.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Feeling abnormal Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

On the 8th I was feeling congested and had a scratchy throat. On the 9th I woke up with a sore throat and more congestion. I did two at home tests on the 8th and the 9th and they were both negative. I was developing a fever and felt worse and worse and on the tenth I tested positive. I ended up doing a virtual appointment with my doctor after that test.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: At home CoVID test
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic Hives; Chronic Idiopathic Urticaria; High Cholesterol
Andere Medikamente: Zyrtec, Singulair, Pravastatin, Vitamin D, Famotidine
Allergien: None
Vorherige Impfungen: -

VAERS 2275639

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MO
Alter: 70,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 31.03.2022
Beginn: 07.05.2022
Tage bis Beginn: 37,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Fatigue Feeling abnormal Influenza virus test negative Pyrexia SARS-CoV-2 test positive

Symptomtext

It really hit me like a wave. I wasn't sick and then all of sudden I felt really strange. We came home and I was ok but the next day I had chills, fever, and brain fog which lasted for a day. I emailed my doctor and they called me after I had taken a home test that was negative. I went to take a PCR test as requested by the doctor. It was positive so the doctor prescribed Paxlovid. I was extremely tired throughout this process. Today is the best that I have felt. I do believe that I have completely recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: PCR COVID test-Positive, Influenza Test-negative
Aktuelle Erkrankungen: none
Vorgeschichte: diabetes, kidney disease
Andere Medikamente: Januvia, atorvastatin, Losartan, Estradiol, Vitamin D, Allegra, Metamucil
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2269126

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 78,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 04.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 26,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Headache Malaise Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On 05/01/2022 I started with a runny nose, Monday I took the COVID-19 test because my sister called and told me they all had COVID-19 and we were all at the same event. I did a home test that was positive. And then I went and did a PCR, I called the doctor and told him I was positive and he ordered Paxlovid and I started it that night. On 05/04/2022 the PCR came back positive. I had very mild symptoms, no fever, just the runny nose and a little bit of a headache. I isolated for 5 days. On day 4, I was feelin fine, and I was over it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Home COVID-19 test positive, PCR positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroid GERD Chronic Pancreatitis
Andere Medikamente: Levothyroxine Prilosec Methyl Multivitamins w/o Iron AREDS 2 Turmeric Cranberry Omega 3 CoQ10 D-mannose Vitamin D3 Magnesium Vitamin C
Allergien: Penicillin Vancomycin IV dye Demerol Oxycontin
Vorherige Impfungen: -

VAERS 2268802

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MD
Alter: 78,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 11.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Headache Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID-19 breakthrough: I received my 2nd booster shot on 04/11/2022. I started experiencing adverse even on 04/27/2022 in the morning around 8:00AM. I tested positive on the same day, and I also tested every other day. I started with a deep cough, fever, and a headache. I took Paxlovid from 04/27/2022 for 5 days. I contacted my doctor the same day I tested positive, and I started taking the medication on the same night. Its May I still have cough, not as bad as before, but it's getting better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 home tests
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Blood Pressure Medication Clonidine Amlodipine Olmesartan Meloxicam Doxazosin Baby Aspirin at night
Allergien: N/A
Vorherige Impfungen: Old Shingles Vaccine: Hives

VAERS 2267523

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 69,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 06.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 21,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Nasal congestion Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I flew to attend a wedding. Somebody at the wedding was exposed to someone who had tested positive for COVID-19. Then a couple of my brothers and sisters caught it, and then I got it. I didn't have any severe symptoms. I had nasal congestion, a sore throat, and a fever at the highest being 101.7 degrees for a couple of days. I called my doctor, and I ended up speaking with a triage nurse. She suggested that I go to an urgent care. I went to an urgent care and they confirmed that I was positive for COVID-19. I was given a 5 day treatment of antivirals. My fever went away the next day after starting the medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 1st At Home COVID-19 Test- positive COVID-19 Test- positive 2nd At Home COVID-19 Test- positive (very faint line) 3rd At home COVID-19 Test- negative
Aktuelle Erkrankungen: None
Vorgeschichte: Morbid Obesity
Andere Medikamente: Multivitamins
Allergien: Raw Bananas (uncooked bananas) Hay Fever (possibly)
Vorherige Impfungen: -

VAERS 2267251

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: OH
Alter: 26,0
Geschlecht: F
Eingang: 09.05.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Product administered at inappropriate site

Symptomtext

Site: Pain at Injection Site-Medium, Additional Details: PATIENT THINKS VACCINE WAS GIVEN TOO HIGH IN THE ARM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266116

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 59,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 04.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 26,0
Dosis: 3
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Blood test normal COVID-19 Feeling abnormal Influenza A virus test negative Influenza B virus test Nasal congestion Nasopharyngitis Pain SARS-CoV-2 test positive

Symptomtext

4 /30 /2022 I woke up that morning and it felt like a really bad cold. I had a lot of aches and pains, more than usual. I lost my sense of taste, maybe my sense of smell. My nose was so stopped up, so I am not as sure if that is what caused it. I went to the Urgent Care. They tested for COVID-19 and it was negative. The rest of the week, I got progressively worse...The cold was really bad. I had to wait to find DAYQUIL and NYQUIL. I did not take it after I received it several days later because I felt really bad. I went back to Urgent Care and my COVID-19 test was positive. I started Remdesivir, NYQUIL and DAYQUIL. I started feeling a little better mid-morning today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: COVID-19 tests 2 were negative and 1 was positive FLU A and B All were negative Blood Work, normal
Aktuelle Erkrankungen: None
Vorgeschichte: MS
Andere Medikamente: Trazadone 50mg Melatonin Advanced Sleep 10mg Atorvastatin 10 mg Cialis 5mg Pregabalin 200 mg Tylenol Arthritis Vitamin D3 5000IU Vitamin B6 and B12 Magnesium 400 mg Metoprolol 12.5 mg
Allergien: INH
Vorherige Impfungen: Flu, felt like I had the flu with several vaccines, then it stopped. Shingles, felt very run down. Felt like a virus for couple.

VAERS 2264616

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 57,0
Geschlecht: F
Eingang: 05.05.2022
Impfdatum: 17.03.2022
Beginn: 08.04.2022
Tage bis Beginn: 22,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Chills Feeling abnormal Haemorrhage Lung disorder Malaise Nausea Pyrexia SARS-CoV-2 test negative Urine analysis normal Vomiting

Symptomtext

When I got up on the 8th I didn't feel good. I went to the bathroom and filled the toilet bowl with blood. I went to the emergency room. The doctor ran a urine test and there was no sign of infection. The doctor stated that it could possibly be a yeast infection but I had no signs of that. After she gave me some medicine I still didn't feel well. I felt run down and weak. On 4/22 I started feeling really bad. I had a high fever, chills, nausea, and vomiting. I went to urgent care they did a COVID test that came back negative, I was prescribed an inhaler, Z-PAK and a steroids. All they knew was there was something affecting my lungs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Urine test; COVID test- negative.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Naproxen Sodium
Allergien: Codeine Vicodin Hydrocodone
Vorherige Impfungen: -

VAERS 2264567

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 68,0
Geschlecht: M
Eingang: 05.05.2022
Impfdatum: 13.04.2022
Beginn: 24.04.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Headache Hypersomnia Nasal congestion Nasopharyngitis SARS-CoV-2 test positive

Symptomtext

Sunday evening 04/24/2022, I noticed some head cold like symptoms with minor stuffiness and headache. I did an at home COVID-19 test the next morning on 4/25/2022 which was negative. The cold symptoms remained and got a bit worse. I was experiencing fatigue and headache so I was sleeping a lot for the next few days. On Thursday, I tested again and it came back positive. So I called the doctor who prescribed antivirals and advised that I increase my vitamin D and water intake and lowered my recommended blood pressure medication dosage. Overall it has been a mild case, perhaps a 6 on a scale of 1 to 10.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: At Home COVID-19 Tests
Aktuelle Erkrankungen: None
Vorgeschichte: A-fib High blood Pressure Irregular Heartbeat Chronic Kidney Disease Gout
Andere Medikamente: Diltiazem 360mg Chlorthalidone 25mg Alopurinol 300mg Uric Acid Support Centrum for Adults Vitamin D3 Vitamin C 1000mg Vitamin E
Allergien: Nexium
Vorherige Impfungen: -

VAERS 2262042

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

mild

Staat: CA
Alter: 71,0
Geschlecht: F
Eingang: 03.05.2022
Impfdatum: 02.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 24,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Eye disorder Headache

Symptomtext

eye issues, headache,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2258636

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NJ
Alter: 75,0
Geschlecht: M
Eingang: 29.04.2022
Impfdatum: 04.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Dizziness Fatigue Headache SARS-CoV-2 test positive

Symptomtext

Apr 11, I felt dizzy, then you felt tired and a headache. I tested positive for three home tests. I called the doctor on Apr 12. I was fine in one week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: 3 Home COVID-19
Aktuelle Erkrankungen: No
Vorgeschichte: Mitral Valve Prolapse
Andere Medikamente: N/A
Allergien: Lactose Intolerant; Dilaudin; whatever that is in Aleve-Naproxen
Vorherige Impfungen: -

VAERS 2256736

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: RI
Alter: 75,0
Geschlecht: F
Eingang: 28.04.2022
Impfdatum: 04.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Feeling abnormal Malaise Oropharyngeal pain SARS-CoV-2 test positive Sneezing

Symptomtext

On 4/20 I started having a sore throat and I ended up doing a home test which came back negative. On the 23rd I was still feeling poorly and was planning on visiting my daughter and wanted to make sure I was not COVID-19 positive in which case I would have cancelled the trip. I tested twice that day and both came back negative so did end up visiting her that Sunday. On Monday I was still not feeling well, coughing, sneezing, and the sore throat continued. I called my doctor's office, and they could not get me so they sent me to urgent care. Tuesday the 26th I did go to urgent care tested positive on a PCR test. Today I am still symptomatic, but the sore throat has calmed down. I did get the Monoclonal antibody treatment last night and if I am symptom free on Monday, I will be able to return to work.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: At home COVID-19 test; PCR COVID-19 test
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; High Cholesterol; Osteopenia
Andere Medikamente: Calcium with Vitamin D, Vitamin B12, Lisinopril , Atorvastatin, Fosamax
Allergien: None
Vorherige Impfungen: -

VAERS 2254596

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: OH
Alter: 65,0
Geschlecht: F
Eingang: 27.04.2022
Impfdatum: 27.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Injection site swelling Interchange of vaccine products

Symptomtext

CLIENT CAME TO WALK-IN COVID CLINIC AT HEALTH DEPARTMENT AND REQUESTED 2ND BOOSTER DOSE DUE TO UPCOMING TRAVEL. CLIENT DID NOT HAVE COVID CARD AND STATED SHE HAD J&J INITIAL DOSE IN MARCH 2021. CLIENT REQUESTED MODERNA BOOSTER. THIS RN GAVE 0.5 ML MODERNA VACCINE TO LEFT DELTOID. AFTER REALIZING INCORRECT DOSAGE GIVEN TO CLIENT, THIS RN HAD CLIENT WAIT 30 MINUTES AFTER RECEIVING BOOSTER DOSE. INJECTION SITE ASSESSED AFTER 30 MINUTES - SLIGHTLY PUFFY AT INJECTION NEEDLE SITE. CLIENT ALERT AND ORIENTED X3. NO C/O OF SIDE EFFECTS/ADVERSE EFFECTS. CLIENT INFORMED THAT VAERS REPORT WOULD BE SUBMITTED BY DEPARTMENT. CLIENT LEFT CLINIC AT 9:30 AM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site swelling
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 2252810

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: WA
Alter: 39,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 26.03.2022
Beginn: 26.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Headache

Symptomtext

Adult pt thought that 1st dose was Pfizer and requested 2nd dose in series be Moderna. Moderna 0.5 ml dose was administered based on this. It was discovered later that pt had actually not received Pfizer but, Janssen (one dose) given on 2/10/2022. Pt reports that he has been experiencing frequent headaches since receiving the 1st Covid vaccine on 2/10/2022. He denies any changes since receiving dose on 3/26/22. I recommended that he see a medical provider d/t reports of headaches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2252208

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.02.2022
Beginn: 23.02.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Pain

Symptomtext

Arm still hurts at injection site after second Moderna Covid Shot in series after a little over 2 months. Hurts to move arm backwards (opposite of lift). SJe mentioned this to PCP at recent visit. He said sometimes people require steroid injection due to that

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: Sleep issues, Metabolic Syndrome, Hypertension. High Cholesterol, Anemia, Heart Burn, Depression
Andere Medikamente: Losartan, Duloxetine, Elavil, Carvedilol, Pantoprazole, Ferrous Sulfate, HCTZ, Metformin, Albuterol Inhaler
Allergien: Tramadol, NSAIDS, Penicillin, Macrolides, Celebrex
Vorherige Impfungen: -

VAERS 2250218

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 26,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 11.03.2022
Beginn: 12.03.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Injection site rash Pruritus Rash Rash erythematous Rash papular Rash pruritic Skin discolouration Skin texture abnormal

Symptomtext

I didn?t notice it until a day or two after my vaccine, but I developed a rash all over my face and at my injection site. My skin was covered in teeny, tiny bumps, my face was red all over, and I was mildly itchy. I gave it a couple of days to see if it lessened, and then I contacted my doctor. They told me to take Benadryl at night for a few days. This helped the bumps smooth out, but my skin was still covered in red marks where each bump had been. I continued the Benadryl for a couple of weeks and also tried Benadryl and hydrocortisone cremes. After a month, my skin was smooth, the correct color, and only had a few red marks on either cheek. At this point I stopped treatments beyond my regular Zyrtec and aloe Vera. About 10-12 days later, I noticed the raised, itchy, red bumps were coming back on my face (but not on my arm). It did not come back as strongly as before, but it was obviously back. I contacted my doctor again, who told me to use hydrocortisone cr?me twice a day for 3-4 weeks and if it is still not gone, I will be referred to a dermatologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site rash
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Ulcerative colitis flare up in February. Prednisone taken from 2/11/22-3/10/22
Vorgeschichte: Ulcerative Colitis PCOS Asthma
Andere Medikamente: Remicade, Mesalamine, Zyrtec, Junel Fe 1.5/30, Montelukast, Symbicort
Allergien: None
Vorherige Impfungen: -

VAERS 2250157

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NV
Alter: 27,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 24.03.2022
Beginn: 03.04.2022
Tage bis Beginn: 10,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Delivery Erythema Exposure during pregnancy Pruritus Urticaria

Symptomtext

I was pregnant at the time. It started off as severe itching all over my body, however I did not have a rash. I sought care from my OBGYN because I thought it was a side effect of being pregnant. I got blood work to see if it was cholestasis. My OBGYN put me on medication in case it was cholestasis. I ended up going into labor a week later. The symptom are still present. The itching hasn't gotten any better. Whenever I have any kind of skin contact it results in redness, welts and itchiness in that area. My estimated date of delivery was April 22nd, I delivered my baby early, The birth weight was 7 pounds 14 ounces.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: Blood work
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Prenatal
Allergien: None
Vorherige Impfungen: -

VAERS 2247954

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: IN
Alter: 61,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 20.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Muscular weakness Pyrexia Vomiting

Symptomtext

3 Pfizer : no reactions 1 Moderna: continuous vomiting, fever of 102, headache, muscle weakness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Foods
Vorherige Impfungen: -

VAERS 2243762

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: GA
Alter: 66,0
Geschlecht: F
Eingang: 20.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immunisation reaction Injection site induration Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Itching and burning at shot site. Next day it got enlarged and hard feeling. Also itching terribly. I think they call it COVID arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site induration
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: Bacterial Infection
Vorgeschichte: Lung Disease- Lams; Afib; Diabetes; Arthritis
Andere Medikamente: Sotalol Eliquis Crestor Cozaar Vascepa Anastrozole Seroquel Calcium Vitamin D3 and C Probiotics Multivitamin Metformin
Allergien: Versed Petromax Amoxicillin Latex
Vorherige Impfungen: -

VAERS 2235907

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

mild

Staat: HI
Alter: 63,0
Geschlecht: F
Eingang: 15.04.2022
Impfdatum: 25.02.2022
Beginn: 26.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain

Symptomtext

Site: Pain at Injection Site-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2233703

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 58,0
Geschlecht: F
Eingang: 14.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration Injection site pain Injection site pruritus Injection site swelling

Symptomtext

This COVID booster (#2) was given SQ instead of IM. I had no reaction as I had with previous vaccines (flu-like symptoms) and I have a swollen, tender, itchy area where the vaccine was given subcutaneously. I called Allergy dr and the message sent to me was that Dr said I would have an immune response anyway. Nothing else. It is too early to know if there will be other issues with this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: asthma
Andere Medikamente: Wellbutrin, Levothyroxine, Vitamin D3 and K2, Cod Liver Oil, Escitalopram, Montelukast, "Sleep 3", Dulera Inhaler, Qnasl,
Allergien: Sulfa medications, Codeine, Erythromycin, Milk protein
Vorherige Impfungen: -

VAERS 2231193

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 68,0
Geschlecht: M
Eingang: 13.04.2022
Impfdatum: 09.04.2022
Beginn: 12.04.2022
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cellulitis Chills Injection site erythema Pain

Symptomtext

He got his vaccine, had no initial reaction other than chills that went away within a day. He had soreness and pain, but thought that was normal. He had redness around vaccine area, probably about circumference of about 3". He marked it to see if it was growing. He saw his cardiologist who diagnosed him with cellulitis and was prescribed antibiotics, which he has not started yet. He then notified his PCP which told him to continue on that regimen. He was instructed to keep an eye on it, he marked the area with a pen to see if it gets larger and worsens.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: High blood pressure, diverticulitis, acid reflux.
Andere Medikamente: Omeprazole 40 mg, Hydrochlorothiazide 12.5 mg, Diltiazem 180 mg.
Allergien: Cipro, Protonix.
Vorherige Impfungen: -

VAERS 2231137

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 57,0
Geschlecht: F
Eingang: 13.04.2022
Impfdatum: 31.03.2022
Beginn: 31.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Axillary pain Breast swelling Fatigue Headache Hyperhidrosis Injection site pain Pain Swelling

Symptomtext

She got her vaccine, the minute it went in it stung. The next day she had pain in her left armpit, which she did not have with the 1st 2. Then she had tiredness, slight headache, but that went away in a couple of days. The stinging armpit area is bothering her, it is always there and when she sweats it is worse and uses cold compresses to calm it down. Everything in that area felt swollen, including her breasts. She called her doctor and cannot go see him until she gets new insurance in place.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None.
Vorgeschichte: Hypothyroidism.
Andere Medikamente: Synthroid.
Allergien: Latex.
Vorherige Impfungen: -

VAERS 2228665

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 68,0
Geschlecht: F
Eingang: 12.04.2022
Impfdatum: 05.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Muscular weakness Pain Pain in extremity Peripheral swelling Pyrexia Ultrasound scan normal

Symptomtext

At first normal/expected fever, exhaustion and body aches, but graduated into severe throbbing in my right arm and swelling of my little finger and ring finger. Started upon waking Friday am and visited urgent care on Sunday afternoon. An ultrasound was performed on Monday and no evidence of a blood clot was seen, but throbbing has continued, though less severe today, but some weakness still persists in my right (injecton) arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Ultrasound - 4/11/2022 12:30pm, Radiology - did not show any signs of a blood clot
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: Ramipril, Synthroid, Atorvastatin, Hydrochlorothiazide, Calcium w/D,
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2225940

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: TX
Alter: 53,0
Geschlecht: F
Eingang: 11.04.2022
Impfdatum: 05.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Lymph node pain Lymphadenopathy Myalgia

Symptomtext

Severe chills, Muscle aches, and development of approx 2 cm enlarged painful lymph node in the LT axilla which has taken a week to diminish in size

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: NONE
Vorgeschichte: Hypothyrodism , RT wrist giant cell tumor
Andere Medikamente: Levothyroxine 125 mcg, ASA 81mg, Super B complex Vitamin, Vitamin D3 5000IU I-Thyroid 12.5 mg , probiotic 10 Billion CFU, Womens Multivitamin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2225509

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: AZ
Alter: 66,0
Geschlecht: M
Eingang: 10.04.2022
Impfdatum: 09.04.2022
Beginn: 10.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Myalgia Pyrexia

Symptomtext

High grade fever (103 degrees F), severe myalgia/arthralgia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Anxiety, depression
Andere Medikamente: Mupirocin, bupropion, clonazepam
Allergien: None
Vorherige Impfungen: -

VAERS 2222992

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 84,0
Geschlecht: F
Eingang: 08.04.2022
Impfdatum: 06.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Decreased appetite Dizziness Insomnia Nausea

Symptomtext

Dizziness began 2nd day after booster at approx 3am-woke me up from sleep; difficulty returning to sleep Nausea began at the same, No vomiting, loss of appetite continues to the time of this report *Note: patient did not experience any sides effects, including those listed here, from previous 3 Covid Vaccine injections

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure Overactive Bladder (OAB)
Andere Medikamente: RX: Losartan-Potassium 50mg Myrbetriq 50mg Vitamin D3 400iu
Allergien: None
Vorherige Impfungen: -

VAERS 2220168

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: OH
Alter: 58,0
Geschlecht: F
Eingang: 07.04.2022
Impfdatum: 01.04.2022
Beginn: 03.04.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash erythematous Rash papular

Symptomtext

Red raised rash, possible hives, within 48 hours of vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash erythematous
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Had COPD exacerbation with possible bacterial source 1 month prior
Vorgeschichte: COPD, osteoporosis, prediabetes, depression, fibromyalgia
Andere Medikamente: Albuterol, fosamax, baclofen, vitamin D, vitamin B12, Advair, lasix, ibuprofen, metformin, effexor
Allergien: Celebrex, sulfa, cymbalta, doxycycline, savella, Prolia, wellbutrin.
Vorherige Impfungen: -

VAERS 2218064

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: PA
Alter: 68,0
Geschlecht: M
Eingang: 06.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Insomnia Pain

Symptomtext

Severe throbbing pain at site of injection approximately 4 hours after administration that would not diminish after ice or ibuprofen. Unable to move arm without having severe pain. Unable to sleep due to pain. On 4/4/22 finally called PCP for further treatment which included pain medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: omeprazole, Tamsulosin, Losartan,, montelukast, pravastatin
Allergien: None
Vorherige Impfungen: -

VAERS 2215927

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 32,0
Geschlecht: F
Eingang: 05.04.2022
Impfdatum: 17.03.2022
Beginn: 28.03.2022
Tage bis Beginn: 11,0
Dosis: 3
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Mechanical urticaria Urticaria

Symptomtext

Urticaria/hives of trunk, shoulders, forearms, legs and dermatographism beginning 3/28/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mechanical urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2213467

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: OH
Alter: 39,0
Geschlecht: M
Eingang: 04.04.2022
Impfdatum: 26.02.2022
Beginn: 01.03.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Feeling abnormal Pruritus Pyrexia Rash Vaccination site rash Vaccination site reaction

Symptomtext

Covid arm; Rash on vaccination site left arm, 48 hours after 2nd shot; Felt warm day after 2nd shot, Fever unmeasured day after 2nd shot; front right elbow has a rash, he has been breaking out in other spot; looked like something bit him; neck is itchy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (looked like something bit him), PRURITUS (neck is itchy), VACCINATION SITE REACTION (Covid arm), RASH (front right elbow has a rash, he has been breaking out in other spot) and VACCINATION SITE RASH (Rash on vaccination site left arm, 48 hours after 2nd shot) in a 39-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 048L21A and 027L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Skin rash. On 26-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Mar-2022 at 4:00 PM, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. In March 2022, the patient experienced FEELING ABNORMAL (looked like something bit him), PRURITUS (neck is itchy) and RASH (front right elbow has a rash, he has been breaking out in other spot). On 27-Mar-2022, the patient experienced PYREXIA (Felt warm day after 2nd shot, Fever unmeasured day after 2nd shot). On 28-Mar-2022, after starting mRNA-1273 (Spikevax), the patient experienced VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE RASH (Rash on vaccination site left arm, 48 hours after 2nd shot). On 28-Mar-2022, PYREXIA (Felt warm day after 2nd shot, Fever unmeasured day after 2nd shot) had resolved. At the time of the report, FEELING ABNORMAL (looked like something bit him), PRURITUS (neck is itchy), RASH (front right elbow has a rash, he has been breaking out in other spot) and VACCINATION SITE RASH (Rash on vaccination site left arm, 48 hours after 2nd shot) outcome was unknown and VACCINATION SITE REACTION (Covid arm) was resolving. Patient reported that he is prone to skin rash and it has happened prior to vaccination several times, he usually applies a cream and it goes away. Patient did not experience any side effect from first dose. He confirmed that he did not have a rash anywhere else on his body at that time and also stated on 31 MAR 2022, COVID arm was improving. Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2022: Follow-up received includes medical history, dose 1 details, event fever added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Skin rash
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2213039

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 40,0
Geschlecht: F
Eingang: 02.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling abnormal Lethargy Maternal exposure during breast feeding Pain in extremity

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breast feeding), FEELING ABNORMAL (head fog), LETHARGY (lethargic) and PAIN IN EXTREMITY (sore arm) in a 40-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 30-Mar-2022, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breast feeding), FEELING ABNORMAL (head fog), LETHARGY (lethargic) and PAIN IN EXTREMITY (sore arm). On 30-Mar-2022, MATERNAL EXPOSURE DURING BREAST FEEDING (breast feeding), FEELING ABNORMAL (head fog) and LETHARGY (lethargic) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medication were reported. It was reported, patient had a child on 25-OCT-2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2211442

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21a

mild

Staat: MD
Alter: 44,0
Geschlecht: F
Eingang: 01.04.2022
Impfdatum: 21.03.2022
Beginn: 22.03.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site swelling Lymphadenopathy Oedema peripheral

Symptomtext

Site: Swelling at Injection Site-Medium, Systemic: swelling of the left armpit-Medium, Systemic: Lymph Node Swelling-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site swelling
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2210243

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: WA
Alter: 78,0
Geschlecht: M
Eingang: 31.03.2022
Impfdatum: 18.03.2022
Beginn: 18.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dry skin Erythema Injection site reaction Pruritus

Symptomtext

injection site reaction that spread to neck, arm and across chest. Skin was red, itchy and rough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2209994

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 85,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling cold Gait disturbance Gingival pain Incontinence Pain

Symptomtext

Bones felt like they were frozen. Gum line at site of each tooth ached as if I had been punched in the mouth (would soon lose all my teeth). Loss of bladder control. For 4 hours, pain so severe I felt I could not walk to medicine cabinet for Tylenol pain relief. By 3:00 am the next morning (Mar 31), I took a Tylenol and able to fall asleep. Don't know if the Tylenol eased the pain, or if the symptoms subsided on their own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Gingival pain
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: Glaucoma
Andere Medikamente: Dorzolamide, Timolol, Vyzulta, Rhopressa, Acetazolamide, Atorvastatin, Myrbetriq, Multivitamins/Minerals, Calcium, Fish oil (recently stopped using)
Allergien: Alphagan, Bacitracin
Vorherige Impfungen: -

VAERS 2209247

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 43,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 07.12.2021
Beginn: 17.12.2021
Tage bis Beginn: 10,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Pruritus Stool analysis Urticaria

Symptomtext

Approximately around 10 days after my booster shot I experienced the following symptoms: Hives (Different parts of my body), Itchiness. I have taken some Benadryl to try ease the symptoms but it did not do anything to improve the situation. I called my doctor and had a Telehealth appointment and was prescribed with Prednisone and some other medication and it did help ease the itchiness. When I stopped taking the medications I would start to have some small flare up from different parts of my body even up to this day (03/31/2022). I saw a dermatologist and prescribed me with Montelukast, Allegra and Zyrtec.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: Blood work, Stool sample.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2209162

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 21,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 28.03.2022
Beginn: 29.03.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Bone pain Fatigue Headache Interchange of vaccine products Pain Pruritus Vomiting

Symptomtext

Four hours after vaccination patient began vomiting, experienced headache, diffuse body aches, as well as diffuse itching of her skin. She took Benadryl which reduced the itching, but did not resolve it. The day after vaccination she continued to vomit as well as experience fatigue, diffuse bone and joint aching, as well as continued itching and headache. Patient was seen in my office two days after vaccination and was still experiencing diffuse itching, as well as joint and bone aching and a headache.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None indicated so far.
Aktuelle Erkrankungen: none
Vorgeschichte: anemia
Andere Medikamente: Liletta IUD
Allergien: Johnson and Johnson Covid-19 vaccine
Vorherige Impfungen: Hives,dyspnea, and fever, 20yrs old, 9/2021, Johnson and Johnson Covid-19 vaccine

VAERS 2208942

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 48,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 28.03.2022
Beginn: 28.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Glossodynia Neck pain Pharyngeal swelling Swollen tongue Vaccination site pain

Symptomtext

swollen tongue; swollen throat; pain around tongue; pain around neck; Arm pain around injection site; This spontaneous case was reported by an other caregiver and describes the occurrence of SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site) in a 48-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Mar-2022, the patient experienced SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), GLOSSODYNIA (pain around tongue), NECK PAIN (pain around neck) and VACCINATION SITE PAIN (Arm pain around injection site) had not resolved. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. No concomitant medications were reported. Patient was planning to go to emergency room for check-up for all the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Neck pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2206937

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: IN
Alter: 29,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Headache Injection site pain Nausea Pain Pyrexia Tinnitus Vomiting

Symptomtext

Both vaccines once given I had side effects within 2-3 hours. Listed below: High fever (101-102 F) 2-3 days long Full body aches Nausea Headache Severely sore arm pain at location of shot Vomiting (first day/night) Ringing in ears Light headed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2201806

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: 62,0
Geschlecht: F
Eingang: 28.03.2022
Impfdatum: 18.03.2022
Beginn: 21.03.2022
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inflammation Rash Rash erythematous Rash pruritic

Symptomtext

Patient reported red itchy and inflamed rash on both arms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: malignant tumor of breast, mixed hyperlipidemia, prediabetes, rheumatoid arthritis.
Andere Medikamente: none
Allergien: Cephalexin, clindamycin, methotrexate, penicillin's, phenytoin sodium, and phenytoin sodium extended
Vorherige Impfungen: -

VAERS 2201587

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: OH
Alter: 36,0
Geschlecht: M
Eingang: 28.03.2022
Impfdatum: 25.03.2022
Beginn: 26.03.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Body temperature increased Chills Nausea Pain Urine analysis Vomiting

Symptomtext

103.5 temp for several hours Body aches Chills Nausea Vomiting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Urinalysis
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: OTC, Creatine supplement OTC, Prilosec
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2196581

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NJ
Alter: 21,0
Geschlecht: F
Eingang: 24.03.2022
Impfdatum: 25.02.2022
Beginn: 08.03.2022
Tage bis Beginn: 11,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mechanical urticaria Pruritus Throat tightness Urticaria

Symptomtext

Intense itching, dermatographia, urticaria full body 10 days after booster dose. Began in scalp and spread to neck, ears, rest of body. Throat tightening but no angioedema or difficulty breathing. Over 1 month since onset of symptoms and little to no change of symptoms after hydrocortisone, prednisone, and daily antihistamine (Zyrtec).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mechanical urticaria
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: post-concussion syndrome
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2179787

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: KY
Alter: 55,0
Geschlecht: F
Eingang: 15.03.2022
Impfdatum: 11.03.2022
Beginn: 11.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Feeling abnormal Gait disturbance Injection site erythema Injection site pain

Symptomtext

Patient received Moderna Booster dose of 0.25ml IM on 3/11/2022. Called clinic on 3/15/22. Reports had weakness and "felt out of her head" beginning on 3/11/22. Reports on 3/12/22 had difficulty walking. Continues to have soreness and redness to injection site. Reports symptoms have all resolved except for the arm soreness. Did not seek medical treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2177630

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: OH
Alter: 40,0
Geschlecht: F
Eingang: 14.03.2022
Impfdatum: 07.03.2022
Beginn: 12.03.2022
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cheilitis Feeling hot Rash Rash erythematous Rash papular

Symptomtext

On 3/12/2022 my face was feeling very hot and then I noticed my entire face was covered in a raised, red rash. It was covering my cheeks, chin, and upper lip area. It was rad and warm, not itchy. I took Ibuprofen and after two days now it seems to have gone almost completely away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: fish oil
Allergien: thimerosal
Vorherige Impfungen: -

VAERS 2173190

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CA
Alter: -
Geschlecht: U
Eingang: 11.03.2022
Impfdatum: 28.02.2022
Beginn: 01.03.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Headache Impaired work ability Pain Pyrexia

Symptomtext

Sick x8 days with headache. Received required booster (I am an RN at a Medical Center) on 2/28/22 per recommendation for health care workers. I had 3 days of body aches, low grade temperature, and 8 days of severe headaches. This required 3 days of sick calls.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 2167766

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

mild

Staat: TN
Alter: 20,0
Geschlecht: F
Eingang: 09.03.2022
Impfdatum: 27.02.2022
Beginn: 07.03.2022
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema

Symptomtext

Site: Redness at Injection Site-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2155720

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NJ
Alter: 36,0
Geschlecht: F
Eingang: 03.03.2022
Impfdatum: 21.02.2022
Beginn: 22.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache

Symptomtext

headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: lamortigine, vit d, c, calcium, iron, multivitamins
Allergien: nka
Vorherige Impfungen: -

VAERS 2151400

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CO
Alter: 25,0
Geschlecht: F
Eingang: 01.03.2022
Impfdatum: 01.03.2022
Beginn: 01.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Illness Nausea Tinnitus Vomiting

Symptomtext

10:20 AM Emesis liquid mucous. Resp intacr. No food intake today. Initially ringing in ears. 15 mins post vaccine. 10:25 am 136/90-HR 98- R 18- O2 Sat 93% Cont nausea 10:30 am Cont nausea 10:35 am Nausea easing 10:40 am 122/83- HR 96 - R 16- O2 Sat 94% Pt feels ok to leave and plans to eat. Boyfriend said she may be pregnant. Pt called back to clinic later and said dgt sick and vomting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: 2/23/22 UTI
Vorgeschichte: No significant history
Andere Medikamente: 2/23/22 Macrobid
Allergien: NKA
Vorherige Impfungen: -

VAERS 2147492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: CT
Alter: 55,0
Geschlecht: F
Eingang: 27.02.2022
Impfdatum: 24.02.2022
Beginn: 25.02.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Injection site erythema Injection site pain Injection site swelling Skin warm

Symptomtext

Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: pt said that she started getting a sore arm that is red and hot and swollen. It is getting worse (now 2 days after) not better. I told her to go to urgent care to have it looked at.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2136774

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21A

mild

Staat: NY
Alter: 31,0
Geschlecht: F
Eingang: 24.02.2022
Impfdatum: 20.02.2022
Beginn: 23.02.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Injection site erythema Injection site pruritus Injection site swelling Pruritus

Symptomtext

Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Patient complaining of injection site redness and swelling, extremely red (pt will take antihistamine and make appt with provider to get further guidance)-Severe

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2135372

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: SD
Alter: 59,0
Geschlecht: F
Eingang: 23.02.2022
Impfdatum: 22.02.2022
Beginn: 22.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Injection site erythema Injection site pain Injection site swelling Pain Vaccine positive rechallenge

Symptomtext

Large, red, warm, painful bump on administration arm at and around site of injection. Started later in the day after her dose. This happened on the first dose too and lasted several days. Also experienced fatigue, body aches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Macrolides, Penicillins
Vorherige Impfungen: Same exact results with Dose 1 in January 2022.

VAERS 2134559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 46,0
Geschlecht: F
Eingang: 23.02.2022
Impfdatum: 16.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Headache Laboratory test Lymphadenopathy Myalgia Pain

Symptomtext

Achy body, headache, chills, muscle pain, and swollen lymph nodes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Labs
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Adderall, estradiol
Allergien: -
Vorherige Impfungen: -

VAERS 2134291

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: RI
Alter: 35,0
Geschlecht: F
Eingang: 23.02.2022
Impfdatum: 18.02.2022
Beginn: 19.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Burning sensation Pruritus Rash Rash erythematous Urticaria

Symptomtext

Red rash/hives on breasts and abdomen. Burning/itching. Not relieved with Benadryl. Lasted for 48 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: -
Andere Medikamente: Methylphenidate ER, Lexapro
Allergien: n/a
Vorherige Impfungen: -

VAERS 2126426

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

mild

Staat: DC
Alter: 59,0
Geschlecht: F
Eingang: 19.02.2022
Impfdatum: 17.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Additional Details: After the vaccine the patient reported that they were dizzy and felt lightheaded. The patient was given water to drink and later taken to the emergency room. Prior to the vaccines, the patient reported that they were at the doctors office and they got blood drawn.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2123570

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: TX
Alter: 32,0
Geschlecht: F
Eingang: 18.02.2022
Impfdatum: 16.02.2022
Beginn: 18.02.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Facial pain Lip swelling Pain in extremity

Symptomtext

Patient has recent lip filler and called complained about increase in lip swelling and facial and arm pain. Patient was advised to take Benadryl and seek medical attention. Patient stated no anaphylaxis reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2113137

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MI
Alter: 31,0
Geschlecht: F
Eingang: 15.02.2022
Impfdatum: 12.11.2021
Beginn: 23.11.2021
Tage bis Beginn: 11,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Pruritus Rash Urticaria

Symptomtext

Began with itching on head and chest and turned into body wide hives a little over a week after vaccination. Needing urgent care visit with starting zyrtec twice a day, steroid cream, and oral steroid. Rash improved over course of 10 day oral steroid but once the oral steroid was completed within 48 hours the rash/hives came back on neck, head, arms, and chest. Dermatologist seen for follow-up visit for acne and was given diagnosis of hives and the doctor thought likely from the COVID booster. Steroid injection given and Allegra added. Still taking zyrtec twice a day and Allegra once a day with occasional itchiness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension, thyroid nodule, depression/anxiety
Andere Medikamente: birth control, lisinopril, hydrochlorothiazide, synthroid, pristiq, trazodone, spironalact
Allergien: augmenton - rash
Vorherige Impfungen: -

VAERS 2112616

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: SC
Alter: 52,0
Geschlecht: F
Eingang: 15.02.2022
Impfdatum: 14.02.2022
Beginn: 14.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site extravasation Injection site pain

Symptomtext

Site: Pain at Injection Site-Mild, Additional Details: Gave 0.5ml 3rd dose to immunocompromised patient; dose immediately leaked out of her arm, down to elbow and onto chair. I called Moderna and was advised to repeat the full 0.5ml dose. Wanted to document this here, in case needed in the future.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site extravasation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2109590

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MA
Alter: 67,0
Geschlecht: F
Eingang: 13.02.2022
Impfdatum: 11.02.2022
Beginn: 12.02.2022
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Hyperacusis Hypersomnia Nausea Photophobia Vertigo

Symptomtext

Was very tired the next day and took a 2 hour nap around 2 pm, feeling better after waking. Vertigo started the following afternoon and by the 24 hour mark was totally incapacitating. I couldn't stand any noise or light and became overwhelmingly nauseous with vomiting occurring around 8 pm. After sleeping for an hour the nausea was gone but the vertigo remained to the point where I needed assistance to safely get to the bathroom. By about 11 pm the vertigo subsided significantly and I was able to walk unaided again. I slept for 11 hours and today (Feb 13, 2022) I'm only feeling somewhat tired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Covid 19 Jan.25, 2022
Vorgeschichte: SLE, Reynauds
Andere Medikamente: OTC ibuprofen
Allergien: teteanus shots reactions
Vorherige Impfungen: tetanus booster, age approx 19 and 29, high fever (above 103) and delusions, brand not known

VAERS 2109428

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: MD
Alter: 33,0
Geschlecht: F
Eingang: 12.02.2022
Impfdatum: 11.02.2022
Beginn: 12.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Chills Diarrhoea Nausea Pain

Symptomtext

Chills & Body Aches started at 11am Stomach cramping / Nausea/ Diarrhea 5pm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: None
Vorgeschichte: NA
Andere Medikamente: Adderall XR, Wellbutrin, ibuprofen
Allergien: NA
Vorherige Impfungen: -

VAERS 2095976

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

mild

Staat: NY
Alter: 85,0
Geschlecht: F
Eingang: 08.02.2022
Impfdatum: 08.02.2022
Beginn: 08.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pruritus Urticaria

Symptomtext

patient was vaccinated at ~9:50 am. Daughter decided to give patient an ibuprofen "just in case she had side effects" around 12:30-1:00. Shortly thereafter, patient started to itch on scalp and palms of hands and "a couple" of hives noted on back. patient was advised to take a benadryl. Daughter reports that one hour later, patient is symptom free. Advised to call pcp to report this, as patient may be allergic to the ibuprofen. Patient does not usually take ibuprofen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM2, HTN, elevated Cholesterol
Andere Medikamente: Metoprolol, atorvastatin, metformin
Allergien: Denies
Vorherige Impfungen: -

VAERS 2092849

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

mild

Staat: FL
Alter: 54,0
Geschlecht: F
Eingang: 07.02.2022
Impfdatum: 01.02.2022
Beginn: 06.02.2022
Tage bis Beginn: 5,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dysgeusia Headache Interchange of vaccine products Pyrexia

Symptomtext

Metallic taste in mouth, fever 103 chills and headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Iodine
Vorherige Impfungen: Pfizer

VAERS 2664919

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 96,0
Geschlecht: F
Eingang: 02.08.2023
Impfdatum: 26.03.2022
Beginn: 02.11.2022
Tage bis Beginn: 221,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 1/19/21 lot# 011L20A; Moderna 2/16/21 lot# 004M20A; Moderna 3/26/22 lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2645460

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 027L21A

gering

Staat: MN
Alter: 77,0
Geschlecht: M
Eingang: 15.06.2023
Impfdatum: 27.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Drug ineffective; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 77-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Sep2022 as dose 5 (booster), single (Lot number: 027L21A) at the age of 77 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulpha drugs" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN, start date: 01Aug2021, stop date: 31May2023; LISINOPRIL, start date: 01Aug2021. The following information was reported: COVID-19 (medically significant) with onset 2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset 2023, outcome "unknown". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with Paxlovid from 31May2023 to 05Jun2023. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300219453 Same reporter/patient, different product/AE.;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy
Andere Medikamente: ROSUVASTATIN; LISINOPRIL
Allergien: -
Vorherige Impfungen: -

VAERS 2645192

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 14.06.2023
Impfdatum: 11.02.2022
Beginn: 23.03.2022
Tage bis Beginn: 40,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Obstructive sleep apnoea syndrome

Symptomtext

OBSTRUCTIVE SLEEP APNEA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Obstructive sleep apnoea syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2629758

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 10.05.2023
Impfdatum: 03.04.2022
Beginn: 12.05.2022
Tage bis Beginn: 39,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines mOderna 1/20/21 Lot# 027L20A; Moderna 2/17/21 Lot# 007M20A; Moderna 11/2/21 Lot# 017F21A; Moderna 4/3/22 Lot# 027L21A;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627022

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 63,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 29.03.2021
Beginn: 29.06.2021
Tage bis Beginn: 92,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Biopsy bone marrow Blood smear test Blood test abnormal Infusion Neutrophil count decreased Platelet count decreased White blood cell count decreased

Symptomtext

Provider told me my platelet count was low and to stop donating platelets (July/2021) Annual Physical blood work showed platelets, WBC and neutraphils were below normal range (Dec /2021) Referal to Hemotologist Hemotogist observed for 9 months. Blood work continued to be below normal range for platelets, WBC and neutraphils. No treatments were administerd. Annual Physical blood work showed platelets, WBC and neutraphils still below normal range. 2nd hemotologist was referred. (11/2022) Under Dr. care, one iron infusion treatment (3/13/2023 & 3/16/2023). Bone marrow biopsy for suspect pancytopenia (procedure done on 4/27/2023).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Biopsy bone marrow
Hospital-Tage: -
Labordaten: Various blood smear tests Bone Marrow Biopsy 4/27/2023
Aktuelle Erkrankungen: none
Vorgeschichte: seasonal allergies
Andere Medikamente: Loratatin, multi-vitamin, vitimin D,
Allergien: shell fish, chocolate, strawberries, sun dried tomatoes,
Vorherige Impfungen: -

VAERS 2621347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 67,0
Geschlecht: F
Eingang: 26.04.2023
Impfdatum: 18.04.2022
Beginn: 18.07.2022
Tage bis Beginn: 91,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Obstructive sleep apnoea syndrome

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Obstructive sleep apnoea syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2612251

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 56,0
Geschlecht: F
Eingang: 10.04.2023
Impfdatum: 05.04.2022
Beginn: 05.04.2023
Tage bis Beginn: 365,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Productive cough Sputum discoloured

Symptomtext

I had a very bad cough, a little yellow fluid. I am at home recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Productive cough
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Breast Cancer; Lower Back; High Blood Pressure; Anxiety
Andere Medikamente: Clonidine; clonazepam; pantoprazole; lisinopril; venlafaxine; gabapentin; nebivolol
Allergien: N/A
Vorherige Impfungen: -

VAERS 2611578

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: FL
Alter: 66,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 28.02.2022
Beginn: 20.01.2023
Tage bis Beginn: 326,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Urinary tract infection Urine analysis abnormal

Symptomtext

I was diagnosed with UTI in January 2023 and was antibiotics form my symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urinary tract infection
Hospital-Tage: -
Labordaten: UTI lab
Aktuelle Erkrankungen: N/A
Vorgeschichte: UTI
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2610401

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 20,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 06.07.2022
Beginn: 06.07.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration No adverse event

Symptomtext

First Primary dose on 06JUL2022/ 2nd Primary monovalent dose on 19AUG2022; No adverse event; patient received expired first primary Monovalent Moderna COVID-19 vaccine; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired first primary Monovalent Moderna COVID-19 vaccine), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary dose on 06JUL2022/ 2nd Primary monovalent dose on 19AUG2022) and NO ADVERSE EVENT (No adverse event) in a 20-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 055A22A and 027L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 06-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Aug-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 06-Jul-2022, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired first primary Monovalent Moderna COVID-19 vaccine). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary dose on 06JUL2022/ 2nd Primary monovalent dose on 19AUG2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired first primary Monovalent Moderna COVID-19 vaccine), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary dose on 06JUL2022/ 2nd Primary monovalent dose on 19AUG2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient received expired first primary Monovalent Moderna COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Primary dose on 06JUL2022/ 2nd Primary monovalent dose on 19AUG2022). No concomitant medication details was reported. Intact cartons was used and vial size was 2.5ml. The vial was initially stored in the refrigerator on 06-JUL-2022. The vial did not undergo any temperature excursions. No treatment medication details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2606302

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 29.03.2023
Impfdatum: 03.10.2022
Beginn: 26.03.2023
Tage bis Beginn: 174,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient with history of COVID vaccines who admitted to hospital with COVID detcted PCR. Provider d/c note: "COVID-19 Was screen to have roommate -Asymptomatic, reported positive 1/23, likely residual"

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 3,0
Labordaten: COVID detected PCR 3/27/23
Aktuelle Erkrankungen: -
Vorgeschichte: Cerebral palsy Essential hypertension, benign Chronic obstructive pulmonary disease History of ischemic stroke Bipolar 1 disorder Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin Normocytic anemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2606035

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 61,0
Geschlecht: F
Eingang: 29.03.2023
Impfdatum: 13.04.2022
Beginn: 01.11.2022
Tage bis Beginn: 202,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Discomfort Eczema SARS-CoV-2 test positive

Symptomtext

I was getting eczema on the inside of my elbows after the booster. The eczema was on the right and left arm. It was uncomfortable enough to see the dermatologist. I had to have cream prescribed. I never had this before having the COVID-19 booster. I did try over the counter medication like hydrocortisone cream that was effective. I only use Triamcinolone as needed. It took 5-7 days to clear up the symptoms. The symptoms come and go, and I use the medication when they break out again. It appears that its not going to be gone forever as it continues to come back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: COVID-19 Positive 10/31/2022
Vorgeschichte: High Blood Pressure
Andere Medikamente: Losartan; Metoprolol
Allergien: Amoxicillin; Red Dye
Vorherige Impfungen: Moderna Booster-chills, fever, nausea, and body aches-60 years old

VAERS 2593778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 11.11.2022
Beginn: 08.03.2023
Tage bis Beginn: 117,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

hospitalization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2593207

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21a

gering

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 08.03.2023
Impfdatum: 30.03.2022
Beginn: 19.08.2022
Tage bis Beginn: 142,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Pfizer 12/29/20 Lot# El0140; Pfizer 1/15/21 Lot# EK9231; Pfizer 8/30/21 Lot# FC3183; MOderna 3/30/22 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2584666

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 41,0
Geschlecht: F
Eingang: 21.02.2023
Impfdatum: 29.01.2022
Beginn: 13.02.2023
Tage bis Beginn: 380,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines ; Moderna 3/29/21 Lot# 002B21A; MOderna 4/26/21; Lot# 048B21A; Moderna 1/29/22 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567791

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 07.04.2021
Beginn: 03.08.2022
Tage bis Beginn: 483,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after three vaccines Moderna 2/25/21 Lot# 023M20A; Moderna 3/25/21 Lot# 007B21A; Moderna 4/7/21 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539468

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MO
Alter: 64,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 07.04.2022
Beginn: 01.07.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Breast cancer stage I Breast conserving surgery Mammogram Oncotype test Radiotherapy

Symptomtext

Diagnosed with Stage 1A breast cancer July 2022. Underwent lumpectomy Sept 2022, completed radiation Nov 2022 - all successful and tolerated well. Began endocrine therapy Nov 28, 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breast cancer stage I
Hospital-Tage: -
Labordaten: Mammograms (multiple; July & Aug 2022 Biopsy - July 2022 Oncotype testing - Sept 2022
Aktuelle Erkrankungen: none
Vorgeschichte: high cholesterol; glaucoma
Andere Medikamente: simvastatin latanaprost nasonex estradiol
Allergien: none
Vorherige Impfungen: ill after shingles vaccine, though not seriously

VAERS 2530001

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AR
Alter: 88,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 01.04.2022
Beginn: 12.12.2022
Tage bis Beginn: 255,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

hospitalized with covid; fully vaccinated with booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: positive covid antigen 12/12/22
Aktuelle Erkrankungen: unknown
Vorgeschichte: Coronary Artery Disease, COPD, CVA, Diabetes, Hyperlipidemia, Hypertension, Myocardial Infarction, Obstructive Sleep Apnea (non-compliant with cpap), Thyroid and Other (recent bilateral subdural hematoma)
Andere Medikamente: unknown
Allergien: aloe vera, erythromycin base, penicillins, zolpidem tartrate
Vorherige Impfungen: -

VAERS 2513067

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: FL
Alter: 74,0
Geschlecht: M
Eingang: 21.11.2022
Impfdatum: 04.04.2022
Beginn: 20.11.2022
Tage bis Beginn: 230,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

patient hospitalized

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2502020

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: KY
Alter: 80,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 18.04.2022
Beginn: 04.11.2022
Tage bis Beginn: 200,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

Admitted to hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2458854

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 28,0
Geschlecht: M
Eingang: 24.09.2022
Impfdatum: 01.06.2020
Beginn: 01.02.2022
Tage bis Beginn: 610,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Abdominal rigidity Crohn's disease Gastrointestinal sounds abnormal Inflammation Muscle spasms

Symptomtext

Symptoms from Chron's/ Crohn's disease flare up; Tightness in lower abdomen/gurgling; Tightness in lower abdomen/gurgling; Bloating; Inflammed; Cramps; This spontaneous case was reported by a consumer and describes the occurrence of CROHN'S DISEASE (Symptoms from Chron's/ Crohn's disease flare up) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease. The patient's past medical history included Ex-tobacco user (A pack of cigarette per week or every two weeks) from 2019 to January 2022 and COVID-19 (COVID-19 positive) in January 2022. Concurrent medical conditions included Crohn's disease (Moderate to severe adult Crohn's disease), Abstains from alcohol, Peanut allergy (manifested by moderate to severe break out in hives), Allergy to nuts (manifested by moderate to severe outbreak in hives), Pollen allergy (skin and respiratory related), Airway secretion excessive since January 2022, Chest pain since January 2022, Back pain since January 2022, Vitamin D decreased since December 2021 and Blood iron decreased since December 2021. In June 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On 17-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. In February 2022, the patient experienced CROHN'S DISEASE (Symptoms from Chron's/ Crohn's disease flare up) (seriousness criterion medically significant), GASTROINTESTINAL SOUNDS ABNORMAL (Tightness in lower abdomen/gurgling), ABDOMINAL RIGIDITY (Tightness in lower abdomen/gurgling), ABDOMINAL DISTENSION (Bloating), INFLAMMATION (Inflammed) and MUSCLE SPASMS (Cramps). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, CROHN'S DISEASE (Symptoms from Chron's/ Crohn's disease flare up), GASTROINTESTINAL SOUNDS ABNORMAL (Tightness in lower abdomen/gurgling), ABDOMINAL RIGIDITY (Tightness in lower abdomen/gurgling), ABDOMINAL DISTENSION (Bloating) and INFLAMMATION (Inflammed) was resolving and MUSCLE SPASMS (Cramps) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. Company comment : This spontaneous case concerns a 28-year-old, male patient with relevant medical history of Moderate-to-severe Crohn's disease previously treated with the co-suspect product Humira (adalimumab) which was discontinued in Feb2021, who experienced the unexpected, serious (medically significant) event of Crohn's disease (Crohn's disease aggravated) and other unexpected, non-serious events. The events occurred unknown number of days after receiving the first dose of the mRNA-1273 vaccine. Of note, the onset dates were reported as unspecified dates in Feb2022, hence, the onset latency could not be assessed. It was reported that the patient experienced tightness in the lower abdomen with gurgling, bloating, symptoms of Crohn's disease flare-up (bloody stools), inflammation and cramps. The patient was treated with prednisone (unspecified dose, frequency and duration). The reporter stated that the alternative etiology for the patient's symptoms was due to being off of Humira. The medical history of Crohn's disease remains a confounder for the event Crohn's disease aggravated since waxing and waning of symptoms is part of the natural course of the disease. The discontinuation of Humira also remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report. No concomitant medication was reported. The reporter alternate etiology for events of cramping, bloating, gurgling, tightness in lower abdomen and bloody stools were reported as off Humira and for the events of chest pain and chest with mucus were reported as after stopped smoking. It was unknown if patient was enrolled in a COVID-19 vaccine trial. The reporter's causality for the events of tightness in lower abdomen/gurgling, bloating, symptoms from Crohn's/ Crohn's disease flare up, inflamed and cramps with Humira (adalimumab) was no reasonable possibility. Patient had some lab data: BONE DENSITY SCAN - ??-Dec-2021 COVID-19 ANTIBODY SWAB TEST - ??-Jan-2022 IRON - ??-Dec-2021 STOOL TEST - ??-Dec-2021 VITAMIN D - ??-Dec-2021 This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2022: Follow-up received: Event "cramp" was added. Update product dose no, Current condition added and lab data removed inarrative supplement updated.; Sender's Comments: This spontaneous case concerns a 28-year-old, male patient with relevant medical history of Moderate-to-severe Crohn's disease previously treated with the co-suspect product Humira (adalimumab) which was discontinued in Feb2021, who experienced the unexpected, serious (medically significant) event of Crohn's disease (Crohn's disease aggravated) and other unexpected, non-serious events. The events occurred unknown number of days after receiving the first dose of the mRNA-1273 vaccine. Of note, the onset dates were reported as unspecified dates in Feb2022, hence, the onset latency could not be assessed. It was reported that the patient experienced tightness in the lower abdomen with gurgling, bloating, symptoms of Crohn's disease flare-up (bloody stools), inflammation and cramps. The patient was treated with prednisone (unspecified dose, frequency and duration). The reporter stated that the alternative etiology for the patient's symptoms was due to being off of Humira. The medical history of Crohn's disease remains a confounder for the event Crohn's disease aggravated since waxing and waning of symptoms is part of the natural course of the disease. The discontinuation of Humira also remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal distension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Abstains from alcohol; Airway secretion excessive; Allergy to nuts (manifested by moderate to severe outbreak in hives); Back pain; Blood iron decreased; Chest pain; Crohn's disease (Moderate to severe adult Crohn's disease); Peanut allergy (manifested by moderate to severe break out in hives); Pollen allergy (skin and respiratory related); Vitamin D decreased
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (COVID-19 positive); Ex-tobacco user (A pack of cigarette per week or every two weeks)
Andere Medikamente: HUMIRA
Allergien: -
Vorherige Impfungen: -

VAERS 2451288

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: CA
Alter: 75,0
Geschlecht: M
Eingang: 19.09.2022
Impfdatum: 20.01.2021
Beginn: 16.08.2022
Tage bis Beginn: 573,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Break Through COVID on Aug 16th 2022. Lasting 4 days, treated with Paxlovid, Rebound infection on Aug 23 lasting until Sep 2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: iHealth COVID-19 Antigen Rapid Test
Aktuelle Erkrankungen: -
Vorgeschichte: High Blood Pressure, Diabetes type 2, Heart disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2442815

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 01.03.2022
Beginn: 04.09.2022
Tage bis Beginn: 187,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after three vaccines Moderna 3/18/21 Lot# 002B21A; Moderna 4/15/21 Lot# 040B21A; Moderna 3/1/22 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440901

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 53,0
Geschlecht: M
Eingang: 12.09.2022
Impfdatum: 31.03.2022
Beginn: 07.09.2022
Tage bis Beginn: 160,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 1/4/21 Lot# 026L20A; Moderna 2/1/21 Lot# 007M20a; Moderna 11/12/21 Lot# 034F21A; Moderna 3/31/22 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433651

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 88,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 19.01.2021
Beginn: 29.08.2022
Tage bis Beginn: 587,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Mental status changes SARS-CoV-2 test positive

Symptomtext

08/29/22 presents to EC ED for "altered mental status". PMHx of "type 2 diabetes, coronary artery disease, stage II as of CKD"

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 08/29/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433385

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: GA
Alter: 21,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 04.09.2022
Beginn: 04.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2423841

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 36,0
Geschlecht: F
Eingang: 30.08.2022
Impfdatum: 22.02.2022
Beginn: 22.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

No adverse event; First moderna dose on 10DEC2021 and second moderna dose on 22FEB2022; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First moderna dose on 10DEC2021 and second moderna dose on 22FEB2022) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022 at 2:23 PM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 22-Feb-2022 at 2:23 PM, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First moderna dose on 10DEC2021 and second moderna dose on 22FEB2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First moderna dose on 10DEC2021 and second moderna dose on 22FEB2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First moderna dose on 10DEC2021 and second moderna dose on 22FEB2022). Concomitant medications were not reported. Patient had no acute illnesses at the time of vaccination and up to one month before. Patient had no chronic long standing health conditions. On 10-Dec-2021, at 12:38 PM patient received first dose of Moderna Covid-19 vaccine at a posology of 0.5 ml intramuscularly on left deltoid. The batch number was reported as 037f21a. There was no ill reaction associated with this event. Treatment medications were not reported. This case was linked to MOD-2022-632620 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2422708

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 29.08.2022
Impfdatum: 11.04.2022
Beginn: 31.07.2022
Tage bis Beginn: 111,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 12/30/20 Lot# 025L20A; Moderna 1/27/21 Lot#004M20A; Moderna 10/26/21 Lot# 041C21A; Moderna 4/11/22 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2415782

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: KY
Alter: 65,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 15.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Unevaluable event

Symptomtext

None.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Synthroid 112mcg, Maxzide-25
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2408443

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 11.08.2022
Impfdatum: 17.02.2022
Beginn: 05.08.2022
Tage bis Beginn: 169,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Cough

Symptomtext

cough

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2406916

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: GA
Alter: 44,0
Geschlecht: F
Eingang: 10.08.2022
Impfdatum: 08.08.2022
Beginn: 08.08.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Received expired first dose after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired first dose after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Aug-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired first dose after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired first dose after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Received expired first dose after manufacturer date of expiry). No concomitant medications were reported. No treatment details were reported. Number of doses from vial was 1 dose from 1 vial. The vial was initially stored in the refrigerator on 08-Aug-2022 The vial did not undergo any temperature excursions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2401249

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 67,0
Geschlecht: F
Eingang: 04.08.2022
Impfdatum: 01.04.2022
Beginn: 16.05.2022
Tage bis Beginn: 45,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Blood test abnormal COVID-19 Inflammation Psoriatic arthropathy Rheumatoid arthritis

Symptomtext

Contracted Covid on 4/18/22. On 5/19/22 blood tests confirmed rheumatoid &/or Soriatic arthritis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test abnormal
Hospital-Tage: -
Labordaten: Multiple blood tests for various inflammation (5/18/22)
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin D, calcium
Allergien: None
Vorherige Impfungen: -

VAERS 2394986

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 45,0
Geschlecht: M
Eingang: 28.07.2022
Impfdatum: 01.04.2022
Beginn: 25.07.2022
Tage bis Beginn: 115,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Cough Respiratory tract congestion

Symptomtext

Cough and congestion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2374934

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 76,0
Geschlecht: M
Eingang: 20.07.2022
Impfdatum: 18.04.2022
Beginn: 14.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough SARS-CoV-2 test positive

Symptomtext

04/18/2022 Vaccination 07/10/2022 Believe where I became infected at a banquet dinner. 07/14/2022 I had a dry cough 07/15/2022 I tested COVID-19 POSITIVE on a rapid test. PCR test at the doctor office. Started the Plaxovid in the evening.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID-19 POSITIVE
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; High Cholesterol; GERD
Andere Medikamente: Blood pressure medication; Cholesterol medication; Multi Vitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2372770

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AZ
Alter: 45,0
Geschlecht: M
Eingang: 18.07.2022
Impfdatum: 07.07.2022
Beginn: 07.07.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered No adverse event

Symptomtext

Patient given an expired lot. Vaccine expired 07/02/2022. Received vaccine 07/07/2022. No adverse events occurred.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2372765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AZ
Alter: 70,0
Geschlecht: M
Eingang: 18.07.2022
Impfdatum: 07.07.2022
Beginn: 07.07.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered No adverse event

Symptomtext

Expired vaccine was given. Vaccine expired 07/02/2022 and was given to patient on 07/07/2022. No adverse reactions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension, prostate cancer, type 2 diabetes, dyslipidemia
Andere Medikamente: Metformin, hydrochlorothiazide, metamucil, enzalutamide, flomax, glipizide, amlodipine, atorvastatin, lisinopril, Oscal-500
Allergien: No known Allergies
Vorherige Impfungen: -

VAERS 2370119

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: AZ
Alter: 45,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 07.07.2022
Beginn: 07.07.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022; Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.) and PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022) in a 45-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027l21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.) and PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. On 07-Jul-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. The patient received 2nd dose, which had expired on 02-Jul-2022. Treatment information was not provided. This case was linked to MOD-2022-606376 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370116

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: AZ
Alter: 70,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 07.07.2022
Beginn: 07.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022; Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.) and PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027l21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.) and PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. On 07-Jul-2022, the vial was initially stored in the refrigerator. Patient received second booster shot. The vial did not undergo any temperature excursions. Treatment information was not provided by the reporter. This case was linked to MOD-2022-606413 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2368035

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 54,0
Geschlecht: F
Eingang: 13.07.2022
Impfdatum: 12.04.2022
Beginn: 21.06.2022
Tage bis Beginn: 70,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acne Pustule Smear cervix Swelling

Symptomtext

For a long time I had a pimple on my chest. It swelled up to the size of a ping pong ball, and it has fluid in it. I went to see my doctor. They referred me to see a dermatologist. The dermatologist was concerned with the size of it, and its also located on my breast. I haven't had a mammogram since the beginning of the pandemic. Tomorrow I am scheduled for a mammogram, sonogram, and another pap smear.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acne
Hospital-Tage: -
Labordaten: 6/28/2022- Pap Smear- unreadable
Aktuelle Erkrankungen: None
Vorgeschichte: Primary Biliary Cirrhosis
Andere Medikamente: Citalopram; Ursodiol
Allergien: None
Vorherige Impfungen: -

VAERS 2367882

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 13.07.2022
Impfdatum: 23.02.2022
Beginn: 06.07.2022
Tage bis Beginn: 133,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19

Symptomtext

covid

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2366862

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21A

gering

Staat: OH
Alter: 79,0
Geschlecht: M
Eingang: 13.07.2022
Impfdatum: 01.04.2022
Beginn: 27.05.2022
Tage bis Beginn: 56,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

Tested positive for Covid 19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: P.CR test, May 27, 2022
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: lisinopril, gabapentin, tamsulosin, atorvastain, sildenafil
Allergien: None
Vorherige Impfungen: -

VAERS 2366226

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MA
Alter: 68,0
Geschlecht: F
Eingang: 12.07.2022
Impfdatum: 11.04.2022
Beginn: 26.06.2022
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a clear runny nose and I took two COVID-19 test at home that came back positive. I also took a PCR COVID-19 test that came back positive as well. I called my doctor, and they prescribed me PAXLOVID. I did not develop any other symptoms besides the clear runny nose that lasted for two days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID 19 test- positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Prediabetes
Andere Medikamente: Metformin; citalopram; vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2362592

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 08.07.2022
Impfdatum: 07.04.2022
Beginn: 22.06.2022
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Influenza like illness Nasopharyngitis SARS-CoV-2 test Vaccine breakthrough infection

Symptomtext

About 2 months receiving 4th dose of Moderna I experienced a breakthrough case of COVID-19. Began as mild cold like symptoms. Symptoms began to worsen and become more Flu like. Fever was never above 99.7. Saw PCP when I returned home and he prescribed prednisone and inhaler.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes; Hypothyroidism; Low White Cell count; A1A deficiency; Asthma
Andere Medikamente: Hydroxychloroquine; Pravastatin; Gabapentin; Levothyroxine; Baby Aspirin; Xolair
Allergien: Codeine; Pseudoephedrine; Seasonal
Vorherige Impfungen: 1976 Swine FLu Vaccine - developed case of swine flu old tetanus shot Fever, vomiting

VAERS 2359481

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: SC
Alter: 66,0
Geschlecht: M
Eingang: 06.07.2022
Impfdatum: 31.03.2022
Beginn: 29.06.2022
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Nasal congestion Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the vaccine but I did contract COVID-19. Test positive on June 30. I had a stuffy nose, congestion and a dry cough. I went to see my doctor and he didn't think I needed a prescription. I took over-the-counter cold medication for my symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Home test for COVID-19 positive on June 30.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: lisinopril; rosuvastatin
Allergien: None
Vorherige Impfungen: -

VAERS 2357735

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 81,0
Geschlecht: F
Eingang: 05.07.2022
Impfdatum: 18.04.2022
Beginn: 03.07.2022
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 doses Moderna 2/16/21 Lot# 013M20A; Moderan 3/16/21 Lot# 030A21A; Moderan 11/5/21 Lot# 077C21B; Moderna 4/18/22 Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355973

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 19,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022; Administered vaccine after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022) in a 19-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. Patient had no known allergies to medications, food and other products, and also patient did not have any acute illness at the time of vaccination and up to one month before. Patient did not have any chronic illness or long-standing health conditions. Patient neither diagnosed with COVID-19 nor tested positive. Patient was not taking prescriptions, over the counter medications, dietary supplements, or herbal remedies at time of vaccination or at the time of the adverse event. No other vaccines received within one month prior to any dose of Moderna vaccine. On 16-May-2022 at 11:00 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 16-May-2022 at 11:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Reported that administered vaccine after the Beyond Use by Date (BUD) from 08-Mar-2022 to 01-Jun-2022. The vial was initially stored in refrigerator on 08-Mar-2022. The vial did not undergo the temperature excursion. The patient had not reported symptoms. No additional doses, medications, or treatments had been administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known allergies to medications, food and other products, and also patient did not have any acute illness at the time of vaccination and up to one month before. Patient did not have any chronic illness or long-standing health conditions. Patient neither diagnosed with COVID-19 nor tested positive. Patient was not taking prescriptions, over the counter medications, dietary supplements, or herbal remedies at time of vaccination or at the time of the adverse event. No other vaccines received within one month prior to any dose of Moderna vaccine.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355938

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 65,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was initially stored on 08 Mar 2022 in refrigerator and vaccine administered on 16 May 2022.; Vaccine were administered after the 30 day BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine were administered after the 30 day BUD) and PRODUCT STORAGE ERROR (Vial was initially stored on 08 Mar 2022 in refrigerator and vaccine administered on 16 May 2022.) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 16-May-2022 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2022 at 11:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine were administered after the 30 day BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored on 08 Mar 2022 in refrigerator and vaccine administered on 16 May 2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine were administered after the 30 day BUD) and PRODUCT STORAGE ERROR (Vial was initially stored on 08 Mar 2022 in refrigerator and vaccine administered on 16 May 2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. Six (6) vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022. The vials did not undergo any temperature excursions. The patient had not reported symptoms. Treatment details was not reported by the reporter. As per Moderna Lot analysis, Doses administered on 06May 2022,16 May 2022,20 May 2022,24May 2022,27May 2022,01June 2022:Moderna cannot guarantee patient received full protection against the COVID-19 Virus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355931

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 25,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 27-May-2022; Administered vaccine after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 27-May-2022) in a 25-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. No known allergies reported, Patient was not diagnosed with or tested positive for COVID-19. Patient not had acute illnesses at the time of vaccination and up to one month before. Patient not had Chronic or long standing health conditions. On 27-May-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 27-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 27-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 27-May-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Reported that patient was not taking prescriptions, over the counter medications, dietary supplements, or herbal remedies at time of vaccination or at the time of the adverse event. Time of administration for first dose reported as 12:00 am. Reported that administered vaccine after the BUD from 08-Mar-2022 to 01-Jun-2022. The vial was initially stored in refrigerator on 08-Mar-2022. The vial did not undergo the temperature excursion. The patient had not reported symptoms. No additional doses, medications, or treatments had been administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No known allergies reported, Patient was not diagnosed with or tested positive for COVID-19. Patient not had acute illnesses at the time of vaccination and up to one month before. Patient not had Chronic or long standing health conditions.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355905

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 67,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 08-Mar-2022 and administered on 01-Jun-2022; Vaccine was administered after the 30 days beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after the 30 days beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and administered on 01-Jun-2022) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. The patient had never been diagnosed with or tested positive for COVID-19. Acute illnesses at the time of vaccination and up to one month before were none. It was unknown whether the patient had any chronic or long-standing health conditions. Concurrent medical conditions included Hypertension, Diabetes and Hypercholesteraemia. Concomitant products included INSULIN GLARGINE (LANTUS) and INSULIN LISPRO (HUMALOG) from 01-May-2022 to an unknown date for Diabetes, ATORVASTATIN from 01-May-2020 to an unknown date for Hypercholesteraemia, AMLODIPIN [AMLODIPINE] and LOSARTAN from 01-May-2020 to an unknown date for Hypertension. On 01-Jun-2022 at 1:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2022 at 1:00 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after the 30 days beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and administered on 01-Jun-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after the 30 days beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and administered on 01-Jun-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication Lantus was started on 01-May unknown year. Number of doses/vials were 6 vials. The vial was initially stored in the refrigerator on 08-Mar-2022. The vial did not undergo any temperature excursions. Treatment information was not provided. This case was linked to MOD-2022-583062 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes; Hypercholesteraemia; Hypertension
Vorgeschichte: Comments: The patient had never been diagnosed with or tested positive for COVID-19. Acute illnesses at the time of vaccination and up to one month before were none. It was unknown whether the patient had any chronic or long-standing health conditions.
Andere Medikamente: AMLODIPIN [AMLODIPINE]; LOSARTAN; ATORVASTATIN; LANTUS; HUMALOG
Allergien: -
Vorherige Impfungen: -

VAERS 2355901

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 79,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vail was initially stored in refrigerator on 08-Mar-2022 and administered on 27-May-2022; administered Moderna COVID-19 vaccine after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered Moderna COVID-19 vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vail was initially stored in refrigerator on 08-Mar-2022 and administered on 27-May-2022) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. The patient had no known allergies. The patient was not diagnosed with / tested positive for COVID-19. On 27-May-2022 at 2:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered Moderna COVID-19 vaccine after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vail was initially stored in refrigerator on 08-Mar-2022 and administered on 27-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered Moderna COVID-19 vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vail was initially stored in refrigerator on 08-Mar-2022 and administered on 27-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that, the patient was administered Moderna COVID-19 vaccine after the 30 days beyond use date. The patient had not reported any symptoms. The vial was initially stored in refrigerator on 08-Mar-2022 and the vial did not undergo temperature excursion. No additional doses, medications, or treatments were administered. This case was linked to MOD-2022-583062 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known allergies. The patient was not diagnosed with / tested positive for COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355899

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 39,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received dose from a vial which was initially stored in the refrigerator 08-Mar-2022 and administered to patient on 20 May 2022 after 30-day Use By Date; The patient administered the vaccine after the 30 days beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days beyond use date) and PRODUCT STORAGE ERROR (Patient received dose from a vial which was initially stored in the refrigerator 08-Mar-2022 and administered to patient on 20 May 2022 after 30-day Use By Date) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Patient was not ever diagnosed with/ tested positive for Covid-19. there were no known drug allergies of the patient to medications, food and other products. It was unknown if patient had any acute illness at the time of vaccination or up to one month before. It was unknown if patient had any chronic or long-standing health conditions. On 20-May-2022 at 3:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 20-May-2022 at 3:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received dose from a vial which was initially stored in the refrigerator 08-Mar-2022 and administered to patient on 20 May 2022 after 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days beyond use date) and PRODUCT STORAGE ERROR (Patient received dose from a vial which was initially stored in the refrigerator 08-Mar-2022 and administered to patient on 20 May 2022 after 30-day Use By Date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. It was unknown if the patient had any prescriptions, over the counter medication, dietary supplements or herbal remedies taken at the time of vaccination Vials with batch no 027L21A were initially stored in the refrigerator on 08-Mar-2022. The vials did not undergo any temperature excursions. The patients had not reported symptoms. No additional doses, medications or treatments had been administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient was not ever diagnosed with/ tested positive for Covid-19. there were no known drug allergies of the patient to medications, food and other products. It was unknown if patient had any acute illness at the time of vaccination or up to one month before. It was unknown if patient had any chronic or long-standing health conditions.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355894

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine stored in refrigerator on 08-Mar-2022/Vaccine administered on 16-May-2022; Patient received vaccine after the beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the beyond use date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 08-Mar-2022/Vaccine administered on 16-May-2022) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. The patient had not been diagnosed/tested positive for COVID-19. It was unknown that the patient had acute illness at the time of vaccination and up to one month before. It was unknown that the patient had chronic or long-lasting illness and patient had taken any prescriptions, over the counter medication, dietary supplements or herbal remedies at the time of vaccination. On 16-May-2022 at 11:00 AM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-May-2022 at 11:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 08-Mar-2022/Vaccine administered on 16-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the beyond use date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 08-Mar-2022/Vaccine administered on 16-May-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Total number of vials was 6. The vial was initially stored in refrigerator on 08-Mar-2022. The vial did not undergo any temperature excursion. The patient did not report any symptoms. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had not been diagnosed/tested positive for COVID-19. It was unknown that the patient had acute illness at the time of vaccination and up to one month before. It was unknown that the patient had chronic or long-lasting illness and patient had taken any prescriptions, over the counter medication, dietary supplements or herbal remedies at the time of vaccination.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355893

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 19,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine were stored more than 30 days in a refrigerator; The patient administered the vaccine after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (Vaccine were stored more than 30 days in a refrigerator) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-May-2022 at 11:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 24-May-2022 at 11:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine were stored more than 30 days in a refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (Vaccine were stored more than 30 days in a refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient had no known allergy. No concomitant medications were reported. The patient had not ever tested positive for COVID-19, and had not taken any prescriptions, over the counter medication, dietary supplement or herbal remedies at the time of vaccination and also not had any acute illness at the time of vaccination and up to 1 month before. Six (6) vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022. The vials did not undergo any temperature excursions. The patients had not reported symptoms. No additional doses, medications, or treatments had been administered. This case was linked to MOD-2022-583062 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355892

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator from the freezer on 08-Mar-2022 and the doses were administered on 16-May-2022; Administered with vaccine that is past beyond the 30 day use; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator from the freezer on 08-Mar-2022 and the doses were administered on 16-May-2022) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Patient was not tested positive or was not diagnosed with COVID-19. On 16-May-2022 at 1:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 16-May-2022 at 1:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator from the freezer on 08-Mar-2022 and the doses were administered on 16-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator from the freezer on 08-Mar-2022 and the doses were administered on 16-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant drug information was provided. It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions. It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. Administered vaccine after the BUD from 08-Mar-2022 to 2-Jun-2022. Number of Vials where 6 vials, the vial was initially stored in refrigerator was 08-MAr- 2022. The vial did not undergo the temperature excursion. Patient had no reported symptoms. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient was not tested positive or was not diagnosed with COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355891

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial initially stored in refrigerator on 08-Mar-2022 and vaccine administered on 20-May-2022; Dose administered after 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 08-Mar-2022 and vaccine administered on 20-May-2022) in a 66-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. It was reported that patient had been neither diagnosed nor tested COVID-19 test positive. No chronic or long standing health conditions were reported. On 20-May-2022 at 10:30 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 20-May-2022 at 10:30 AM, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 08-Mar-2022 and vaccine administered on 20-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 08-Mar-2022 and vaccine administered on 20-May-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported by the reporter. No. of doses/vials were 6 vials. The vial was initially stored in the refrigerator on 08-Mar-2022. No the vial did not undergo any temperature excursions. No treatment medications were reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was reported that patient had been neither diagnosed nor tested COVID-19 test positive. No chronic or long standing health conditions were reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355888

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 35,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022.; Vaccine were administered after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine were administered after the 30 day beyond use date) and PRODUCT STORAGE ERROR (vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022.) in a 35-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-May-2022 at 3:00 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 20-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine were administered after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine were administered after the 30 day beyond use date) and PRODUCT STORAGE ERROR (vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022.) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant products were not provided. Patient neither diagnosed with COVID-19 nor tested positive. Six vials of lot number 027L21A was initially stored in the refrigerator on 08-Mar-2022. The vials did not undergo any temperature excursions. The patient had not reported any symptoms. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2347553

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 53,0
Geschlecht: F
Eingang: 01.07.2022
Impfdatum: 26.02.2022
Beginn: 26.02.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test

Symptomtext

Contracted COVID-19 on 5/21/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 5/24/22 - Home COVID test; 5/27/22 - PCR at Pharmacy
Aktuelle Erkrankungen: none
Vorgeschichte: 1) Relapsing-Remitting Multiple Sclerosis (RRMS)/ cervical myelopathy 2) Heart murmur 3) disc herniation in cervical spine from car accident 4) Diverticulosis 5) Non cystic fibrosis Bronchiectasis 6) Irritable Bowel Syndrome - D 7) Inverted t-wave on EKG 8) Borderline Anemia (non-iron deficiency related) 9) Depression/ Anxiety- in remission 10) Multilevel thoracic spondylosis w/o myelopathy or radiculopathy 11) 1 cm right lower pole thyroid Nodule (was 3mm 5/2020) 12) Pure hypercholesterolemia 13) Atrial Septal Aneurysm 14) Hepatic hemangioma (1.3X1.0X1.0 cm) in the dome of the liver 15) 0.8 cm left renal angiomyolipoma (Kidney) 16) Multiple gallbladder polyps measuring up to 0.6 x 0.7 x 0.8 cm 17) Mild deviation of the nasal septum
Andere Medikamente: Ocrevus 600mg/10ml soln ? 2/x year (Infusion for MS); Duloxetine HCL DR 60 mg -1x/daily (depression/anxiety); Duloxetine HCL DR 30 mg -1x/daily (depression/anxiety); Simvastatin 20 mg ? 1x/daily (cholesterol) ; Bupropion HCL XL 300mg ? 1x/
Allergien: Lactose intolerant; sensitivity to aspirin
Vorherige Impfungen: -

VAERS 2345155

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CT
Alter: 79,0
Geschlecht: M
Eingang: 30.06.2022
Impfdatum: 30.03.2022
Beginn: 18.05.2022
Tage bis Beginn: 49,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asymptomatic COVID-19 Blood test SARS-CoV-2 test positive

Symptomtext

Tested positive for COVID-19 on May 18, 2022 - approximately 2 months after second booster shot. Asymptomatic. Treated with Paxlovid for 5 days. Fully recovered with no side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asymptomatic COVID-19
Hospital-Tage: -
Labordaten: Blood test and PCR test.
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Linzess Montelukast Motegrity
Allergien: None
Vorherige Impfungen: -

VAERS 2344849

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: GA
Alter: 30,0
Geschlecht: F
Eingang: 30.06.2022
Impfdatum: 16.03.2022
Beginn: 16.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2319131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 19,0
Geschlecht: F
Eingang: 25.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 23 days after refrigerator shelf life; Vaccine given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) in a 19-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Drug allergy (Codeine allergy) and Drug allergy (Symbicort allergy). Concomitant products included ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, MONTELUKAST and ETONOGESTREL (NEXPLANON) for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No treatment information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Symbicort allergy); Drug allergy (Codeine allergy)
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; FLUTICASONE PROPIONATE; MONTELUKAST; NEXPLANON
Allergien: -
Vorherige Impfungen: -

VAERS 2319131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 19,0
Geschlecht: F
Eingang: 25.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 23 days after refrigerator shelf life; Vaccine given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) in a 19-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Drug allergy (Codeine allergy) and Drug allergy (Symbicort allergy). Concomitant products included ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, MONTELUKAST and ETONOGESTREL (NEXPLANON) for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No treatment information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Symbicort allergy); Drug allergy (Codeine allergy)
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; FLUTICASONE PROPIONATE; MONTELUKAST; NEXPLANON
Allergien: -
Vorherige Impfungen: -

VAERS 2319005

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 65,0
Geschlecht: F
Eingang: 25.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product use issue

Symptomtext

vaccine given 1 day after refrigerator shelf life; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy. Concomitant products included ESOMEPRAZOLE, FERROUS SULFATE, LEVOTHYROXINE and OXYBUTYNIN HYDROCHLORIDE (OXYBUTYNIN CHLORIDE ER) for an unknown indication. On 14-Apr-2022 at 10:19 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2022 at 10:19 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy
Vorgeschichte: -
Andere Medikamente: ESOMEPRAZOLE; FERROUS SULFATE; LEVOTHYROXINE; OXYBUTYNIN CHLORIDE ER
Allergien: -
Vorherige Impfungen: -

VAERS 2319005

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 65,0
Geschlecht: F
Eingang: 25.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product use issue

Symptomtext

vaccine given 1 day after refrigerator shelf life; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy. Concomitant products included ESOMEPRAZOLE, FERROUS SULFATE, LEVOTHYROXINE and OXYBUTYNIN HYDROCHLORIDE (OXYBUTYNIN CHLORIDE ER) for an unknown indication. On 14-Apr-2022 at 10:19 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2022 at 10:19 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy
Vorgeschichte: -
Andere Medikamente: ESOMEPRAZOLE; FERROUS SULFATE; LEVOTHYROXINE; OXYBUTYNIN CHLORIDE ER
Allergien: -
Vorherige Impfungen: -

VAERS 2319001

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 55,0
Geschlecht: M
Eingang: 25.06.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine given 1 day after refrigerator shelf life; vaccine given 1 day after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccine given 1 day after refrigerator shelf life) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concomitant products included AZATHIOPRINE, PREDNISONE, TAMSULOSIN and URSODIOL for an unknown indication. On 04-Apr-2022 at 4:23 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2022 at 4:23 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine given 1 day after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccine given 1 day after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: AZATHIOPRINE; PREDNISONE; TAMSULOSIN; URSODIOL
Allergien: -
Vorherige Impfungen: -

VAERS 2319001

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 55,0
Geschlecht: M
Eingang: 25.06.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine given 1 day after refrigerator shelf life; vaccine given 1 day after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccine given 1 day after refrigerator shelf life) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concomitant products included AZATHIOPRINE, PREDNISONE, TAMSULOSIN and URSODIOL for an unknown indication. On 04-Apr-2022 at 4:23 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2022 at 4:23 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine given 1 day after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine given 1 day after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccine given 1 day after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: AZATHIOPRINE; PREDNISONE; TAMSULOSIN; URSODIOL
Allergien: -
Vorherige Impfungen: -

VAERS 2331742

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: FL
Alter: 73,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 19.03.2022
Beginn: 10.06.2022
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Exposure to SARS-CoV-2 Feeling abnormal Rhinorrhoea SARS-CoV-2 test positive Sneezing Throat irritation

Symptomtext

06/10/2022 That evening I had a scratchy throat with increased awareness since my husband had tested positive for COVID. I tested positive and began taking Paxlovid on 6/11/2022. By 6/16/2022 I tested negative. I had no symptoms until 06/22/2022. My husband tested positive again, so I took a test and was positive for COVID. On 6/23/2022 I tested again at home and was positive. I began sneezing and had a runny nose and felt fine. I saw my doctor yesterday and he told me not to worry about the positive tests since it had been 2 weeks since last test. Later that day I began feeling crappy, had clear mucous, a lot more sneezing . I took a decongestant, used my inhaler and went to bed. I had no fever. This morning when I woke up, I felt worse. I am using my inhaler. I consulted with my doctor this morning. He is going to have me do a chest x-ray tomorrow if I am not better. Otherwise, I am monitoring my peak flow and it is staying in the normal range for me.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID at home tests. Positive and negative results
Aktuelle Erkrankungen: No
Vorgeschichte: Ashtma, microscopic lympacytic colitis, hypo hroidism
Andere Medikamente: L-thyroxine, Singular, Atorvastatin, Multi vitamin, Vitamin B, Glucosamine Chondroitin , Chromium Picolinate , Areds, Fish Oil, Baby aspirin, Allegra, Cistane Eye drops , Vitamin D
Allergien: Penicillin, Clindamycin, Pollens
Vorherige Impfungen: -

VAERS 2319130

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 21,0
Geschlecht: F
Eingang: 23.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) in a 21-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. The patient does not have any known drug allergies. Concurrent medical conditions included Asthma, Colon cancer (Malignant tumor of colon), Heart disease, unspecified, Hypertensive (Hypertensive disorder), Hypercholesterolemia, Diabetes mellitus and Kidney disorder (Kidney disease). Concomitant products included Cholecalciferol; Ketoconazole; Nexplanon; Omeprazole; and Vitamin D3 for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma; Colon cancer (Malignant tumor of colon); Diabetes mellitus; Heart disease, unspecified; Hypercholesterolemia; Hypertensive (Hypertensive disorder); Kidney disorder (Kidney disease)
Vorgeschichte: Comments: The patient does not have any known drug allergies.
Andere Medikamente: Cholecalciferol; Ketoconazole; Nexplanon; Omeprazole; Vitamin D3
Allergien: -
Vorherige Impfungen: -

VAERS 2319130

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 21,0
Geschlecht: F
Eingang: 23.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) in a 21-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis. The patient does not have any known drug allergies. Concurrent medical conditions included Asthma, Colon cancer (Malignant tumor of colon), Heart disease, unspecified, Hypertensive (Hypertensive disorder), Hypercholesterolemia, Diabetes mellitus and Kidney disorder (Kidney disease). Concomitant products included Cholecalciferol; Ketoconazole; Nexplanon; Omeprazole; and Vitamin D3 for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma; Colon cancer (Malignant tumor of colon); Diabetes mellitus; Heart disease, unspecified; Hypercholesterolemia; Hypertensive (Hypertensive disorder); Kidney disorder (Kidney disease)
Vorgeschichte: Comments: The patient does not have any known drug allergies.
Andere Medikamente: Cholecalciferol; Ketoconazole; Nexplanon; Omeprazole; Vitamin D3
Allergien: -
Vorherige Impfungen: -

VAERS 2319129

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 31,0
Geschlecht: M
Eingang: 23.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine given 23 days after refrigerator shelf life; vaccine given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (vaccine given 23 days after refrigerator shelf life) and EXPIRED PRODUCT ADMINISTERED (vaccine given 23 days after refrigerator shelf life) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Patient had no known drug allergies. Concurrent medical conditions included Depressive disorder, Migraine and Diabetes mellitus. Concomitant products included ACETAZOLAMIDE, AMITRIPTYLINE, ATORVASTATIN, VALPROATE SEMISODIUM (DIVALPROEX), HYDROXYZINE HCL, LEVETIRACETAM, MARIJUANA, PROPRANOLOL and SUMATRIPTAN for an unknown indication. On 06-May-2022 at 3:37 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 3:37 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine given 23 days after refrigerator shelf life). At the time of the report, PRODUCT STORAGE ERROR (vaccine given 23 days after refrigerator shelf life) and EXPIRED PRODUCT ADMINISTERED (vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Depressive disorder; Diabetes mellitus; Migraine
Vorgeschichte: Comments: Patient had no known drug allergies.
Andere Medikamente: ACETAZOLAMIDE; AMITRIPTYLINE; ATORVASTATIN; DIVALPROEX; HYDROXYZINE HCL; LEVETIRACETAM; MARIJUANA; PROPRANOLOL; SUMATRIPTAN
Allergien: -
Vorherige Impfungen: -

VAERS 2319129

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 31,0
Geschlecht: M
Eingang: 23.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine given 23 days after refrigerator shelf life; vaccine given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (vaccine given 23 days after refrigerator shelf life) and EXPIRED PRODUCT ADMINISTERED (vaccine given 23 days after refrigerator shelf life) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Patient had no known drug allergies. Concurrent medical conditions included Depressive disorder, Migraine and Diabetes mellitus. Concomitant products included ACETAZOLAMIDE, AMITRIPTYLINE, ATORVASTATIN, VALPROATE SEMISODIUM (DIVALPROEX), HYDROXYZINE HCL, LEVETIRACETAM, MARIJUANA, PROPRANOLOL and SUMATRIPTAN for an unknown indication. On 06-May-2022 at 3:37 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 3:37 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine given 23 days after refrigerator shelf life). At the time of the report, PRODUCT STORAGE ERROR (vaccine given 23 days after refrigerator shelf life) and EXPIRED PRODUCT ADMINISTERED (vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Depressive disorder; Diabetes mellitus; Migraine
Vorgeschichte: Comments: Patient had no known drug allergies.
Andere Medikamente: ACETAZOLAMIDE; AMITRIPTYLINE; ATORVASTATIN; DIVALPROEX; HYDROXYZINE HCL; LEVETIRACETAM; MARIJUANA; PROPRANOLOL; SUMATRIPTAN
Allergien: -
Vorherige Impfungen: -

VAERS 2319128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 23.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 23 days after refrigerator shelf live; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf live) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. The patient had no known drug allergy. Concurrent medical conditions included Alcohol abuse, Dementia, Depressive disorder, Heart disease, unspecified, Hypertensive, Diabetes mellitus and CVA. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], CARVEDILOL, CINNAMOMUM CASSIA BARK (CINNAMON [CINNAMOMUM CASSIA BARK]), ERGOCALCIFEROL, FLUOXETINE, GLIPIZIDE, EMPAGLIFLOZIN (JARDIANCE), LISINOPRIL, MECLIZINE [MECLOZINE], METFORMIN, OMEPRAZOLE, PRAVASTATIN and LIRAGLUTIDE (VICTOZA) for an unknown indication. On 06-May-2022 at 9:25 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 9:25 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf live). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf live) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol abuse; CVA; Dementia; Depressive disorder; Diabetes mellitus; Heart disease, unspecified; Hypertensive
Vorgeschichte: Comments: The patient had no known drug allergy.
Andere Medikamente: ASPIRIN [ACETYLSALICYLIC ACID]; CARVEDILOL; CINNAMON [CINNAMOMUM CASSIA BARK]; ERGOCALCIFEROL; FLUOXETINE; GLIPIZIDE; JARDIANCE; LISINOPRIL; MECLIZINE [MECLOZINE]; METFORMIN; OMEPRAZOLE; PRAVASTATIN; VICTOZA
Allergien: -
Vorherige Impfungen: -

VAERS 2319128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 23.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 23 days after refrigerator shelf live; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf live) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. The patient had no known drug allergy. Concurrent medical conditions included Alcohol abuse, Dementia, Depressive disorder, Heart disease, unspecified, Hypertensive, Diabetes mellitus and CVA. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], CARVEDILOL, CINNAMOMUM CASSIA BARK (CINNAMON [CINNAMOMUM CASSIA BARK]), ERGOCALCIFEROL, FLUOXETINE, GLIPIZIDE, EMPAGLIFLOZIN (JARDIANCE), LISINOPRIL, MECLIZINE [MECLOZINE], METFORMIN, OMEPRAZOLE, PRAVASTATIN and LIRAGLUTIDE (VICTOZA) for an unknown indication. On 06-May-2022 at 9:25 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 9:25 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf live). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf live) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol abuse; CVA; Dementia; Depressive disorder; Diabetes mellitus; Heart disease, unspecified; Hypertensive
Vorgeschichte: Comments: The patient had no known drug allergy.
Andere Medikamente: ASPIRIN [ACETYLSALICYLIC ACID]; CARVEDILOL; CINNAMON [CINNAMOMUM CASSIA BARK]; ERGOCALCIFEROL; FLUOXETINE; GLIPIZIDE; JARDIANCE; LISINOPRIL; MECLIZINE [MECLOZINE]; METFORMIN; OMEPRAZOLE; PRAVASTATIN; VICTOZA
Allergien: -
Vorherige Impfungen: -

VAERS 2319125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccines given 23 days after refrigerator shelf life; vaccines given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Allergy to antibiotic (Ampicillin, Metformin Allergy), Drug allergy (Demerol , Propoxyphene , Valium Allergy), Penicillin allergy, Myocardial infarction and Neuropathy. Concomitant products included SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), AMITRIPTYLINE, THYROID (ARMOUR THYROID), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN, INSULIN GLARGINE (BASAGLAR KWIKPEN), CYCLOBENZAPRINE, EZETIMIBE, EMPAGLIFLOZIN (JARDIANCE), LATANOPROST, LISINOPRIL, METOPROLOL TARTRATE, MONTELUKAST, VITAMINS NOS (MULTIVITAMINUM), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), PIOGLITAZONE, DULAGLUTIDE (TRULICITY), VITAMIN D NOS and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Further Concomitant medication reported pen Needle and a fine Micro pen Needle. No Treatment medication reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Ampicillin, Metformin Allergy); Drug allergy (Demerol , Propoxyphene , Valium Allergy); Penicillin allergy
Vorgeschichte: Medical History/Concurrent Conditions: Myocardial infarction; Neuropathy
Andere Medikamente: ALBUTEROL SULFATE HFA; AMITRIPTYLINE; ARMOUR THYROID; ASPIRIN; ATORVASTATIN; BASAGLAR KWIKPEN; CYCLOBENZAPRINE; EZETIMIBE; JARDIANCE; LATANOPROST; LISINOPRIL; METOPROLOL TARTRATE; MONTELUKAST; MULTIVITAMINUM; NEXIUM [ESOMEPRAZOLE SODIUM]; P
Allergien: -
Vorherige Impfungen: -

VAERS 2319125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccines given 23 days after refrigerator shelf life; vaccines given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Allergy to antibiotic (Ampicillin, Metformin Allergy), Drug allergy (Demerol , Propoxyphene , Valium Allergy), Penicillin allergy, Myocardial infarction and Neuropathy. Concomitant products included SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), AMITRIPTYLINE, THYROID (ARMOUR THYROID), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN, INSULIN GLARGINE (BASAGLAR KWIKPEN), CYCLOBENZAPRINE, EZETIMIBE, EMPAGLIFLOZIN (JARDIANCE), LATANOPROST, LISINOPRIL, METOPROLOL TARTRATE, MONTELUKAST, VITAMINS NOS (MULTIVITAMINUM), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), PIOGLITAZONE, DULAGLUTIDE (TRULICITY), VITAMIN D NOS and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Further Concomitant medication reported pen Needle and a fine Micro pen Needle. No Treatment medication reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Ampicillin, Metformin Allergy); Drug allergy (Demerol , Propoxyphene , Valium Allergy); Penicillin allergy
Vorgeschichte: Medical History/Concurrent Conditions: Myocardial infarction; Neuropathy
Andere Medikamente: ALBUTEROL SULFATE HFA; AMITRIPTYLINE; ARMOUR THYROID; ASPIRIN; ATORVASTATIN; BASAGLAR KWIKPEN; CYCLOBENZAPRINE; EZETIMIBE; JARDIANCE; LATANOPROST; LISINOPRIL; METOPROLOL TARTRATE; MONTELUKAST; MULTIVITAMINUM; NEXIUM [ESOMEPRAZOLE SODIUM]; P
Allergien: -
Vorherige Impfungen: -

VAERS 2319124

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 65,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 23 days after refrigerator shelf life; Vaccine given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Myocardial infarction, Heart disease, unspecified, Migraine, Malignant breast neoplasm, Hypertension, Diabetes mellitus, Drug allergy (codeine), Drug allergy (morphine), Drug allergy (mucinex phenylephrine) and Drug allergy (sertraline). Concomitant products included SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), ALLOPURINOL, ATORVASTATIN, BETAMETHASONE VALERATE and CLINDAMYCIN HCL for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Other Concomitant medications includes Aloe Vesta Cleansing topical foam, Aloe Vesta Protectant Ointment. Treatment details was not reported by the reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes mellitus; Drug allergy (sertraline); Drug allergy (mucinex phenylephrine); Drug allergy (morphine); Heart disease, unspecified; Hypertension; Malignant breast neoplasm; Migraine; Myocardial infarction
Vorgeschichte: Medical History/Concurrent Conditions: Drug allergy (codeine)
Andere Medikamente: ALBUTEROL SULFATE HFA; ALLOPURINOL; ATORVASTATIN; BETAMETHASONE VALERATE; CLINDAMYCIN HCL
Allergien: -
Vorherige Impfungen: -

VAERS 2319124

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 65,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 23 days after refrigerator shelf life; Vaccine given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Myocardial infarction, Heart disease, unspecified, Migraine, Malignant breast neoplasm, Hypertension, Diabetes mellitus, Drug allergy (codeine), Drug allergy (morphine), Drug allergy (mucinex phenylephrine) and Drug allergy (sertraline). Concomitant products included SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), ALLOPURINOL, ATORVASTATIN, BETAMETHASONE VALERATE and CLINDAMYCIN HCL for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 23 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Other Concomitant medications includes Aloe Vesta Cleansing topical foam, Aloe Vesta Protectant Ointment. Treatment details was not reported by the reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes mellitus; Drug allergy (sertraline); Drug allergy (mucinex phenylephrine); Drug allergy (morphine); Heart disease, unspecified; Hypertension; Malignant breast neoplasm; Migraine; Myocardial infarction
Vorgeschichte: Medical History/Concurrent Conditions: Drug allergy (codeine)
Andere Medikamente: ALBUTEROL SULFATE HFA; ALLOPURINOL; ATORVASTATIN; BETAMETHASONE VALERATE; CLINDAMYCIN HCL
Allergien: -
Vorherige Impfungen: -

VAERS 2319122

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 57,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccines given 23 days after refrigerator shelf life; vaccines given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Allergy to metals (contact metal agent), Penicillin allergy and Drug allergy (prednisone). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), BUPROPION HYDROCHLORIDE (BUPROPION HCL ER), CLINDAMYCIN HCL, FLUCONAZOLE, GABAPENTIN, IBUPROFEN, SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), LISINOPRIL, NYSTATIN, PANTOPRAZOLE, TADALAFIL and VENLAFAXINE for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications included Lancet, Test Strip, Meter. Treatment medication was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to metals (contact metal agent); Drug allergy (prednisone); Penicillin allergy
Vorgeschichte: -
Andere Medikamente: ASPIRIN 81; BUPROPION HCL ER; CLINDAMYCIN HCL; FLUCONAZOLE; GABAPENTIN; IBUPROFEN; JANUVIA; JARDIANCE; LISINOPRIL; NYSTATIN; PANTOPRAZOLE; TADALAFIL; VENLAFAXINE
Allergien: -
Vorherige Impfungen: -

VAERS 2319122

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 57,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccines given 23 days after refrigerator shelf life; vaccines given 23 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Allergy to metals (contact metal agent), Penicillin allergy and Drug allergy (prednisone). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), BUPROPION HYDROCHLORIDE (BUPROPION HCL ER), CLINDAMYCIN HCL, FLUCONAZOLE, GABAPENTIN, IBUPROFEN, SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), LISINOPRIL, NYSTATIN, PANTOPRAZOLE, TADALAFIL and VENLAFAXINE for an unknown indication. On 06-May-2022 at 5:07 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2022 at 5:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccines given 23 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (vaccines given 23 days after refrigerator shelf life) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications included Lancet, Test Strip, Meter. Treatment medication was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to metals (contact metal agent); Drug allergy (prednisone); Penicillin allergy
Vorgeschichte: -
Andere Medikamente: ASPIRIN 81; BUPROPION HCL ER; CLINDAMYCIN HCL; FLUCONAZOLE; GABAPENTIN; IBUPROFEN; JANUVIA; JARDIANCE; LISINOPRIL; NYSTATIN; PANTOPRAZOLE; TADALAFIL; VENLAFAXINE
Allergien: -
Vorherige Impfungen: -

VAERS 2317265

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 42,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 22.03.2022
Beginn: 22.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine was given 5 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given 5 days after refrigerator shelf life) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Type 2 diabetes mellitus, Major depressive disorder, Insomnia (Persistant), Latex allergy, Drug allergy (Diltiazem), Penicillin allergy (Pinicillins), Drug allergy (Tramadol), Allergy to antibiotic (Vancomycin) and Allergy to antibiotic (Doxycycline). Concomitant products included ATORVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], CANDESARTAN and CLONAZEPAM for an unknown indication. On 22-Mar-2022 at 12:06 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2022 at 12:06 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given 5 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given 5 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was unknown if the patient ever had an adverse event following any previous vaccine. Concomitant medications of the patient also included Benzonates and Novol. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Vancomycin); Allergy to antibiotic (Doxycycline); Drug allergy (Tramadol); Drug allergy (Diltiazem); Insomnia (Persistant); Latex allergy; Major depressive disorder; Penicillin allergy (Pinicillins); Type 2 diabetes mellitus
Vorgeschichte: -
Andere Medikamente: ATORVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]; CANDESARTAN; CLONAZEPAM
Allergien: -
Vorherige Impfungen: -

VAERS 2317265

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 42,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 22.03.2022
Beginn: 22.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine was given 5 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given 5 days after refrigerator shelf life) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 prophylaxis. Concurrent medical conditions included Type 2 diabetes mellitus, Major depressive disorder, Insomnia (Persistant), Latex allergy, Drug allergy (Diltiazem), Penicillin allergy (Pinicillins), Drug allergy (Tramadol), Allergy to antibiotic (Vancomycin) and Allergy to antibiotic (Doxycycline). Concomitant products included ATORVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], CANDESARTAN and CLONAZEPAM for an unknown indication. On 22-Mar-2022 at 12:06 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2022 at 12:06 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given 5 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given 5 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was unknown if the patient ever had an adverse event following any previous vaccine. Concomitant medications of the patient also included Benzonates and Novol. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Vancomycin); Allergy to antibiotic (Doxycycline); Drug allergy (Tramadol); Drug allergy (Diltiazem); Insomnia (Persistant); Latex allergy; Major depressive disorder; Penicillin allergy (Pinicillins); Type 2 diabetes mellitus
Vorgeschichte: -
Andere Medikamente: ATORVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]; CANDESARTAN; CLONAZEPAM
Allergien: -
Vorherige Impfungen: -

VAERS 2324628

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 52,0
Geschlecht: F
Eingang: 21.06.2022
Impfdatum: 13.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Haematocrit decreased Haemoglobin decreased Heavy menstrual bleeding Menstruation irregular

Symptomtext

Uterine Shredding- Extremely, extremely heavy menstrual bleeding that occurred outside of my normal menstrual cycle which are very regular. This was the first booster shot. This heavy bleeding also occurred with my 2nd dose in April of 2021 but I did not report it because I was not completely sure if was from the vaccine. Now that the heavy bleeding occurred again with the booster I KNOW it was related to the COVID vaccine. I heard others also experienced the same heavy periods once I expressed my experience with some of my female co-workers.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Haematocrit decreased
Hospital-Tage: -
Labordaten: low hemoglobin and hematocrit lab results, 11 and 34. Menstrual Cycle irregularity.
Aktuelle Erkrankungen: none
Vorgeschichte: High Blood Pressure Osteoarthritis Cyclic Benign Neutropenia
Andere Medikamente: Lisinopril 20 MG Women's Multivitamin
Allergien: Penicillin
Vorherige Impfungen: second dose of Moderna COVID Vaccine- heavy menstural bleeding

VAERS 2323194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 23,0
Geschlecht: F
Eingang: 17.06.2022
Impfdatum: 17.06.2022
Beginn: 17.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Pt came in requesting third vaccine due to being obese and also wanting to be protected for new job 3rd dose given too soon after primary dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: morbid obesity
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2319061

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 55,0
Geschlecht: M
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccine given 6 days after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: cerebrovascular accident, dementia, hypertensive disorder, hypercholesterolemia, alcohol abuse, kidney disease, depressive disorder
Andere Medikamente: amitriptyline, amLODIPine, atorvastatin, FLUoxetine, LORazepam, losartan, ProAir HFA
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2319058

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 59,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 1 day after refrigerator shelf life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Blood coagulation disorder; hypertensive disorder; migraine; cerebrovascular accident; heart disease.
Andere Medikamente: Alprazolam; Bisoprolol; Cyanocobalamin; Escitalopram
Allergien: Lodinated contrast media.
Vorherige Impfungen: -

VAERS 2319055

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 65,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccine given 1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: ALPRAZolam, amLODIPine, citalopram, lisinopril
Allergien: -
Vorherige Impfungen: -

VAERS 2319030

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 67,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccine given 1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hypertensive disorder
Andere Medikamente: Alcohol prep pads, ALPRAZolam, amitriptyline, atorvastatin, dicyclomine, HYDROcodone, manesium, mefFORMIN ER, Myrbetriq, omeprazole, polymyxin B sulfate, Prelief, propranolol ER, QUEtiapine, True Metrix Glucose Meter, True Metrix Test Str
Allergien: Avelox, moxifloxacin, sulfa
Vorherige Impfungen: -

VAERS 2319024

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 73,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccine given 1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: malignant tumor of breast, diabeteds mellitus, hypertensive disorder, heart disease, osteoporosis,malignant tumor of colon, kidney disease, cerebrovascular accident
Andere Medikamente: Multi Vitamin, pantoprazole, venlafaxine ER, albuterol sulf, alendronate, atorvastatin, biotin,calcium, fluticasone propionate, HYDROcodone, ketorolac, L-Lysine,lisinopril, loratadine, methylPREDNISolone,
Allergien: codeine
Vorherige Impfungen: -

VAERS 2319021

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccines given1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hypercholesterolemia, hypertensive disorder
Andere Medikamente: atorvastatin, lisinopril, Vitamin D
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2319018

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 37,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccine given 1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: depressive disorder, hypertensive disorder, malignant tumor of cervix, obesity, mental disorder, hypoglycemia
Andere Medikamente: albuterol sulfate HFA, cetirizine, clindamycin HCL, desvenlafaxine succinate ER, EluRyng, Epi E-A Pen, flunisolide, furosemide, ibuprofen, levothyroxine, linzess, sulfamethoxazole, triamcinolone acetonide cream, True Metrix Glucose ,Trulici
Allergien: meloxicam, nut, penicillins wellbutrin
Vorherige Impfungen: -

VAERS 2319012

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 32,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

vaccine given 1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: ferrous sulfate, hydrOXYzine HCL, levETIRAcetam, Prenatal Plus
Allergien: bee venom protein, lactose
Vorherige Impfungen: -

VAERS 2319008

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 27,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

vaccine given 1 day after refrigerator shelf life

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: depressive order, migraine, ADHD, pulmonary embolism
Andere Medikamente: famotidine, ibuprofen, medroxyPROGESTERone,Nurtec ODT, pantoprazole, traZODone
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2312520

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 32,0
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 15.03.2022
Beginn: 17.05.2022
Tage bis Beginn: 63,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error

Symptomtext

vaccine had been expired for 2 week and stored in refrigerator on 17-May-2022; Received first dose on 15-Mar-2022 and second dose on 17-May-2022; Patient Administered Expired Doses; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (vaccine had been expired for 2 week and stored in refrigerator on 17-May-2022), EXPIRED PRODUCT ADMINISTERED (Patient Administered Expired Doses) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 15-Mar-2022 and second dose on 17-May-2022) in a 32-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 083J21A and 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to antibiotic (Bactrim). On 15-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient Administered Expired Doses). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine had been expired for 2 week and stored in refrigerator on 17-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 15-Mar-2022 and second dose on 17-May-2022). At the time of the report, PRODUCT STORAGE ERROR (vaccine had been expired for 2 week and stored in refrigerator on 17-May-2022), EXPIRED PRODUCT ADMINISTERED (Patient Administered Expired Doses) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 15-Mar-2022 and second dose on 17-May-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. The caller was a health care professional who stated that they administered the Moderna COVID-19 vaccine on 17-May-2022 and found out that the vaccine had been expired for 2 weeks. The caller explained that since the expiration date was not written on the vial, they had not noticed it had already expired Vaccine was stored in refrigerator on 17-May-2022. The vial did not undergo any temperature excursions. Number of doses/vials are 26 doses No treatment medication information was given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Bactrim)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312519

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 37,0
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 22.02.2022
Beginn: 17.05.2022
Tage bis Beginn: 84,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error SARS-CoV-2 test

Symptomtext

Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022; First dose on 22-Feb-2022 and second dose on 17-May-2022; Patient received Moderna vaccine that had been expired for 2 weeks; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine that had been expired for 2 weeks), PRODUCT STORAGE ERROR (Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 22-Feb-2022 and second dose on 17-May-2022) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 083J21A and 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy. On 22-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine that had been expired for 2 weeks) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 22-Feb-2022 and second dose on 17-May-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine that had been expired for 2 weeks), PRODUCT STORAGE ERROR (Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 22-Feb-2022 and second dose on 17-May-2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported It was found out that the vaccine had been expired for 2 weeks It was reported that since the expiration date was not written on the vial they did not noticed it had already expired. On an unknown date the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. The vaccine stored in fridge on 17-May-2022. No treatment drugs were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Test Name: COVID-19 test; Test Result: Negative ; Result Unstructured Data: Negative
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312518

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 29,0
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 22.02.2022
Beginn: 17.05.2022
Tage bis Beginn: 84,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error SARS-CoV-2 test

Symptomtext

Vaccine had been expired for 2 weeks and stored in fridge on 17 May 2022; Dose 1 administered on 22 Feb 2022 and Dose 2 administered on 17 May 2022; Received the Moderna COVID 19 vaccine after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the Moderna COVID 19 vaccine after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vaccine had been expired for 2 weeks and stored in fridge on 17 May 2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 administered on 22 Feb 2022 and Dose 2 administered on 17 May 2022) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 083J21A and 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Lidocaine), Drug allergy (Lamictal) and Drug allergy (Effexor). On 22-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the Moderna COVID 19 vaccine after manufacturer date of expiry) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 administered on 22 Feb 2022 and Dose 2 administered on 17 May 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine had been expired for 2 weeks and stored in fridge on 17 May 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received the Moderna COVID 19 vaccine after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vaccine had been expired for 2 weeks and stored in fridge on 17 May 2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 administered on 22 Feb 2022 and Dose 2 administered on 17 May 2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was found out that the administered vaccine had been expired for 2 weeks. The HCP mentioned that since the expiration date was not written on the vial, they did not notice it had already expired. It was unknown when the vial was initially stored in the refrigerator. On 17-May-2022, the vial was stored in the refrigerator and the vial did not undergo any temperature excursions. The patient did not report any side effects. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Test Name: COVID-19 virus test; Test Result: Positive; Result Unstructured Data: Positive.
Aktuelle Erkrankungen: Drug allergy (Lidocaine); Drug allergy (Lamictal); Drug allergy (Effexor).
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312517

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 25,0
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 22.02.2022
Beginn: 17.05.2022
Tage bis Beginn: 84,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error SARS-CoV-2 test

Symptomtext

Moderna Covid 19 vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks; Received the Moderna Covid 19 vaccine after manufacturer date of expiry/Patient Administered Expired Doses; Dose 1 was administered on 22-Feb-2022 and dose 2 was administered on 17-May-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the Moderna Covid 19 vaccine after manufacturer date of expiry/Patient Administered Expired Doses), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 22-Feb-2022 and dose 2 was administered on 17-May-2022) and PRODUCT STORAGE ERROR (Moderna Covid 19 vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks) in a 25-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 083J21A and 027L21A) for COVID-19 vaccination. Patient had no known drug allergies (NKDA). On 22-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the Moderna Covid 19 vaccine after manufacturer date of expiry/Patient Administered Expired Doses) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 22-Feb-2022 and dose 2 was administered on 17-May-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid 19 vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received the Moderna Covid 19 vaccine after manufacturer date of expiry/Patient Administered Expired Doses), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 22-Feb-2022 and dose 2 was administered on 17-May-2022) and PRODUCT STORAGE ERROR (Moderna Covid 19 vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Number of doses/vials: 26 doses some were primary doses and some boosters On 17-May-2022, the vial was stored in fridge. The vial did not undergo any temperature excursions. Reporter stated that none of them had reported side effects. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Test Name: SARS-CoV-2 test; Test Result: Negative ; Result Unstructured Data: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known drug allergies (NKDA).
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312516

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 59,0
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 22.02.2022
Beginn: 17.05.2022
Tage bis Beginn: 84,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error SARS-CoV-2 test

Symptomtext

Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022; Received the Moderna Covid 19 vaccine after manufacturer date of expiry; second dose was adminstered after 2 months 25 day; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the Moderna Covid 19 vaccine after manufacturer date of expiry), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was adminstered after 2 months 25 day) and PRODUCT STORAGE ERROR (Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 027L21A and 083J21A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Drug allergy (Azithromycin allergy), Drug allergy (Amoxicillin allergy), Drug allergy (Codeine allergy), Drug allergy (Promethazine allergy), Drug allergy (sulfa allergy), Iodine contrast media allergy (intravenous pyelogram (IVP) dye allergy), Drug allergy (Keflex allergy) and Allergy to NSAIDs. On 22-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the Moderna Covid 19 vaccine after manufacturer date of expiry) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was adminstered after 2 months 25 day). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received the Moderna Covid 19 vaccine after manufacturer date of expiry), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was adminstered after 2 months 25 day) and PRODUCT STORAGE ERROR (Patient received Moderna vaccine that had been expired for 2 weeks/ stored in fridge on 17-May-2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative, Patient was not positive for covid-19. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was provided by the reporter. Number of doses/vials were 26 doses. The reporter reported that, found out that the vaccine had been expired for 2 weeks and the expiration date was not written on the vial and did not noticed it had already expired. The vaccine stored in fridge on 17-May-2022. The vials did not undergo any temperature excursion. No treatment medications was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Test Name: Covid-19 test; Test Result: Negative ; Result Unstructured Data: Negative, Patient was not positive for covid-19.
Aktuelle Erkrankungen: Allergy to NSAIDs; Drug allergy (sulfa allergy); Drug allergy (Promethazine allergy); Drug allergy (Keflex allergy); Drug allergy (Codeine allergy); Drug allergy (Azithromycin allergy); Drug allergy (Amoxicillin allergy); Iodine contrast media allergy (intravenous pyelogram (IVP) dye allergy); Penicillin allergy.
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312513

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 32,0
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 22.02.2022
Beginn: 17.05.2022
Tage bis Beginn: 84,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error SARS-CoV-2 test

Symptomtext

vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks; Dose 1 received was on 22-Feb-2022 , while dose 2 received on 17-May-2022; Patient received vaccine that had been expired for 2 weeks; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that had been expired for 2 weeks), PRODUCT STORAGE ERROR (vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received was on 22-Feb-2022 , while dose 2 received on 17-May-2022) in a 32-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 083J21A and 027L21A) for COVID-19 vaccination. Patient do not have any allergies. On 22-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that had been expired for 2 weeks) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received was on 22-Feb-2022 , while dose 2 received on 17-May-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that had been expired for 2 weeks), PRODUCT STORAGE ERROR (vaccine was stored and administered on 17-May-2022 and found out that the vaccine had been expired for 2 weeks) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received was on 22-Feb-2022 , while dose 2 received on 17-May-2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Number of doses/vials: 26 doses some were primary doses and some boosters . The health care professional (HCP) states that they administered the Moderna COVID 19 vaccine on 17-May-2022 and found out that the vaccine had been expired for 2 weeks. The HCP explains that since the expiration date was not written on the vial, they did not notice it had already expired. On 17-May-2022, the vial was initially stored in the refrigerator and the vial did not undergo any temperature excursions. Reporter stated that none of them had reported side effects. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient do not have any allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 79,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312085

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 67,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND THE USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: DIABETES AND HYPERTENSION
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312080

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312075

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 25,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION GIVEN BEYOND THE USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312074

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 19,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312073

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO EA, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 39,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312059

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 28,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACINATION WAS GIVEN BEYOND THE USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312058

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 20.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2312050

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 41,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2311920

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2311919

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 65,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION WAS GIVEN BEYOND USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2311911

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 19,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

NO AE, VACCINATION GIVEN BEYOND USAGE DATE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2311776

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 18,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

NO ADVERSE EVENTS, HOWEVER THE VACCINES WAS BEYOND THE USAGE DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NK
Vorgeschichte: NK
Andere Medikamente: NK
Allergien: NK
Vorherige Impfungen: -

VAERS 2309487

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 04.06.2022
Impfdatum: 22.03.2022
Beginn: 22.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 16FEB2022, Refrigeration Expiry date was 17MAR2022/ Date of administration of vaccine was on 22MAR2022; Patient received expired Moderna COVID-19 vaccine beyond the 30 day refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 16FEB2022, Refrigeration Expiry date was 17MAR2022/ Date of administration of vaccine was on 22MAR2022) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 vaccine beyond the 30 day refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 16FEB2022, Refrigeration Expiry date was 17MAR2022/ Date of administration of vaccine was on 22MAR2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 16FEB2022, Refrigeration Expiry date was 17MAR2022/ Date of administration of vaccine was on 22MAR2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. It was reported that, patient received first booster dose. Number of doses/vials was 1 dose/ 1 vial. Date the vial was initially stored in the refrigerator was 16FEB2022 (Refrigeration Expiry date 17MAR2022). The vial did not undergone any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2302990

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: WA
Alter: 69,0
Geschlecht: M
Eingang: 31.05.2022
Impfdatum: 18.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid-19) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Hyperlipidemia, Hypertension and Allergy NOS. Concomitant products included ATORVASTATIN for an unknown indication. On 18-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 09-May-2022 to 13-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (covid-19) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment medication was not provided by the reporter. Company Comment: This spontaneous case concerns a 69-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 unspecified days after receiving fourth dose of mRNA-1273 vaccine. It was reported that patient started with Paxlovid On 09-May-2022. and Covid symptoms returned and tested positive on antigen test 8 days after starting with Paxlovid. The current pandemic situation of COVID-19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 69-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 unspecified days after receiving fourth dose of mRNA-1273 vaccine. It was reported that patient started with Paxlovid On 09-May-2022. and Covid symptoms returned and tested positive on antigen test 8 days after starting with Paxlovid. The current pandemic situation of COVID-19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 202205; Test Name: Antigen test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Allergy NOS; Hyperlipidemia; Hypertension
Vorgeschichte: -
Andere Medikamente: ATORVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2301475

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 16,0
Geschlecht: F
Eingang: 28.05.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administered to patient of inappropriate age

Symptomtext

NO ADVERSE REACTION REPORTED

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: ALLERGIES
Vorgeschichte: NONE
Andere Medikamente: NO ADVERSE REACTIONS REPORTED
Allergien: NO ADVERSE REACTIONS REPORTED
Vorherige Impfungen: -

VAERS 2298633

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administration error

Symptomtext

Injected patient, felt bone, pulled needle all the way back Re-adjusted site location and injected patient again and administered vaccine in muscle area Patient did not have any effects during the 15 min wait.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administration error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2290945

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 78,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered No adverse event

Symptomtext

No adverse effects but patient was not supposed to receive a 5th dose as it has not been approved yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2290653

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MA
Alter: 57,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 30.03.2022
Beginn: 31.03.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

I have tinnitus in both ears, which I never had before. This was my 4th Moderna shot, or 2nd booster shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: None yet, waiting to see an ENT specialist
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis
Andere Medikamente: Vitamin C ? 1000mg 1x day Vitamin D 1000 IU 25mcg 2 per day Triple Iodine complex 1 capsule per day Biotin, 10,000 mcg 2 capsules per day Vitamin K2 MK-7 gold 120mcg 2 capsules per day Magnesium 3 in one L threonate 1 capsule per day Black
Allergien: Fentanyl, Morphine, Pollen
Vorherige Impfungen: -

VAERS 2289186

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 69,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289185

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 76,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289184

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 76,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289183

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 86,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289182

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 49,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289181

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 83,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289180

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 72,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289179

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 90,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289177

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 72,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289176

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 58,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289175

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 78,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289174

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 77,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282871

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 67,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282870

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 78,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282869

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 73,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282864

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 68,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282862

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 70,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282859

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275477

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 77,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275465

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 81,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275463

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 70,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275461

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 67,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275457

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: VA
Alter: 56,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278431

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 11.04.2022
Beginn: 14.05.2022
Tage bis Beginn: 33,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4th vaccine 2/27/21 Moderna Lot# 025A21A 3/23/21 Moderna Lott# 045A21A 10/22/21 Moderna Lot# 025D21A 4/11/22 Moderna Lot# 027L21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 5/14/22 COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278403

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: NY
Alter: 40,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 09.03.2022
Beginn: 09.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Underdose

Symptomtext

patient received a booster dose (0.25ml) when she should have received a full 3rd dose as she is immunocompromised.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275476

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 65,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275475

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 68,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275474

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 73,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275473

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 76,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275472

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 75,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275471

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 72,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275470

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 76,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275469

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 75,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275468

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 84,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275467

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 78,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275460

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 68,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275459

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 70,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275456

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (ex. temp./location)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2270824

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: -
Alter: 45,0
Geschlecht: M
Eingang: 11.05.2022
Impfdatum: 30.04.2021
Beginn: 01.03.2022
Tage bis Beginn: 305,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Bradycardia COVID-19 SARS-CoV-2 test positive

Symptomtext

03/01/22 presents to ED for "generalized weakness, bradycardia". PMHx of "insulin-dependent diabetes, CKD, CAD"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asthenia
Hospital-Tage: -
Labordaten: 03/01/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268999

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 13,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Interchange of vaccine products

Symptomtext

PATIENT WAS GIVEN A COVID MODERNA VACCINE SHOULD HAVE RECEIVED PFIZER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Interchange of vaccine products
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: LACTOSE INTOLERANCE
Vorgeschichte: -
Andere Medikamente: ZYRTEC 10MG ONCE PER DAY FLUTICASONE 50MCG ACT MONTELUKAST 10MG
Allergien: SEASONAL ALLERGIES
Vorherige Impfungen: -

VAERS 2268987

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 16,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

PATIENT RECEIVED COVID MODERNA VACCINE INSTEAD OF PFIZER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: none
Vorgeschichte: hx of skin cancer Strabismus
Andere Medikamente: none known
Allergien: goat products
Vorherige Impfungen: -

VAERS 2268532

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 28,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 07.04.2022
Beginn: 05.05.2022
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose

Symptomtext

Administered half dose (0.25ml red cap vial) for the 2nd primary dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Administered half dose (0.25ml red cap vial) for the 2nd primary dose) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 05-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .25 milliliter. On 05-May-2022, after starting mRNA-1273 (Spikevax), the patient experienced ACCIDENTAL UNDERDOSE (Administered half dose (0.25ml red cap vial) for the 2nd primary dose). At the time of the report, ACCIDENTAL UNDERDOSE (Administered half dose (0.25ml red cap vial) for the 2nd primary dose) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medications was not provided by the reporter. Patient administered half dose (0.25ml red cap vial) instead of full dose by mistake. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2267332

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MA
Alter: 62,0
Geschlecht: F
Eingang: 09.05.2022
Impfdatum: 06.04.2022
Beginn: 09.04.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Left ear ringing non-stop. Have not seen a doctor about this. Daughter recently had brain surgery so there been no time to see my physician who works very limited hours. Regarding Q21 since I can't go on with this report with our answering something, I will call and let them know that I have this symptom today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: Only sore arm, headache and fatigue

VAERS 2263506

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MN
Alter: 19,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 03.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Individual came to walk -in clinic on morning of 5/3/2022 to get her Covid booster shot. She had received 1st vaccine of J & J on 3/22/2022 and she was receptive to getting MRNA vaccine for booster. Moderna booster dose was given too early. This was brought to PHN's attention on 5/4/22 after dose was entered into the system and came up as "invalid" . When checked guidelines for actions to take, the recommendation stated not repeat the vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2261907

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 55,0
Geschlecht: M
Eingang: 03.05.2022
Impfdatum: 19.02.2022
Beginn: 27.04.2022
Tage bis Beginn: 67,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19

Symptomtext

covid

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2259632

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 61,0
Geschlecht: F
Eingang: 30.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine was administered on 06-Apr-2022, stored in refrigerator on 25-Feb-2022 and was expired on 25-Mar-2022; Patient was administered with vaccine which was expired on 25-Mar-2022 and past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine which was expired on 25-Mar-2022 and past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Vaccine was administered on 06-Apr-2022, stored in refrigerator on 25-Feb-2022 and was expired on 25-Mar-2022) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Hydrochlorothiazide allergy), Drug allergy (Lisinopril allergy), Latex allergy and Drug allergy. Concomitant products included FLUTICASONE FUROATE (ARNUITY ELLIPTA), CYCLOBENZAPRINE, GABAPENTIN, EPINEPHRINE (EPIPEN), MOMETASONE FUROATE (NASONEX), SALBUTAMOL (VENTOLIN [SALBUTAMOL]), DIAZEPAM (DELICA), ASCORBIC ACID, FERROUS FUMARATE (VITRON C [ASCORBIC ACID;FERROUS FUMARATE]), IBUPROFEN, ALLOPURINOL, LOSARTAN, GLIPIZIDE, LEVOCETIRIZINE, CARVEDILOL, FUROSEMIDE, AMLODIPINE BESYLATE and TRIAMCINOLONE ACETONIDE for an unknown indication. On 06-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine which was expired on 25-Mar-2022 and past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was administered on 06-Apr-2022, stored in refrigerator on 25-Feb-2022 and was expired on 25-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine which was expired on 25-Mar-2022 and past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Vaccine was administered on 06-Apr-2022, stored in refrigerator on 25-Feb-2022 and was expired on 25-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient took one touch verio as concomitant medication. The patient received vaccine which was refrigerated on 25-Feb-2022 and was administered on 06-Apr-2022 after the expiration date of 25-Mar-2022. The vial did not undergo any temperature excursions. Patient did not experience any side effects at the time reporting. Patient have not experienced COVID-19 within last month. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Lisinopril allergy); Drug allergy (Hydrochlorothiazide allergy); Drug allergy; Latex allergy
Vorgeschichte: -
Andere Medikamente: ARNUITY ELLIPTA; CYCLOBENZAPRINE; GABAPENTIN; EPIPEN; NASONEX; VENTOLIN [SALBUTAMOL]; DELICA; VITRON C [ASCORBIC ACID;FERROUS FUMARATE]; IBUPROFEN; ALLOPURINOL; LOSARTAN; GLIPIZIDE; LEVOCETIRIZINE; CARVEDILOL; FUROSEMIDE; AMLODIPINE BESYLAT
Allergien: -
Vorherige Impfungen: -

VAERS 2254089

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 53,0
Geschlecht: M
Eingang: 27.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25 Feb 2022 and administered on 06 Apr 2022; Received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25 Feb 2022 and administered on 06 Apr 2022) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known allergies. Concurrent medical conditions included GERD and Hyperlipidemia. Concomitant products included OMEPRAZOLE and SIMVASTATIN for an unknown indication. On 06-Apr-2022 at 11:17 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 11:17 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25 Feb 2022 and administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25 Feb 2022 and administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Vial did not undergo any temperature excursions It was reported the patients were vaccinated with the Moderna Vaccine after the expiration of 25 Mar 2022. Reporter confirmed that the patients were not experiencing any side effects yet. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: GERD; Hyperlipidemia
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: OMEPRAZOLE; SIMVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2254088

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 42,0
Geschlecht: M
Eingang: 27.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

received a vaccine past the 30 day storage on the refrigerator; Doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) in a 42-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. It was reported that patient had no known allergies. Patient was not tested positive for COVID within last month. Concomitant products included SODIUM FLUORIDE and TRIAMCINOLONE ACETONIDE for an unknown indication. On 06-Apr-2022 at 3:04 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 06-Apr-2022 at 3:04 PM, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Date the vial was initially stored in refrigerator 25-Feb-2022. The vial did not undergo any temperature excursions. HCP confirmed that the patients were not experiencing any side effects at the time of this report. Expiry date of vaccine was reported as 25-Mar-2022. No treatment details were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was reported that patient had no known allergies. Patient was not tested positive for COVID within last month.
Andere Medikamente: SODIUM FLUORIDE; TRIAMCINOLONE ACETONIDE
Allergien: -
Vorherige Impfungen: -

VAERS 2254087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 18,0
Geschlecht: F
Eingang: 27.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

patients that received a vaccine past the 30 day storage on the refrigerator.; patients that received a vaccine past the 30 day storage on the refrigerator.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients that received a vaccine past the 30 day storage on the refrigerator.) and PRODUCT STORAGE ERROR (patients that received a vaccine past the 30 day storage on the refrigerator.) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. It was reported that patient had no known drug allergies (NKDA). Concomitant products included TRIAMCINOLONE and MELATONIN for an unknown indication. On 20-Apr-2022 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 11:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients that received a vaccine past the 30 day storage on the refrigerator.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patients that received a vaccine past the 30 day storage on the refrigerator.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients that received a vaccine past the 30 day storage on the refrigerator.) and PRODUCT STORAGE ERROR (patients that received a vaccine past the 30 day storage on the refrigerator.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vial was initially stored in the refrigerator on 25-Feb-2022.The vial did not undergo any temperature excursions.HCP confirmed that the patients are not experiencing any side effects yet. No treatment information was provided. This case was linked to MOD-2022-545267 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was reported that patient had no known drug allergies (NKDA).
Andere Medikamente: TRIAMCINOLONE; MELATONIN.
Allergien: -
Vorherige Impfungen: -

VAERS 2254077

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 56,0
Geschlecht: F
Eingang: 27.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022; received a vaccine past the 30 day storage on the refrigerator.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (received a vaccine past the 30 day storage on the refrigerator.) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (ASA), Allergic reaction to analgesics (Morphine) and Diabetes. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), LORATADINE, TRIAMCINOLONE, LOVASTATIN, SALBUTAMOL (VENTOLIN [SALBUTAMOL]), FLUTICASONE PROPIONATE (FLOVENT), GLIMEPIRIDE, LISINOPRIL and METFORMIN for an unknown indication. On 06-Apr-2022 at 9:07 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 9:07 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a vaccine past the 30 day storage on the refrigerator.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (received a vaccine past the 30 day storage on the refrigerator.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient was not COVID positive within last month. On 25-Feb-2022 vial was initially stored in the refrigerator. It was reported the patients were vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022 Vial did not undergo any temperature excursions HCP confirmed that the patients were not experiencing any side effects yet. Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2022: Follow-up received, report type changed (Invalid to Valid) spontaneous, reporter type updated, contact information added. Patient details, medical history, dosage details and concomitant medication added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergic reaction to analgesics (Morphine); Diabetes; Drug allergy (ASA)
Vorgeschichte: -
Andere Medikamente: FLONASE [FLUTICASONE PROPIONATE]; LORATADINE; TRIAMCINOLONE; LOVASTATIN; VENTOLIN [SALBUTAMOL]; FLOVENT; GLIMEPIRIDE; LISINOPRIL; METFORMIN
Allergien: -
Vorherige Impfungen: -

VAERS 2252819

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: WA
Alter: 46,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 26.03.2022
Beginn: 26.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Wrong product administered

Symptomtext

Adult pt requested dose #2 of Moderna, reporting that her 1st dose was Pfizer. Previous vaccine records were not available. Full dose of Moderna was administered. Later it was discovered that pt had received only J&J single dose previously on 4/5/2021. Unable to reach pt by phone at this time

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2251777

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 62,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20 Apr 2022; Expired Vaccine Used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20 Apr 2022) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergy or had no food and medication allergy patent had no acute illness. On 20-Apr-2022 at 11:39 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 11:39 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was provided by the reporter. Dose administered past the 30 day storage on the refrigerator Number of doses or vials administered 36 doses. Date and time the vial was initially stored in the refrigerator 25-Feb-2022. The vial had not undergone any temperature excursion. No treatment medications were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known drug allergy or had no food and medication allergy patent had no acute illness
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 44,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-Mar-2022; dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-Mar-2022) in a 44-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. BMI was reported as 40.0-44.9 Patient had no known drug allergies. Patient had morbid (severe). Patient not tested positive for COVID within last month. The patient's past medical history included Tubal ligation. Concurrent medical conditions included Obesity, Hyperlipidemia, Acute atopic conjunctivitis, Visual disturbances, Acute nasopharyngitis, Tooth development disorder, Pain in knee, Cervical pain, Snoring, Pelvic pain, Perineal pain, Glucose abnormal, Vitamin D deficiency and Gastritis haemorrhagic. Concomitant products included FAMOTIDINE, SALBUTAMOL (VENTOLINE [SALBUTAMOL]), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and VITAMIN D3 for an unknown indication. On 30-Mar-2022 at 10:40 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 30-Mar-2022 at 10:40 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-Mar-2022) outcome was unknown. Not Provided For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The product expiration date was 25-Mar-2022. It was reported that HCP confirmed the patients did not experience any side effects yet. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022 and expired. The vial did not undergo any temperature excursions. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Acute atopic conjunctivitis; Acute nasopharyngitis; Cervical pain; Gastritis haemorrhagic; Glucose abnormal; Hyperlipidemia; Obesity; Pain in knee; Pelvic pain; Perineal pain; Snoring; Tooth development disorder; Visual disturbances; Vitamin D deficiency.
Vorgeschichte: Medical History/Concurrent Conditions: Tubal ligation; Comments: BMI was reported as 40.0-44.9. Patient had no known drug allergies. Patient had morbid (severe). Patient not tested positive for COVID within last month.
Andere Medikamente: FAMOTIDINE; VENTOLINE [SALBUTAMOL]; VITAMIN D [COLECALCIFEROL]; VITAMIN D3.
Allergien: -
Vorherige Impfungen: -

VAERS 2251568

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 34,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 01-Apr- 2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 01-Apr- 2022) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concomitant products included OMEPRAZOLE, IRON and CLINDAMYCIN for an unknown indication. On 01-Apr-2022 at 11:22 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 11:22 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 01-Apr- 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 01-Apr- 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022. The vial did not undergo any temperature excursions. Patient was administered with booster dose. No treatment information was reported. Patient did not had COVID-19 preceding month of vaccination. Patient had no known allergies of medicines and food.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: OMEPRAZOLE; IRON; CLINDAMYCIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251564

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 66,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had Statin allergy, Amlodipine Allergy and Ezetimibe Allergy. It was unknown if the patient tested positive/negative for COVID-19 within last month. Concurrent medical conditions included Drug allergy, Diabetes, Drug allergy and Drug allergy. Concomitant products included TRIAMCINOLONE, ESCITALOPRAM, IBUPROFEN, LORATADINE, ASA, LORAZEPAM, PRAZOSIN, ALBUTEROL SULFATE, BENZONATATE, FLUTICASONE, LOSARTAN, NIFEDIPINE and MUPIROCIN for an unknown indication. On 06-Apr-2022 at 9:31 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 9:31 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient was not COVID-19 positive within last month. The number of doses/vials was 36. On 25-Feb-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Patient did not experience any side effects at the time of report. No Treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes; Drug allergy
Vorgeschichte: Comments: Patient had Statin allergy, Amlodipine Allergy and Ezetimibe Allergy. It was unknown if the patient tested positive/negative for COVID-19 within last month.
Andere Medikamente: TRIAMCINOLONE; ESCITALOPRAM; IBUPROFEN; LORATADINE; ASA; LORAZEPAM; PRAZOSIN; ALBUTEROL SULFATE; BENZONATATE; FLUTICASONE; LOSARTAN; NIFEDIPINE; MUPIROCIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251563

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 45,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 06-Apr-2022; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 06-Apr-2022) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), IBUPROFEN, VITAMIN D3, CETIRIZINE and ETHINYLESTRADIOL, NORGESTIMATE (SPRINTEC) for an unknown indication. On 06-Apr-2022 at 10:32 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 10:32 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 06-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 06-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The expiration date was 25 Mar 2022. Date and time the vial was initially stored in the refrigerator on 25 Feb 2022. No treatment medication information provided. Covid positive or negative within last month was reported as No.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: -
Andere Medikamente: FLONASE [FLUTICASONE PROPIONATE]; IBUPROFEN; VITAMIN D3; CETIRIZINE; SPRINTEC
Allergien: -
Vorherige Impfungen: -

VAERS 2251562

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 72,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Patient was administered vaccine after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered vaccine after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension, Hyperlipidemia and Glaucoma. Concomitant products included GABAPENTIN, LOVASTATIN and LISINOPRIL for an unknown indication. On 20-Apr-2022 at 8:49 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 8:49 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered vaccine after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered vaccine after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not had any allergies to food or medications. Patient did not had COVID-19 positive or negative preceding month of vaccination. Total number of doses/vials was 36. Vial did not undergo any temperature excursions. Patient not experienced any side effects yet. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Glaucoma; Hyperlipidemia; Hypertension
Vorgeschichte: -
Andere Medikamente: GABAPENTIN; LOVASTATIN; LISINOPRIL
Allergien: -
Vorherige Impfungen: -

VAERS 2251561

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 36,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 36-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. Patient had no allergies, acute/chronic illnesses and daily medications. Patient not tested positive for COVID within last month. On 13-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The product expiration date was 25 Mar 2022. It was reported that HCP confirmed the patients did not experience any side effects yet. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022 and expired. The vial did not undergo any temperature excursions. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no allergies, acute/chronic illnesses and daily medications. Patient not tested positive for COVID within last month.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251560

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 41,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergies or food and none daily medications were reported. Positive or negative COVID-19 within last month of vaccination was not applicable. Concurrent medical conditions included Hyperlipidemia and Bipolar disorder (Bipolar). On 06-Apr-2022 at 9:25 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 9:25 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment information was reported. Patient received a vaccine past the 30-day storage on the refrigerator. The Moderna vaccine in question had been put aside and was not currently being used until further notice. The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 06-Apr-2022 (administered after 30-day Use By Date). Vial did not undergo any temperature excursions. The patient was not experiencing any side effects yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Bipolar disorder (Bipolar); Hyperlipidemia
Vorgeschichte: Comments: Patient had no known drug allergies or food and none daily medications were reported. Positive or negative COVID-19 within last month of vaccination was not applicable.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251558

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A .

gering

Staat: MD
Alter: 43,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A .) for COVID-19 vaccination. Concurrent medical conditions included Leiomyoma of uterus, unspecified and Drug allergy (CHLOROQUINE allergy). Concomitant products included PROPRANOLOL, IBUPROFEN, NORETHINDRONE [NORETHISTERONE] and LOSARTAN for an unknown indication. On 06-Apr-2022 at 10:16 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 10:16 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022. The vial did not undergo any temperature excursions. No Treatment information was reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (CHLOROQUINE allergy); Leiomyoma of uterus, unspecified
Vorgeschichte: -
Andere Medikamente: PROPRANOLOL; IBUPROFEN; NORETHINDRONE [NORETHISTERONE]; LOSARTAN
Allergien: -
Vorherige Impfungen: -

VAERS 2251557

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 63,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; Dose administered after 30-day Use By Date/vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date/vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Hypocalcemia. Concomitant products included IBUPROFEN, FLUCONAZOLE, FLUTICASONE PROPIONATE and OMEPRAZOLE for an unknown indication. On 13-Apr-2022 at 1:46 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022 at 1:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date/vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date/vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not have any known allergies. On 25-Feb-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Patient did not experience any side effects yet. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypocalcemia
Vorgeschichte: -
Andere Medikamente: IBUPROFEN; FLUCONAZOLE; FLUTICASONE PROPIONATE; OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 2251556

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 57,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 20-Apr-2022; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 20-Apr-2022) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. Concomitant products included ATENOLOL and HCTZ for an unknown indication. On 20-Apr-2022 at 11:27 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 11:27 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 20-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25-Feb-2022 and date administered on 20-Apr-2022) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vaccine expiration date was 25-Mar-2022. The date and time the vial was initially stored in the refrigerator was on 25-Feb-2022. The vial did not undergo any temperature excursions. The patient had not experienced any side effects yet. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypertension.
Vorgeschichte: -
Andere Medikamente: ATENOLOL; HCTZ.
Allergien: -
Vorherige Impfungen: -

VAERS 2251555

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 37,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known drug allergies. Concurrent medical conditions included Asthma. Concomitant products included Melatonin; Acyclovir [Aciclovir]; Albuterol Sulfate for an unknown indication. On 20-Apr-2022 at 11:43 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 11:43 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vial was initially stored in refrigerator on 25-Feb-2022. The vial did not undergo temperature excursion. It was reported that the patient was vaccinated post 30 day use period (expiration date 25-Mar-2022). The patient did not experience any side effects. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma
Vorgeschichte: Comments: The patient had no known drug allergies.
Andere Medikamente: Melatonin; Acyclovir [Aciclovir]; Albuterol Sulfate
Allergien: -
Vorherige Impfungen: -

VAERS 2251554

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 44,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022; 36 doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No relevant medical history reported. Concomitant products included LISINOPRIL, ZOLPIDEM and DICLOFENAC for an unknown indication. On 06-Apr-2022 at 8:56 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 8:56 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that HCP confirmed the patients did not experience any side effects yet. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022 and expired. The vial did not undergo any temperature excursions. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No relevant medical history reported.
Andere Medikamente: LISINOPRIL; ZOLPIDEM; DICLOFENAC
Allergien: -
Vorherige Impfungen: -

VAERS 2251552

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 66,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient did not had COVID-19 preceding month of vaccination. Patient had no known allergies of medicines and food. Concurrent medical conditions included Hyperlipidemia. Concomitant products included ASA, VALACYCLOVIR [VALACICLOVIR] and ATORVASTATIN for an unknown indication. On 06-Apr-2022 at 3:07 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 3:07 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022. The vial did not undergo any temperature excursions. No Treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hyperlipidemia
Vorgeschichte: Comments: Patient did not had COVID-19 preceding month of vaccination. Patient had no known allergies of medicines and food.
Andere Medikamente: ASA; VALACYCLOVIR [VALACICLOVIR]; ATORVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251551

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 38,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 immunisation. Patient was not allergic to medicine/food. Patient had no acute/chronic illnesses. On 13-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not receive any concomitant medication. Patient received booster dose of Moderna vaccine. On 25-Feb-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Patient did not experience any side effects yet. No treatment medication was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient was not allergic to medicine/food. Patient had no acute/chronic illnesses.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251550

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 73,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergy or medication of food allergy. Concurrent medical conditions included Type 2 diabetes mellitus, Hyperglyceridemia, Hypertension, Chest pain and Dorsalgia. Concomitant products included Esomeprazole; Atorvastatin; Amlodipine; Aspirin; Losartan; Metformin; Triamcinolone for an unknown indication. On 30-Mar-2022 at 9:59 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022 at 9:59 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had other medication such as Omicron. Dose administered past the 30 day storage on the refrigerator. Number of doses or vials administered 36 doses. Date and time the vial was initially stored in the refrigerator 25 Feb 2022. The vial had not undergone any temperature excursion. Covid positive or negative within last month was reported as N. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Chest pain; Dorsalgia; Hyperglyceridemia; Hypertension; Type 2 diabetes mellitus
Vorgeschichte: Comments: Patient had no known drug allergy or medication of food allergy
Andere Medikamente: Esomeprazole; Atorvastatin; Amlodipine; Aspirin; Losartan; Metformin; Triamcinolone
Allergien: -
Vorherige Impfungen: -

VAERS 2251549

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 78,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concomitant products included DILTIAZEM HYDROCHLORIDE (CARTIA [DILTIAZEM HYDROCHLORIDE]), METFORMIN, METOPROLOL, DILTIAZEM and LOVASTATIN for an unknown indication. On 20-Apr-2022 at 11:25 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 11:25 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not had any allergies to food or medications. Total number of doses/vials was 36. Vial did not undergo any temperature excursions. Patient not experienced any side effects yet. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: CARTIA [DILTIAZEM HYDROCHLORIDE]; METFORMIN; METOPROLOL; DILTIAZEM; LOVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251548

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 66,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No known drug allergy was reported. Concurrent medical conditions included Hypertension. Concomitant products included HYDROCHLOROTHIAZIDE, IRBESARTAN (IRBESART AND HYDROCHLOROTHIAZIDE), AMLODIPINE, METOPROLOL, FAMOTIDINE (PEPCID [FAMOTIDINE]) and CETIRIZINE HYDROCHLORIDE (CITIRIZINE [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On 30-Mar-2022 at 9:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Date the vial was initially stored in the refrigerator: 25-FEB-2022 Vial didn't undergo any temperature excursions. Patient had not experienced any side effects yet. No treatment details were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: Comments: No known drug allergy was reported.
Andere Medikamente: IRBESART AND HYDROCHLOROTHIAZIDE; AMLODIPINE; METOPROLOL; PEPCID [FAMOTIDINE]; CITIRIZINE [CETIRIZINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 2251547

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 48,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.; Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022) and PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient did not have COVID-19 preceding the month of vaccination. No allergies nor any Acute and Chronic illness was reported. On 01-Apr-2022 at 10:59 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 10:59 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022) and PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022. Vial did not undergo any temperature excursions. Patient did not experience any side effects yet. Concomitant drugs were not reported. Treatment details were not given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient did not have COVID-19 preceding the month of vaccination. No allergies nor any Acute and Chronic illness was reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251546

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 68,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-MAR-2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-MAR-2022) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Allergies included no known drug allergies. Concurrent medical conditions included Type 2 diabetes mellitus and Hypertension. On 30-Mar-2022 at 10:53 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022 at 10:53 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-MAR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 30-MAR-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that the patient took Diabetes 2 and hypertension medications. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022. The vial did not undergo any temperature excursions. It was reported that the patient not experienced any side effect. No treatment information was reported. The patient not had COVID-19 within last month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypertension; Type 2 diabetes mellitus
Vorgeschichte: Comments: Allergies included no known drug allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251544

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 37,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine was initial stored in refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; 36 doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vaccine was initial stored in refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 37-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initial stored in refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vaccine was initial stored in refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No Concomitant Products were reported. It was reported that date the vial was initially stored in the refrigerator was 25-FEB-2022. Vial didn't undergo any temperature excursions. Patient did not experienced any side effects yet. No Treatment information was reported. This case was linked to MOD-2022-545267 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251543

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 26,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022; doses administered after 30-day Use By Date and after expiry date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and after expiry date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) in a 26-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known meds/food allergies. The patient had no chronic/acute illness. On 06-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and after expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and after expiry date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The patient had not received any daily medications. The vial was initially stored in the refrigerator on 25-Feb-2022. Expiration date for vaccine 25-Mar-2022. The vial did not undergo any temperature excursions. It was reported that the patient not experienced any side effect. No treatment information was reported. Patient had not tested COVID-19 within last month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known meds/food allergies. The patient had no chronic/acute illness.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251541

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 52,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.; Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022) and PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.) In a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient did not have COVID-19 preceding the month of vaccination. No allergies were reported. Concurrent medical conditions included Hypertension, Diabetes mellitus, Hyperlipidemia and Chronic kidney disease. On 01-Apr-2022 at 10:18 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 10:18 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022) and PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022.Vial didn't undergo any temperature excursions. Patient did not experience any side effects yet. Concomitant drugs were not reported. Treatment details were not given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Chronic kidney disease; Diabetes mellitus; Hyperlipidemia; Hypertension
Vorgeschichte: Comments: Patient did not have COVID-19 preceding the month of vaccination. No allergies were reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251540

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 62,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 01-Apr-2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 01-Apr-2022) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to antibiotic (Amoxicillin), Diabetes mellitus, Hypertension, Sciatica and Fibromyalgia. On 01-Apr-2022 at 11:24 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 11:24 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 01-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator/ Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 01-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that the patient was on multiple medications. The patient took booster dose. The vial was initially stored in the refrigerator on 25-Feb-2022, its 30 day used by date was 25-Mar-2022. The vial did not underwent any temperature excursions. It was reported that the patient did not experienced any side effect. No treatment information was reported. The patient not had COVID-19 within last month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Amoxicillin); Diabetes mellitus; Fibromyalgia; Hypertension; Sciatica
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251538

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 48,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

doses administered after 30-day Use By Date and expiry date; doses administered after 30-day Use By Date and expiry date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and expiry date) and PRODUCT STORAGE ERROR (doses administered after 30-day Use By Date and expiry date) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. It was reported that Patient did not have COVID positive or negative within last month. The patient's past medical history included Anemia. Concurrent medical conditions included Diabetes, Drug allergy (Allergy to Glipizide) and Drug allergy (Allergy to Novolin 70/30). Concomitant products included METFORMIN and LISINOPRIL for an unknown indication. On 06-Apr-2022 at 3:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 3:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (doses administered after 30-day Use By Date and expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and expiry date) and PRODUCT STORAGE ERROR (doses administered after 30-day Use By Date and expiry date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Other Concomitant medication included Lantus Solostar The number of doses/vials was 36. The vial was initially stored in the refrigerator on 25-Feb-2022 The vials did not undergo any temperature excursion. The healthcare professional (HCP) wanted to know how to proceed with 36 patients that received a vaccine past the 30 day storage on the refrigerator. HCP confirmed that the patients were not experiencing any side effects yet. No treatments were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes; Drug allergy (Allergy to Novolin 70/30); Drug allergy (Allergy to Glipizide)
Vorgeschichte: Medical History/Concurrent Conditions: Anemia; Comments: It was reported that Patient did not have COVID positive or negative within last month
Andere Medikamente: METFORMIN; LISINOPRIL
Allergien: -
Vorherige Impfungen: -

VAERS 2251537

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 57,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20Apr2022; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20Apr2022) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergy or medication and food. Concurrent medical conditions included Sarcoidosis, Type 2 diabetes mellitus and Multiple myeloma. Concomitant products included SIMVASTATIN, ZOLEDRONIC ACID MONOHYDRATE (ZOMETA), METFORMIN, DEXAMETHASONE, LISINOPRIL, LEVOTHYROXINE and GABAPENTIN for an unknown indication. On 20-Apr-2022 at 9:26 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 9:26 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 20Apr2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient received other medication such as Acyclovir Dose administered after 30 day use by date or after manufacturer date of expiry. Number of doses or vials administered 36 doses. Date and time the vial was initially stored in the refrigerator 25-Feb-2022. Date and time of administration of vaccine was 01-Apr-2022 and 08-Apr-2022. The vial had not undergone any temperature excursion. No treatment medications were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Multiple myeloma; Sarcoidosis; Type 2 diabetes mellitus
Vorgeschichte: Comments: Patient had no known drug allergy or medication and food.
Andere Medikamente: SIMVASTATIN; ZOMETA; METFORMIN; DEXAMETHASONE; LISINOPRIL; LEVOTHYROXINE; GABAPENTIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251535

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 71,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known allergies. Patient did not have COVID-19 preceding the month of vaccination. Concurrent medical conditions included Diabetes, Anemia, Hyperlipidemia and Thrombocytopenia. Concomitant products included GLIPIZIDE for an unknown indication. On 06-Apr-2022 at 3:14 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 3:14 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022. The vial did not undergo any temperature excursions. Treatment details were not given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Anemia; Diabetes; Hyperlipidemia; Thrombocytopenia
Vorgeschichte: Comments: The patient had no known allergies. Patient did not have COVID-19 preceding the month of vaccination.
Andere Medikamente: GLIPIZIDE
Allergien: -
Vorherige Impfungen: -

VAERS 2251532

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 42,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

doses administered after 30-day Use By Date and expiry date; doses administered after 30-day Use By Date and expiry date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and expiry date) and PRODUCT STORAGE ERROR (doses administered after 30-day Use By Date and expiry date) in a 42-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known drug allergies. The patient had no chronic/acute illness and it was unknown if the patient tested positive/negative for COVID-19 within last month. Concomitant products included MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) for an unknown indication. In April 2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In April 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (doses administered after 30-day Use By Date and expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date and expiry date) and PRODUCT STORAGE ERROR (doses administered after 30-day Use By Date and expiry date) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The number of doses/vials was 36. The vial was initially stored in the refrigerator on 25-Feb-2022. It was reported that date and time of administration of vaccine was 1-Apr-2022 and 8-Apr-2022. The vials did not undergo any temperature excursion. The patient had not received any daily medications. HCP confirmed that the patient was not experiencing any side effects at the time of reporting. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known drug allergies. The patient had no chronic/acute illness and it was unknown if the patient tested positive/negative for COVID-19 within last month.
Andere Medikamente: FLONASE [MOMETASONE FUROATE]
Allergien: -
Vorherige Impfungen: -

VAERS 2251531

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 91,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had No Known Drug Allergies. The patient's past medical history included Stent placement. Concurrent medical conditions included Hypertension, Diabetes mellitus and Peripheral vascular disease. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX), LISINOPRIL, ACETAMINOPHEN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) and MEMANTINE for an unknown indication. On 06-Apr-2022 at 9:13 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021 at 9:13 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The expiration date was reported as 25 Mar 2022. It was reported that patients that received a vaccine past the 30 day storage on the refrigerator. It was reported that the vial did not undergo any temperature excursions. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes mellitus; Hypertension; Peripheral vascular disease
Vorgeschichte: Medical History/Concurrent Conditions: Stent placement; Comments: Patient had No Known Drug Allergies.
Andere Medikamente: PLAVIX; LISINOPRIL; ACETAMINOPHEN; JANUMET; MEMANTINE
Allergien: -
Vorherige Impfungen: -

VAERS 2251530

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 42,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022; Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022) and PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergies, none daily medications were reported. Patient did not have positive or negative COVID-19 within last month of vaccination. None acute or chronic illness was reported. On 01-Apr-2022 at 9:21 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 9:21 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 01-Apr-2022, which has got expired on 25-Mar-2022) and PRODUCT STORAGE ERROR (The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details were not given. Patient received a vaccine past the 30 day storage on the refrigerator. The Moderna vaccine in question had been put aside and was not currently being used until further notice. The vaccine was refrigerated on 25-Feb-2022, but it got expired on 25-Mar-2022 and later was administered on 01-Apr-2022 (administered after 30-day Use By Date). Vial did not undergo any temperature excursions. The patient was not experiencing any side effects yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known drug allergies, none daily medications were reported. Patient did not have positive or negative COVID-19 within last month of vaccination. None acute or chronic illness was reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251529

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 57,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known allergies. Concomitant products included AMLODIPINE, LOSARTAN, PHENYTOIN SODIUM, GABAPENTIN, INSULIN GLARGINE (BASAGLAR), NAPROXEN, ASA and ATORVASTATIN for an unknown indication. On 06-Apr-2022 at 9:25 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 9:25 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not had COVID-19 positive or negative preceding month of vaccination. Total number of doses/vials was 36. Vial did not undergo any temperature excursions. Patient not experienced any side effects yet. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known allergies.
Andere Medikamente: AMLODIPINE; LOSARTAN; PHENYTOIN SODIUM; GABAPENTIN; BASAGLAR; NAPROXEN; ASA; ATORVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251528

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 40,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 25-Feb-2022/Patient received the vaccine which was past the 30-day storage on the refrigerator/ Doses were applied between the 01-Apr-2022 and 08-Apr-2022; Dose administered after 30-day Use By Date or after manufacturer date/Patient was vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date/Patient was vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 25-Feb-2022/Patient received the vaccine which was past the 30-day storage on the refrigerator/ Doses were applied between the 01-Apr-2022 and 08-Apr-2022) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient has No known dug allergies (NKDA). Concurrent medical conditions included Hypertension (HTN) and Type 2 diabetes mellitus (DMII). Concomitant products included LOSARTAN and METFORMIN for an unknown indication. On 20-Apr-2022 at 10:07 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 10:07 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date/Patient was vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 25-Feb-2022/Patient received the vaccine which was past the 30-day storage on the refrigerator/ Doses were applied between the 01-Apr-2022 and 08-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date/Patient was vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 25-Feb-2022/Patient received the vaccine which was past the 30-day storage on the refrigerator/ Doses were applied between the 01-Apr-2022 and 08-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that the vial was initially stored on refrigerator on 25-Feb-2022. Number of doses/vial used were 36. The vial did not undergo temperature excursion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypertension (HTN); Type 2 diabetes mellitus (DMII)
Vorgeschichte: Comments: Patient has No known dug allergies (NKDA).
Andere Medikamente: LOSARTAN; METFORMIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251526

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 64,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Hyperlipidemia, Hypertension and Allergy. Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE for Allergy. On 06-Apr-2022 at 4:04 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 4:04 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not had any allergies to food or medications. Patient did not had COVID-19 positive or negative preceding month of vaccination. Total number of doses/vials was 36. Vial did not undergo any temperature excursions. Patient not experienced any side effects yet. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy; Diabetes; Hyperlipidemia; Hypertension
Vorgeschichte: -
Andere Medikamente: LEVOCETIRIZINE DIHYDROCHLORIDE
Allergien: -
Vorherige Impfungen: -

VAERS 2251525

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 58,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 58-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (LANTUS allergy), Drug allergy (PENICILLIN V POTASSIUM allergy) and Type 2 diabetes mellitus. Concomitant products included TERCONAZOLE, BETAMETHASONE, CLOTRIMAZOLE (CLOTRIMAZOLE AND BETAMETHASONE), SALBUTAMOL (VENTOLIN [SALBUTAMOL]), LORATADINE, ALBUTEROL SULFATE, MELOXICAM, LANSOPRAZOL, ASPIRIN [ACETYLSALICYLIC ACID], SIMVASTATIN and LISINOPRIL for an unknown indication. On 13-Apr-2022 at 4:01 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022 at 4:01 PM, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Other concomitant medications included BD Pen and NovoFine. The vial was initially stored in refrigerator on 25-Feb-2022. The vial did not undergo temperature excursion. it was reported that the patient was vaccinated post 30 day use period (expiration date 25-Mar-2022). The patient did not experience any side effects. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (PENICILLIN V POTASSIUM allergy); Drug allergy (LANTUS allergy); Type 2 diabetes mellitus
Vorgeschichte: -
Andere Medikamente: TERCONAZOLE; CLOTRIMAZOLE AND BETAMETHASONE; VENTOLIN [SALBUTAMOL]; LORATADINE; ALBUTEROL SULFATE; MELOXICAM; LANSOPRAZOL; ASPIRIN [ACETYLSALICYLIC ACID]; SIMVASTATIN; LISINOPRIL
Allergien: -
Vorherige Impfungen: -

VAERS 2251524

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 30,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Maternal exposure during pregnancy Product storage error

Symptomtext

received a vaccine past the 30 day storage on the refrigerator; Maternal exposure during pregnancy; doses administered after 30-day Use By Date; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date), PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 30-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergies. Concurrent medical conditions included Pregnant. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 06-Apr-2022 at 9:29 AM, the patient received third dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator). On 06-Apr-2022, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No treatment medication was reported. The vial was initially stored in the refrigerator on 25-Feb-2022. The vial was not undergone any temperature excursion. Company comment: This is an spontaneous case of maternal exposure during pregnancy for a 30-year-old female patient, with no medical history reported, who experienced the non-serious unexpected events of Expired product administered and product storage error, after the third dose of mRNA-1273. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is an spontaneous case of maternal exposure during pregnancy for a 30-year-old female patient, with no medical history reported, who experienced the non-serious unexpected events of Expired product administered and product storage error, after the third dose of mRNA-1273. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Pregnant.
Vorgeschichte: Comments: Patient had no known drug allergies.
Andere Medikamente: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS.]
Allergien: -
Vorherige Impfungen: -

VAERS 2251523

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 67,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Hyperlipidemia, Hypothyroidism and Diabetes. Concomitant products included ACETYLSALICYLIC ACID (ASPIRINE), DOCUSATE SODIUM (COLACE), METFORMIN, VALPROATE SEMISODIUM (DIVALPROEX), LISINOPRIL, GLIMEPIRIDE, ATORVASTATIN CALCIUM, HYDROCHLOROTHIAZIDE and LEVOTHYROXINE SODIUM for an unknown indication. On 13-Apr-2022 at 3:17 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022 at 3:17 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No known allergy was reported to medications, food, and other products. Other additional concomitant medication included True Metrix for an unknown indication. The vial was initially stored in refrigerator on 25-Feb-2022. The vial did not undergo any temperature excursion. The patient was vaccinated past the 30 day storage period. Patient did not experienced covid infection within last month from this report. The patient did not experience any side effects. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes; Hyperlipidemia; Hypothyroidism
Vorgeschichte: -
Andere Medikamente: ASPIRINE; COLACE; METFORMIN; DIVALPROEX; LISINOPRIL; GLIMEPIRIDE; ATORVASTATIN CALCIUM; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE SODIUM
Allergien: -
Vorherige Impfungen: -

VAERS 2251521

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 50,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine past the 30 day storage on the refrigerator and administered on 20-Apr-2022 after expiration; vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (vaccine past the 30 day storage on the refrigerator and administered on 20-Apr-2022 after expiration) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Allergy to Amoxicillin) and Hyperlipidemia. Concomitant products included SIMVASTATIN for an unknown indication. On 20-Apr-2022 at 9:10 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 9:10 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine past the 30 day storage on the refrigerator and administered on 20-Apr-2022 after expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (vaccine past the 30 day storage on the refrigerator and administered on 20-Apr-2022 after expiration) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vial was initially stored in refrigerator on 25-Feb-2022. The vial did not undergo temperature excursion. it was reported that the patient was vaccinated post 30 day use period. The patient did not experience any side effects. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Allergy to Amoxicillin); Hyperlipidemia
Vorgeschichte: -
Andere Medikamente: SIMVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2251520

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 59,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No known allergy was reported to medications, food, and other products. Concurrent medical conditions included Osteoarthritis. Concomitant products included OMEPRAZOLE, AMLODIPINE, ESCITALOPRAM, ERGOCALCIFEROL, IBUPROFEN, ACETAMINOPHEN and TRIAMCINOLONE for an unknown indication. On 13-Apr-2022 at 4:03 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022 at 4:03 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not experienced covid infection within last month. The vial was initially stored in refrigerator on 25-Feb-2022. The vial did not undergo temperature excursion. it was reported that the patient was vaccinated post 30 day use period (expiration date 25-Mar-2022). The patient did not experience any side effects. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Osteoarthritis
Vorgeschichte: Comments: No known allergy was reported to medications, food, and other products.
Andere Medikamente: OMEPRAZOLE; AMLODIPINE; ESCITALOPRAM; ERGOCALCIFEROL; IBUPROFEN; ACETAMINOPHEN; TRIAMCINOLONE
Allergien: -
Vorherige Impfungen: -

VAERS 2251517

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 59,0
Geschlecht: U
Eingang: 26.04.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator 25Feb2022 and date administered on 8 Apr 2022; dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 8 Apr 2022) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no allergies, no acute/ chronic illnesses. On 08-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 8 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 8 Apr 2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Patient had no Covid-19 infection within last month.. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported Dose administered after 30 day use by date or after manufacturer date of expiry. Number of doses or vials administered 36 doses. Date and time the vial was initially stored in the refrigerator 25-Feb-2022. The vial had not undergone any temperature excursion. No treatment medications were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19; Test Result: Negative ; Result Unstructured Data: Patient had no Covid-19 infection within last month.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no allergies, no acute/ chronic illnesses.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251516

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 39,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022; 36 doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known allergies. Concurrent medical conditions included Gastritis. Concomitant products included OMEPRAZOLE and ASCORBIC ACID, FERROUS FUMARATE (VITRON C [ASCORBIC ACID;FERROUS FUMARATE]) for an unknown indication. On 13-Apr-2022 at 3:16 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022 at 3:16 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (36 doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 13-Apr-2022) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The vial was initially stored in the refrigerator on 25-Feb-2022. The vial did not undergo any temperature excursions. No treatment medication information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Gastritis
Vorgeschichte: Comments: Patient had no known allergies.
Andere Medikamente: OMEPRAZOLE; VITRON C [ASCORBIC ACID;FERROUS FUMARATE]
Allergien: -
Vorherige Impfungen: -

VAERS 2251513

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 20,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022; doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known drug allergies and no acute/ chronic illnesses. On 30-Mar-2022 at 8:47 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022 at 8:47 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and date administered on 30 Mar 2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Patient had No Covid-19 within last month.. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported Dose administered after 30 day use by date or after manufacturer date of expiry. Number of doses or vials administered 36 doses. Date and time the vial was initially stored in the refrigerator 25-Feb-2022. Date and time of administration of vaccine was 01-Apr-2022 and 08-Apr-2022. The vial had not undergone any temperature excursion. No treatment medications were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19; Test Result: Negative; Result Unstructured Data: Patient had No Covid-19 within last month.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient had no known drug allergies and no acute/ chronic illnesses.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251512

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 23,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vials was stored in a refrigerator post expiration date; Vaccine expired on 25 mar 2022 and was administered on 01 apr 2022.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 25 mar 2022 and was administered on 01 apr 2022.) and PRODUCT STORAGE ERROR (Vials was stored in a refrigerator post expiration date) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known drug allergies to medications and food. It was reported that the patient had no Acute or chronic illness. The patient was not tested positive or negative within last month. On 01-Apr-2022 at 11:26 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 11:26 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 25 mar 2022 and was administered on 01 apr 2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials was stored in a refrigerator post expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 25 mar 2022 and was administered on 01 apr 2022.) and PRODUCT STORAGE ERROR (Vials was stored in a refrigerator post expiration date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient was not taking any daily medications. The patient received the booster dose on 01-Apr-2022 at 11:26AM. The date and time the vial initially stored in the refrigerator was 25-Feb-2022. The vial didn't undergo any temperature excursions. The patient received a vaccine past the 30 day storage on the refrigerator. The patient was vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022. The patient was not experiencing any side effects yet. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known drug allergies to medications and food. It was reported that the patient had no Acute or chronic illness. The patient was not tested positive or negative within last month.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251500

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 33,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Dose administered after 30-day Use by Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Amoxicillin allergy). Concomitant products included SALBUTAMOL SULFATE (VENTOLIN HFA) for an unknown indication. On 06-Apr-2022 at 11:24 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 11:24 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had not tested COVID positive within last month. The expiration date was 25 Mar 2022. Date and time the vial was initially stored in the refrigerator on 25 Feb 2022. Vial didn't undergo any temperature excursions. It was reported that the patient did not experienced any side effects yet. No treatment medication information provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Amoxicillin allergy)
Vorgeschichte: -
Andere Medikamente: VENTOLIN HFA
Allergien: -
Vorherige Impfungen: -

VAERS 2251499

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 69,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Dose administered after 30-day Use by Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) and EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date or after manufacturer date of expiry) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Ceftin allergy), Drug allergy (Losartan allergy), Drug allergy (Potassium allergy) and Hepatitis C. Concomitant products included VARENICLINE TARTRATE (CHANTIX), COLECALCIFEROL (VIT D3), METHIMAZOLE, AMLODIPINE and PRAVASTATIN SODIUM for an unknown indication. On 06-Apr-2022 at 9:32 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 9:32 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) and EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use by Date or after manufacturer date of expiry) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: not tested covid positive within last month (Negative) not tested Covid positive within last month. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had not tested positive for COVID within last month. The expiration date was 25-Mar-2022. Date and time the vial was initially stored in the refrigerator on 25-Feb-2022. Vial didn't undergo any temperature excursions. It was reported that the patient did not experienced any side effects yet. No treatment medication information provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19; Test Result: Negative ; Result Unstructured Data: not tested Covid positive within last month
Aktuelle Erkrankungen: Drug allergy (Potassium allergy); Drug allergy (Losartan allergy); Drug allergy (Ceftin allergy); Hepatitis C
Vorgeschichte: -
Andere Medikamente: CHANTIX; VIT D3; METHIMAZOLE; AMLODIPINE; PRAVASTATIN SODIUM
Allergien: -
Vorherige Impfungen: -

VAERS 2251493

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 60,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022; received vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (received vaccine past the 30 day storage on the refrigerator) in a 60-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Allergic reaction to analgesics (Percocet), Hyperthyroidism and Hepatitis C. Concomitant products included ALBUTEROL SULFATE, FLUTICASONE FUROATE (ARNUITY ELLIPTA), ATORVASTATIN, HYDRALAZINE, AMLODIPINE, HCTZ, FLUTICASONE and PANTOPRAZOLE for an unknown indication. On 06-Apr-2022 at 3:38 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 06-Apr-2022 at 3:38 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (received vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25-Feb-2022 and administered on 06-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (received vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. On 25-Feb-2022 vial was initially stored in the refrigerator. It was reported the patients were vaccinated with the Moderna Vaccine after the expiration of 25-Mar-2022 Vial did not undergo any temperature excursions HCP confirmed that the patients were not experiencing any side effects yet. Patient had not tested COVID-19 within last month. No treatment medication information was given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergic reaction to analgesics (Percocet); Hepatitis C; Hyperthyroidism.
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; ARNUITY ELLIPTA; ATORVASTATIN; HYDRALAZINE; AMLODIPINE; HCTZ; FLUTICASONE; PANTOPRAZOLE.
Allergien: -
Vorherige Impfungen: -

VAERS 2251490

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 63,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 18.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Paitents have been administered from Vaccine that experienced a temperature excursion; Paitents have been administered from Vaccine that experienced a temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Paitents have been administered from Vaccine that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Paitents have been administered from Vaccine that experienced a temperature excursion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Paitents have been administered from Vaccine that experienced a temperature excursion). On 18-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Paitents have been administered from Vaccine that experienced a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Paitents have been administered from Vaccine that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Paitents have been administered from Vaccine that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Storage condition at the time of the excursion was reported as refrigerator. Maximum temperature reached was reported as 64?F. Excursion duration was reported as approximately 7 hours. Date vial moved from freezer to refrigerator was reported as unknown. They were returned to the refrigerator. No changes on visual inspection noting vaccine state. At the time they were unpunctured. The Tran date was reported as 18-Mar-2022. The patient not had any adverse events post injection. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251480

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 36,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error SARS-CoV-2 test

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concomitant products included CARVEDILOL for an unknown indication. On 13-Apr-2022 at 1:46 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022 at 1:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: no No. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not have any known allergies. Patient was not COVID-19 positive withing last month. On 25-Feb-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Patient did not experience any side effects yet. No Treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Test Name: COVID-19 Test; Result Unstructured Data: No
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: CARVEDILOL.
Allergien: -
Vorherige Impfungen: -

VAERS 2251470

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 41,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06Apr2022; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06Apr2022) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient had no known allergies. The patient's past medical history included Torticollis. Concomitant products included ESZOPICLONE (LUNESTA), VILAZODONE HYDROCHLORIDE (VIIBRYD), PREGABALIN (LYRICA), ALBUTEROL SULFATE, CETIRIZINE HCL, NAPROXEN and CYCLOBENZAPRINE for an unknown indication. On 06-Apr-2022 at 2:57 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06Apr2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vial did not undergo any temperature excursions. The patient had not experienced any side effects yet. Treatment medications were not reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Torticollis; Comments: Patient had no known allergies.
Andere Medikamente: LUNESTA; VIIBRYD; LYRICA; ALBUTEROL SULFATE; CETIRIZINE HCL; NAPROXEN; CYCLOBENZAPRINE
Allergien: -
Vorherige Impfungen: -

VAERS 2249873

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 73,0
Geschlecht: M
Eingang: 25.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249872

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 66,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249866

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 49,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine stored in the refrigerator past 30 days; Vaccinated with the Moderna Vaccine after the expiration of 3/25/22; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccinated with the Moderna Vaccine after the expiration of 3/25/22) and PRODUCT STORAGE ERROR (vaccine stored in the refrigerator past 30 days) in a 49-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Type II diabetes mellitus. Concomitant products included NORETHISTERONE (CAMILA), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), GLIPIZIDE, METFORMIN and TERBINAFINE for an unknown indication. On 20-Apr-2022 at 8:43 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccinated with the Moderna Vaccine after the expiration of 3/25/22). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine stored in the refrigerator past 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccinated with the Moderna Vaccine after the expiration of 3/25/22) and PRODUCT STORAGE ERROR (vaccine stored in the refrigerator past 30 days) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No treatment medications were reported The vial was initially stored in the refrigerator on 25-Feb-2022 The vial did not undergo any temperature excursions. Patient did not test positive for COVID within last month. It was reported that patient had no known drug allergies (NKDA). It was reported that HCP confirmed that the patients were not experienced any side effects yet. This case was linked to MOD-2022-545267 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Type II diabetes mellitus.
Vorgeschichte: -
Andere Medikamente: CAMILA; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; GLIPIZIDE; METFORMIN; TERBINAFINE.
Allergien: -
Vorherige Impfungen: -

VAERS 2249865

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 49,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient was administered vaccine after 30-day Use By Date; Patient was administered vaccine after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered vaccine after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient was administered vaccine after 30-day Use By Date) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. The patient had no known drug allergies. The patient had no chronic/acute illness and it was unknown if the patient tested positive/negative for COVID-19 within last month. On 20-Apr-2022 at 9:11 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022 at 9:11 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered vaccine after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient was administered vaccine after 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered vaccine after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient was administered vaccine after 30-day Use By Date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The number of doses/vials was 36. The vial was initially stored in the refrigerator on 25-Feb-2022 The vials did not undergo any temperature excursion. The frequency was reported as times per. The patient had not received any daily medications. The healthcare professional (HCP) wanted to know how to proceed with 36 patients that received a vaccine past the 30 day storage on the refrigerator. HCP confirmed that the patients were not experiencing any side effects yet. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known drug allergies. The patient had no chronic/acute illness and it was unknown if the patient tested positive/negative for COVID-19 within last month.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249864

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 78,0
Geschlecht: M
Eingang: 25.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

received a vaccine past the 30 day storage on the refrigerator; vaccinated with the Moderna Vaccine after the expiration/received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration/received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No known allergies were reported. Concurrent medical conditions included Hypertension. Concomitant products included LOVASTATIN, LEVETIRACETAM and OFLOXACIN for an unknown indication. On 06-Apr-2022 at 10:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration/received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with the Moderna Vaccine after the expiration/received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Total number of doses/vials was 36. On 25 Feb 2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Health Care professional wanted to know how to proceed with 36 patients that received a vaccine past the 30 day storage on the refrigerator. She also wanted to confirm if she needed to report this event as an adverse event, because she was not sure on some storage information on the vaccine and needed further clarification. Treatment medications were not reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: Comments: No known allergies were reported
Andere Medikamente: LOVASTATIN; LEVETIRACETAM; OFLOXACIN
Allergien: -
Vorherige Impfungen: -

VAERS 2249863

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 43,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vaccine stored in the refrigerator past 30 days; Vaccinated with the Moderna Vaccine after the expiration of 3/25/22; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccinated with the Moderna Vaccine after the expiration of 3/25/22) and PRODUCT STORAGE ERROR (vaccine stored in the refrigerator past 30 days) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient did not have any acute or chronic illness and did not test positive for COVID within last month. It was reported that patient had no known drug allergies). Concomitant products included ORAL CONTRACEPTIVE NOS for an unknown indication. On 01-Apr-2022 at 9:53 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 9:53 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccinated with the Moderna Vaccine after the expiration of 3/25/22). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine stored in the refrigerator past 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccinated with the Moderna Vaccine after the expiration of 3/25/22) and PRODUCT STORAGE ERROR (vaccine stored in the refrigerator past 30 days) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that HCP confirmed that the patients were not experiencing any side effects yet. Date the vial was initially stored in the refrigerator was 25-Feb-2022 and the vial did not undergo any temperature excursions. Treatment information was not provided. This case was linked to MOD-2022-545267 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient did not have any acute or chronic illness and did not test positive for COVID within last month. It was reported that patient had no known drug allergies.
Andere Medikamente: ORAL CONTRACEPTIVE NOS
Allergien: -
Vorherige Impfungen: -

VAERS 2249862

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 63,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator; Patient vaccinated with vial that expired on 25-MAR-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient vaccinated with vial that expired on 25-MAR-2022) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient don't have allergies. Patient didn't had COVID-19 within last month. Concurrent medical conditions included Diabetes, Hyperlipidemia, Hypertension and Cardiac murmur. Concomitant products included METFORMIN, LISINOPRIL, GLIPIZIDE, LOVASTATIN, AMLODIPINE, MELOXICAM, SITAGLIPTIN PHOSPHATE (JANUVIA), ASPIRIN [ACETYLSALICYLIC ACID] and LORATADINE for an unknown indication. On 13-Apr-2022 at 3:16 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022 at 3:16 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient vaccinated with vial that expired on 25-MAR-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient vaccinated with vial that expired on 25-MAR-2022) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Date the vial was initially stored in the refrigerator: 25-FEB-2022 Vial didn't undergo any temperature excursions. Patient not experienced any side effects yet. No Treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Cardiac murmur; Diabetes; Hyperlipidemia; Hypertension
Vorgeschichte: Comments: Patient don't have allergies. Patient didn't had COVID-19 within last month.
Andere Medikamente: METFORMIN; LISINOPRIL; GLIPIZIDE; LOVASTATIN; AMLODIPINE; MELOXICAM; JANUVIA; ASPIRIN [ACETYLSALICYLIC ACID]; LORATADINE
Allergien: -
Vorherige Impfungen: -

VAERS 2249860

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 24,0
Geschlecht: M
Eingang: 25.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Patient don't had drug allergies. Patient don't had Acute and Chronic illness. Patient don't have daily medications. Patient didn't had COVID-19 within last month. On 01-Apr-2022 at 10:46 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 10:46 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator, initially stored on 25-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant Products were reported. Date the vial was initially stored in the refrigerator: 25-FEB-2022 Vial didn't undergo any temperature excursions. Patient not experienced any side effects yet. No Treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient don't had drug allergies. Patient don't had Acute and Chronic illness. Patient don't have daily medications. Patient didn't had COVID-19 within last month.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249810

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 35,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient received a vaccine past the 30 day storage on the refrigerator; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 immunisation. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC), ASPIRIN [ACETYLSALICYLIC ACID], FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), LORATADINE, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), ACYCLOVIR [ACICLOVIR] and SALBUTAMOL SULFATE (PROAIR HFA) for an unknown indication. On 01-Apr-2022 at 9:18 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 9:18 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. COVID 19 test:: Negative within last month. No Concomitant Products were reported. Date the vial was initially stored in the refrigerator: 25 Feb 2022. Expiration date of vaccine: 25 Mar 2022. Vial didn't undergo any temperature excursions. Patient not experienced any side effects yet. No Treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PROZAC; ASPIRIN [ACETYLSALICYLIC ACID]; ADVAIR; LORATADINE; ADDERALL; ACYCLOVIR [ACICLOVIR]; PROAIR HFA.
Allergien: -
Vorherige Impfungen: -

VAERS 2249809

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 94,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

product storage error; Doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (product storage error) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Hypothyroidism and Drug allergy (Sulfur). Concomitant products included AMIODARONE, COLECALCIFEROL (VITAMIN D 3), FEXOFENADINE, ESOMEPRAZOLE, APIXABAN (ELIQUIS), PRAVASTATIN SODIUM (PRAVACHOL), MACROGOL 3350 (MIRALAX), FLUTICASONE, FAMOTIDINE and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication. On 06-Apr-2022 at 3:02 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 3:02 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (product storage error) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient did not had COVID-19 preceding month of vaccination. On 25-FEB-2022 the vial was initially stored in the refrigerator. Vial didn't undergo any temperature excursions. It was reported that the patient did not experienced any side effects yet. No Treatment information was reported. This case was linked to MOD-2022-545267 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Sulfur); Hypothyroidism.
Vorgeschichte: -
Andere Medikamente: AMIODARONE; VITAMIN D 3; FEXOFENADINE; ESOMEPRAZOLE; ELIQUIS; PRAVACHOL; MIRALAX; FLUTICASONE; FAMOTIDINE; VITAMIN B12 [VITAMIN B12 NOS.]
Allergien: -
Vorherige Impfungen: -

VAERS 2249807

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MD
Alter: 62,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. Concomitant products included FLUTICASONE, FAMOTIDINE, ASA, LOSARTAN, ESCITALOPRAM, LORAZEPAM, MIRTAZAPINE, OMEPRAZOLE, MECLIZINE [MECLOZINE], CETIRIZINE, BENZONATATE, KETOTIFEN FUMARATE (ZADITOR), ATORVASTATIN, ESOMEPRAZOLE, SITAGLIPTIN PHOSPHATE (JANUVIA), GLIMEPIRIDE and METFORMIN for an unknown indication. On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had not tested positive within last month. The expiration date was 25 Mar 2022. The vaccine adminstration time was 09:35. Date and time the vial was initially stored in the refrigerator on 25 Feb 2022. No treatment medication information provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes.
Vorgeschichte: -
Andere Medikamente: FLUTICASONE; FAMOTIDINE; ASA; LOSARTAN; ESCITALOPRAM; LORAZEPAM; MIRTAZAPINE; OMEPRAZOLE; MECLIZINE [MECLOZINE]; CETIRIZINE; BENZONATATE; ZADITOR; ATORVASTATIN; ESOMEPRAZOLE; JANUVIA; GLIMEPIRIDE; METFORMIN.
Allergien: -
Vorherige Impfungen: -

VAERS 2249340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 58,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 11.03.2022
Beginn: 01.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). In March 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. It was reported product excursion was occurred on 10-Mar-2022. Storage condition at the time of the excursion was reported as refrigerator. Max temperature reached was 64?F. Excursion duration was approximately 7 hours. Three was no changes in visual inspection. It was reported patient had not any adverse events post injection. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249339

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 41,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 14.03.2022
Beginn: 14.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a temperature excursion; Patients have been administered from vaccines that underwent a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that underwent a temperature excursion) in a 41-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 14-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that underwent a temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Date of temperature excursion was 10-Mar-2022. Maximum or minimum temperatures reached was 64 degrees Fahrenheit. Excursion duration was approximately 7 hours. The vaccine was stored in refrigerator at the time of the excursion. There were no changes in visual inspection. Pertinent details: At the time they were unpunctured. Vaccine was administered on 14-Mar-2022 and vials were returned to the refrigerator. Tran date was 15-Mar-2022.The patient did not experience any adverse events post injection. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249338

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 65,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 24.03.2022
Beginn: 01.03.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 65-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In March 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 24-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. It was reported that the temperature excursion duration was approximately 7 hours. The vial had reached the max temperature of 64 degree F. It was reported that the vial was stored in refrigerator at the time of excursion. After administration the vial was returned to refrigerator. The date vial was moved from freezer to refrigerator was unknown. It was reported that the vaccine did not presented any state change on visual inspection. It was unknown the number of vials/doses impacted. Pertinent details of the vial was reported as unpunctured. It was reported that patient did not experienced any adverse events. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 50,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 11.03.2022
Beginn: 11.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

administered from vaccines that experienced a temperature excursion; administered from vaccines that experienced a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (administered from vaccines that experienced a temperature excursion) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (administered from vaccines that experienced a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (administered from vaccines that experienced a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (administered from vaccines that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that, the vial underwent an excursion on 10-Mar-2022 for 7 hours while stored in refrigerator. The maximum temperature reached was 64 F. The vial was returned to the refrigerator. There were no visual inspection noting any vaccine state change. It was reported the vial was unpunctured at the time. The patient had no adverse events post vaccination. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249336

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 55,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant product use was reported. The reporter who was an HCP reported an excursion about a month ago, at the time the reporter didn't asked for a stability report but now the reporter had been asked to send the stability report. The patient didn't had any adverse events post injection. The reporter stated that they were yet to receive the temperature stability report for this excursion that occurred on 10-Mar-2022. The transmission date reported as 15-Mar-2022. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249335

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 25,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a temperature excursion; Patients have been administered from vaccines that experienced a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) in a 25-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 15-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Date of temperature excursion was 10-Mar-2022. Maximum or minimum temperatures reached was 64 degrees Fahrenheit. Excursion duration was approximately 7 hours. The vaccine was stored in refrigerator at the time of the excursion. There were no changes in visual inspection. Pertinent details: At the time they were unpunctured. Vaccine was administered on 15-Mar-2022 and vials were returned to the refrigerator. Tran date was 15-Mar-2022.The patient did not experience any adverse events post injection. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249334

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 38,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 14.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a temperature excursion; Patients have been administered from vaccines that experienced a temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) in a 38-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). On 14-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant products were not provided. It was reported that the temperature excursion duration was approximately 7 hours. The vial had reached the max temperature of 64 degree F. It was reported that the vial was stored in refrigerator at the time of excursion. After administration the vial was returned to refrigerator. The date vial was moved from freezer to refrigerator was unknown. It was reported that the vaccine did not presented any state change on visual inspection. It was unknown the number of vials/doses impacted. Pertinent details of the vial was reported as unpunctured. It was reported that patient did not experienced any adverse events. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249333

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 102,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 17.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) in a 102-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 17-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Date of temperature excursion was 10-Mar-2022. Maximum or minimum temperatures reached was 64 degrees Fahrenheit. Excursion duration was approximately 7 hours. The vaccine was stored in refrigerator at the time of the excursion. There were no changes in visual inspection. Pertinent details: At the time they were unpunctured. Vaccine was administered on 17-Mar-2022 and vials were returned to the refrigerator. Tran date was 17-Mar-2022. The patient did not experience any adverse events post injection. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249332

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 43,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 23.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patient have been administered vaccine while the temperature excursion; Patient have been administered vaccine while the temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered vaccine while the temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered vaccine while the temperature excursion) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered vaccine while the temperature excursion). On 23-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered vaccine while the temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered vaccine while the temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered vaccine while the temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. The healthcare professional (HCP) reported an excursion about a month ago. The HCP also mentioned that the excursion duration was 7 hours instead 5min (previously stated) and the patient had been administered from these vaccines. The vaccine was stored in refrigerator at the time of the excursion. The lot number and expiration date was reported as 046L21A and 06-Jul-2022 in source document. The maximum temperature reached was reported as 64?F. The vials were returned to the refrigerator No vaccine state change was reported. The vials were unpunctured at the time of excursions. The frequency was reported as times per. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249331

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 23,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 24.03.2022
Beginn: 24.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patient was administered from vaccine that experienced a T excursion; Patient was administered from vaccine that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from vaccine that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from vaccine that experienced a T excursion) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from vaccine that experienced a T excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from vaccine that experienced a T excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from vaccine that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from vaccine that experienced a T excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information was provided. The patient did not have any adverse events post injection. It was reported that the storage condition at the time of the excursion was at refrigerator. Maximum temperature reached was 64-degree Fahrenheit, and excursion duration was approximately 7 hours. The vials were returned to the refrigerator. No changes in visual inspection. Pertinent details: At the time they were unpunctured. As per source document the Tran date was reported as 24-Mar-2022. No treatment medication information was given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249330

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 23,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) in a 23-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The vial was stored at the refrigerator at the time of the temperature excursion. The temperature excursion issue occurred on 10-Mar-2022. Maximum temperature reached by the vial was 64 degree Fahrenheit and excursion duration was approximately 7 hours. No changes were noted in the vaccine state. At the time, the vials were unpunctured. The transfer date was reported as 15-Mar-2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249329

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 39,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 14.03.2022
Beginn: 14.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment information was provided. Excursion about a month ago was observed where excursion duration was found to be approximately 7 hours. HCP also mentioned that the excursion duration was 7 hours instead 5 min (previously stated). The vial was refrigerated at the time of excursion. Maximum temperature reached was 64 degree fahrenheit. There were no changes in vaccine state on visual inspection. It was reported in pertinent detail that at the time vials were unpunctured. Patients have been administered from these vaccines but patient experienced no adverse events post injection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249328

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 31,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 10.03.2022
Beginn: 10.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 31-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. Max Temperature reached was 64?F Excursion duration was approximately 7 hours Three was no changes in visual inspection. It was reported patient had not any adverse events post injection. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249327

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 22,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a Temperature excursion; Patients have been administered from vaccines that experienced a Temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a Temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a Temperature excursion) in a 22-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 15-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a Temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a Temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a Temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a Temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not reported. It was reported that the storage condition at the time of excursion was refrigerator. Max Temperature reached to 64 F. Reporter mentioned that the excursion duration was 7 hours instead 5 min. They were returned to the refrigerator after administration. Tran date was reported as 15-Mar-2022. It was reported that the patient did not experienced any adverse event. Treatment medications were not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249326

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 59,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 22.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 22-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No information on concomitant medication was reported. Tran date was reported as 23-Mar-2022. It was reported that , the patient did not have any adverse events post injection. Storage condition at the time of the excursion was refrigerator. Maximum or minimum temperatures reached was 64 degrees Fahrenheit. Excursion duration was approximately 7 hours. The vials were returned to the refrigerator. No changes in visual inspection. Pertinent details: At the time they were unpunctured. Excursion occurred on 10-Apr-2022. No information on treatment medications was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249325

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 24,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 15.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) in a 24-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 15-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that an excursion about a month ago and the excursion duration was 7 hours instead 5 min (previously stated) and the patient had been administered from these vaccines. The vaccine was stored in refrigerator at the time of the excursion. Date of temperature excursion was 10-Mar-2022. Lot number was 027L21A and vaccine was administered on 15-Mar-2022. The other lot number and expiration date was reported as 046L21A and 06-Jul-2022. The maximum temperature reached was reported as 64?F. The vials were returned to the refrigerator. No vaccine state change was reported. The vials were unpunctured at the time of excursions. Tran date was reported as 15-Mar-2022. The patient did not experience any adverse events post injection. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249324

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 62,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 22.03.2022
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product temperature excursion issue

Symptomtext

HCP is calling because she reported an excursion about a month ago; Expired Vaccine Used; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (HCP is calling because she reported an excursion about a month ago) and EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (HCP is calling because she reported an excursion about a month ago) and EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (HCP is calling because she reported an excursion about a month ago) and EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment medication reported. Maximum Temperature reached 64?F. Excursion duration: Approximately 7 hours. Those vials were returned to the freezer/refrigerator or maintained at room temperature. Temperature excursion date was as 10-Mar-2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249323

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 78,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered from vaccine that experienced a T excursion) in a 78-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered from vaccine that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered from vaccine that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information was provided. No treatment medication information was given. The patient did not have any adverse events post injection. It was reported that the storage condition at the time of the excursion was at refrigerator. Maximum temperature reached was 64-degree Fahrenheit, and excursion duration was approximately 7 hours. The vials were returned to the refrigerator. No changes in visual inspection. Pertinent details: At the time they were unpunctured. As per source document the Tran date was reported as 25-Mar-2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249322

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 82,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 22.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a temperature excursion; Patients have been administered from vaccines that experienced a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion). On 22-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Storage condition at the time of the excursion was reported as refrigerator. Maximum temperature reached was reported as 64?F. Excursion duration was reported as approximately 7 hours. Date vial moved from freezer to refrigerator was reported as unknown. They were returned to the refrigerator. No changes on visual inspection noting vaccine state. At the time they were unpunctured. The patient not had any adverse events post injection. The Tran date was reported as 23-Mar-2022. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249321

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 57,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 23.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Excursion vaccine was administered to patient; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Excursion vaccine was administered to patient) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 23-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Excursion vaccine was administered to patient). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Excursion vaccine was administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medication was reported. The reporter informed that an excursion occurred about a month ago, at the time the reporter didn't ask for a stability report but now has been asked to send the stability report, The reporter also mentioned that the excursion duration was 7 hours instead 5. Maximum or minimum temperatures reached was 64 degrees Fahrenheit. Excursion duration was approximately 7 hours. The vaccine was stored in refrigerator at the time of the excursion. There were no changes in visual inspection. Pertinent details: At the time they were unpunctured. Vaccine was administered on 23-Mar-2022 and vials were returned to the refrigerator. Tran date was 23-Mar-2022.The patient did not experience any adverse events post injection. No treatment medication was reported. This case was linked to MOD-2022-545986 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249320

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 32,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 16.03.2022
Beginn: 16.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients administered from vaccines that experienced a Temperature excursion; Patient received vaccine from a vial which came across temperature excursion with duration of 7 hours; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered from vaccines that experienced a Temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received vaccine from a vial which came across temperature excursion with duration of 7 hours) in a 32-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received vaccine from a vial which came across temperature excursion with duration of 7 hours). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered from vaccines that experienced a Temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered from vaccines that experienced a Temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received vaccine from a vial which came across temperature excursion with duration of 7 hours) outcome was unknown. Not Provided For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The reporter informed that an excursion occured about a month ago, at the time she didn't ask for a stability report but now she has been asked to send the stability report, The reporter also mentioned that the excursion duration was 7 hours instead 5. Date of temperature excursion was 10-Mar-2022. Maximum or minimum temperatures reached was 64 degrees Fahrenheit. Excursion duration was approximately 7 hours. The vaccine was stored in refrigerator at the time of the excursion. There were no changes in visual inspection. Pertinent details: At the time they were unpunctured. Vaccine was administered on 16-Mar-2022 and vials were returned to the refrigerator. Tran date was 16-Mar-2022.The patient did not experience any adverse events post injection. This case was linked to MOD-2022-54617.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249319

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 67,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 17.03.2022
Beginn: 17.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patient had been administered from vaccine that experienced Temperature excursion; Patient had been administered from vaccine that experienced Temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered from vaccine that experienced Temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered from vaccine that experienced Temperature excursion) in a 67-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 17-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered from vaccine that experienced Temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered from vaccine that experienced Temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered from vaccine that experienced Temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered from vaccine that experienced Temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The temperature excursion was occurred on 10-Mar-2022. Storage condition at the time of the excursion was refrigerator; maximum or minimum temperatures reached was max temperature reached 64-degree Fahrenheit; excursion duration was 7 hours instead 5 min (previously stated); date the vial was moved from freezer to refrigerator was unknown by the reporter; upon visual inspection no changes of vaccine state was observed and at the time of excursion the vials were unpunctured. The patient did not experience any adverse events post injection. The reporter was yet to receive the temperature stability report. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249318

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 28,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 18.03.2022
Beginn: 18.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion/she reported an excursion about a month ago; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion/she reported an excursion about a month ago) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion/she reported an excursion about a month ago). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion/she reported an excursion about a month ago) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The trans date was given as 18-Mar-2022. HCP was calling because she reported an excursion about a month ago, at the time she did not ask for a stability report but now she had been asked to send the stability report, HCP also mentioned that the excursion duration was 7 hours instead 5 min (previously stated). Storage condition at the time of the excursion: Refrigerator. Maximum or minimum temperatures reached, as applicable (specify temp is in C or F): Max Temperature reached 64?F. Excursion duration: Approximately 7 hours. They were returned to the refrigerator. Visual inspection noting any vaccine state change: (e.g. were frozen vials thawed, were thawed vials re-frozen, were they visualized at all): No changes. Pertinent details: whether the vial(s) were punctured, any previous excursions with the impacted vial(s): At the time they were unpunctured. The patient did not have any adverse events post injection. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249316

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 35,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 14.03.2022
Beginn: 14.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from vaccine that experienced a T excursion) in a 35-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 14-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from vaccine that experienced a T excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from vaccine that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from vaccine that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was reported. The patient did not have any adverse events post injection. It was reported that the storage condition at the time of the excursion was at refrigerator. Maximum temperature reached was 64-degree Fahrenheit, and excursion duration was approximately 7 hours. The vials were returned to the refrigerator. No changes in visual inspection. Pertinent details: At the time they were unpunctured. Temperature excursion occurred on 10 Mar 2022. As per source document the Tran date was reported as 15-Mar-2022. No treatment medication information was given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249314

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 20,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 18.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Excursion vaccine was administered to patient) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccines that experienced a T excursion). On 18-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Excursion vaccine was administered to patient). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Excursion vaccine was administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Storage condition at the time of the excursion was reported as refrigerator. Maximum temperature reached was reported as 64?F. Excursion duration was reported as approximately 7 hours. Date vial moved from freezer to refrigerator was reported as unknown. They were returned to the refrigerator. No changes on visual inspection noting vaccine state. At the time they were unpunctured. The patient not had any adverse events post injection. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249298

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 23.03.2022
Beginn: 23.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 63-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information was provided. The patient did not have any adverse events post injection. It was reported that the storage condition at the time of the excursion was at refrigerator. Maximum temperature reached was 64-degree Fahrenheit, and excursion duration was approximately 7 hours. The vials were returned to the refrigerator. No changes in visual inspection. Pertinent details: At the time they were unpunctured. It was reported as Tran date as 23-Mar-2022 No treatment medication information was given. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2022: Follow up received contains no new information. On 20-Apr-2022: Follow up received contains patient information and dose number.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2247677

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 36,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 23.03.2022
Beginn: 10.03.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 36-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 23-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that excursion duration was approximately 7 hours. The product was refrigerated at the time of excursion. Max Temperature reached was 64?F. There was no change in vaccine state on visual inspection. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2247676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IL
Alter: 50,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 50-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. No treatment information were provided. Max Temperature reached was 64?F Excursion duration was approximately 7 hours Three was no changes in visual inspection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2240883

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MO
Alter: 57,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 14.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

Pt was given additional Moderna vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2239232

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 18.04.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was given 0.5ml instead of 0.25ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2238144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: MA
Alter: 62,0
Geschlecht: F
Eingang: 17.04.2022
Impfdatum: 05.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Systemic: Tinnitus-Medium, Additional Details: Intermittent tinnitus since a few days after administration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2238046

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: CA
Alter: 30,0
Geschlecht: F
Eingang: 16.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2236299

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 70,0
Geschlecht: F
Eingang: 15.04.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Provider provided the vaccine on 4/13/22 for vaccine administration with a beyond use date/time of 12 hours from vial puncture. Staff at the facility did not provide vaccine to the patient until 4/14/22 at 11 AM. Our pharmacist reached out to the company and reported the following: "I called the company and talked to the support team and gave them all the information on what had occurred. Moderna only has efficacy data to support up to 24hrs post vial puncture and that any administration after 24hrs would be up to the healthcare professionals to determine if re-vaccination is required. They also mentioned to monitor for s/s of infection due to there being no preservative in the vaccine formulation. " They will report to the medical doctor to see what further action needs to be.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2235898

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 15.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2228657

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NJ
Alter: 33,0
Geschlecht: F
Eingang: 12.04.2022
Impfdatum: 12.04.2022
Beginn: 12.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

2nd Moderna dose of primary series given 22 days after 1st dose. Patient notified of invalid dose given on same day

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: sickle cell trait
Andere Medikamente: none
Allergien: NKDA, NKA
Vorherige Impfungen: -

VAERS 2223125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: GA
Alter: 61,0
Geschlecht: F
Eingang: 08.04.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event

Symptomtext

NO adverse events or symptoms was seen after patient received her dosage, patient just got a full dose (0.5 ml) of moderna and this was her 4th dose, she had previously gotten a full dose (0.5ml) for her previous 3 doses since she is immunocompromised. I was unaware that the 4th dose, even though she is immunocompromised had to be 1/2 dose(0.25 ml) instead of 0.5 ml.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: immunocompromised, no spleen
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 2220258

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: TX
Alter: 92,0
Geschlecht: F
Eingang: 07.04.2022
Impfdatum: 05.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

Patient received covid-19 vaccine dose a few days early, No reported adverse effects at this time. Doctor and supervisors were notified. No further tests nor orders were requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2220253

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: TX
Alter: 51,0
Geschlecht: F
Eingang: 07.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

There were no adverse, the vaccine was given too early. This was reported to supervisors and doctor. No further test nor orders requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2216680

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: PA
Alter: 74,0
Geschlecht: M
Eingang: 05.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Needle issue

Symptomtext

Vanishpoint syringe was used to draw up vaccine and noticed that it was leaning slightly to one side so was going to discard. Was not discarded and was used for administration (within 10 minutes so timing and dose appropriate). Nothing abnormal about the administration. Reporting since the needle was leaning just slightly one way and was going to be replaced but was not. No known injuries to patient and per wife (unable to talk with him tonight) his arm is fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Needle issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: Diabetes per profile
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2216114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: DC
Alter: 55,0
Geschlecht: F
Eingang: 05.04.2022
Impfdatum: 05.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Interchange of vaccine products No adverse event

Symptomtext

The pt was given Moderna as a booster instead of Pfizer which she requested. Pt reported no adverse reaction to the vaccination and none were observed. Pt was observed for 30 mins after receiving shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Interchange of vaccine products
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Pt denied any.
Vorgeschichte: HTN, DMII, Hyperlipidemia, GERD, mild Asthma
Andere Medikamente: -
Allergien: Tylenol
Vorherige Impfungen: -

VAERS 2214071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 90,0
Geschlecht: M
Eingang: 04.04.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Patient was inadvertently given a booster dose too soon.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: None at this time.
Aktuelle Erkrankungen: None
Vorgeschichte: Heart murmur Hypertension Type 2 Diabetes Mellitus Hyperlipidemia Premature Atrial Contraction GERD
Andere Medikamente: amLODIPine Besylate 5mg daily metFORMIN HCI ER 500MG
Allergien: None
Vorherige Impfungen: -

VAERS 2213294

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 03.04.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2213293

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: TX
Alter: 34,0
Geschlecht: M
Eingang: 03.04.2022
Impfdatum: 21.03.2022
Beginn: 21.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2213236

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: KY
Alter: 19,0
Geschlecht: F
Eingang: 02.04.2022
Impfdatum: 02.04.2022
Beginn: 02.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Maternal exposure during pregnancy No adverse event

Symptomtext

Patient is approximately 9 weeks pregnant. There was no immediate adverse reaction. Patient did wait her 15 minutes and when she was discharged, provider noted that she had no symptoms of distress.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Maternal exposure during pregnancy
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Prenatal
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2209768

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: VA
Alter: 48,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 31.03.2022
Beginn: 31.03.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Immunocompromised patient received 1st booster dose of Moderna Covid-19 vaccine with 0.5ml dose instead of correct 0.25ml dose after initial primary series of 3 doses of 0.5ml. Patient has been contacted and voicemail message left asking patient to return our call.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: None at this time.
Aktuelle Erkrankungen: Psoriasis
Vorgeschichte: Psoriasis
Andere Medikamente: Tremfya
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2203469

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CT
Alter: 61,0
Geschlecht: U
Eingang: 29.03.2022
Impfdatum: 21.03.2022
Beginn: 21.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Product was placed in refrigerator on 19Feb2022; One of our locations give a dose of Moderna Covid-19 vaccine 2 days beyond the 30 day beyond use date.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (One of our locations give a dose of Moderna Covid-19 vaccine 2 days beyond the 30 day beyond use date.) and PRODUCT STORAGE ERROR (Product was placed in refrigerator on 19Feb2022) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 21-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (One of our locations give a dose of Moderna Covid-19 vaccine 2 days beyond the 30 day beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product was placed in refrigerator on 19Feb2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (One of our locations give a dose of Moderna Covid-19 vaccine 2 days beyond the 30 day beyond use date.) and PRODUCT STORAGE ERROR (Product was placed in refrigerator on 19Feb2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Product was placed in refrigerator on 19-Feb-2022 and Use by date was 19-Mar-2022. Reporter reported that at one of our locations give a dose of Moderna Covid-19 vaccine 2 days beyond the 30 day beyond use date. No concomitant drug information was provided. No treatment drug information was reported. Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2022: Follow-up received contains no new information

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2200754

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AZ
Alter: 31,0
Geschlecht: M
Eingang: 27.03.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

Error: Wrong Route (SC, IM, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2200750

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AZ
Alter: 35,0
Geschlecht: F
Eingang: 27.03.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration

Symptomtext

Error: Wrong Route (SC, IM, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2200749

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AZ
Alter: 27,0
Geschlecht: F
Eingang: 27.03.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

Error: Wrong Route (SC, IM, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2200676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: AK
Alter: 60,0
Geschlecht: M
Eingang: 26.03.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

Patient presented to clinic requesting booster/3rd dose of vaccine - administered. On review of chart, this is 4th dose (prior booster in 1/2022). No known adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2198799

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NV
Alter: 66,0
Geschlecht: F
Eingang: 25.03.2022
Impfdatum: 11.03.2022
Beginn: 11.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: ID / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given the wrong dose the patient was given 0.15 ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: The patient was given he wrong dose patient was given 0.15 ml
Allergien: -
Vorherige Impfungen: -

VAERS 2198795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NV
Alter: 65,0
Geschlecht: M
Eingang: 25.03.2022
Impfdatum: 11.03.2022
Beginn: 11.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given the wrong dose patient was given 0.15 ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2193998

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: IN
Alter: 70,0
Geschlecht: M
Eingang: 23.03.2022
Impfdatum: 20.03.2022
Beginn: 20.03.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2193228

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NV
Alter: 74,0
Geschlecht: M
Eingang: 23.03.2022
Impfdatum: 17.03.2022
Beginn: 22.03.2022
Tage bis Beginn: 5,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Head discomfort Musculoskeletal discomfort Tinnitus

Symptomtext

Ringing in both ears, starting at 3am on March 22. 2022. Left ear was extreme. Abated around 8 am. in both ears. Muscular discomfort at neck still applicable and up left side of head. Taking no medication for it. Will see if any more side effects tonight during or after sleep. If so I will make an appointment to see my Doctor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Head discomfort
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Taking blood thinner for being susceptible to blood clotting.
Andere Medikamente: 7.5mg. Warfarin 5mg. Rosuvastatin
Allergien: Heparin
Vorherige Impfungen: -

VAERS 2181479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 16.03.2022
Impfdatum: 09.03.2022
Beginn: 09.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial of the vaccine was initially stored in the refrigerator on 28-Jan-2022 and administered to patient on 09-Mar-2022; Expired vaccine administered to one patient after 30 days use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to one patient after 30 days use by date) and PRODUCT STORAGE ERROR (The vial of the vaccine was initially stored in the refrigerator on 28-Jan-2022 and administered to patient on 09-Mar-2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to one patient after 30 days use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial of the vaccine was initially stored in the refrigerator on 28-Jan-2022 and administered to patient on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to one patient after 30 days use by date) and PRODUCT STORAGE ERROR (The vial of the vaccine was initially stored in the refrigerator on 28-Jan-2022 and administered to patient on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. The vial had not undergone any temperature excursions. The healthcare provider wanted to get directions on what to do with the patients, and asked if they should repeat the dose of the patients. This case was linked to MOD-2022-509838, MOD-2022-509900, MOD-2022-509902, MOD-2022-509907 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2181478

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 16.03.2022
Impfdatum: 04.03.2022
Beginn: 04.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients; They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients) and PRODUCT STORAGE ERROR (They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients) and PRODUCT STORAGE ERROR (They have been administering the vaccine after expiration date/30-day use by date expired vaccine was administered to several patients) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Date the vial was initially stored in the refrigerator was on 28Jan2022. No concomitant medication were reported. No treatment medication were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2171687

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: SC
Alter: 32,0
Geschlecht: F
Eingang: 10.03.2022
Impfdatum: 10.03.2022
Beginn: 10.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event

Symptomtext

Vaccine administered 2 days too early. No adverse reactions noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None noted
Vorgeschichte: None noted
Andere Medikamente: None noted
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2171683

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: SC
Alter: 34,0
Geschlecht: M
Eingang: 10.03.2022
Impfdatum: 10.03.2022
Beginn: 10.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event

Symptomtext

Vaccine administered 2 days too soon. No adverse reactions noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No illnesses
Vorgeschichte: No chronic health conditions
Andere Medikamente: None noted
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2163099

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: IN
Alter: 50,0
Geschlecht: M
Eingang: 07.03.2022
Impfdatum: 03.03.2022
Beginn: 04.03.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Oedema peripheral

Symptomtext

Had a small fever of 99. Have swelling in right arm pit

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oedema peripheral
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Allopurinol, Lisnopril, Omeprazole, Vitamin's c and D
Allergien: No
Vorherige Impfungen: Some body aches like with the flu

VAERS 2162720

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: MO
Alter: 60,0
Geschlecht: M
Eingang: 07.03.2022
Impfdatum: 06.03.2022
Beginn: 06.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Error: Improper Storage (temperature)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2151770

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: NY
Alter: 24,0
Geschlecht: F
Eingang: 02.03.2022
Impfdatum: 01.03.2022
Beginn: 01.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

First Moderna vaccine given 2/15/22. Employee requested a second vaccine through employee health. Per local mandate, employees must have two vaccines by 2/28. Person administering the vaccine did not verify the timing between vaccines. Patient did not understand that she still needed to wait 28 days between doses.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2143121

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: GA
Alter: 39,0
Geschlecht: F
Eingang: 26.02.2022
Impfdatum: 25.02.2022
Beginn: 25.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2140492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027l21a

gering

Staat: OK
Alter: 41,0
Geschlecht: F
Eingang: 25.02.2022
Impfdatum: 25.02.2022
Beginn: 25.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event

Symptomtext

No adverse outcomes noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: None required per provider.
Aktuelle Erkrankungen: none
Vorgeschichte: cervicalgia, contraceptive management, depression, HTN, GERD
Andere Medikamente: metronidazole 500mg PO
Allergien: Augmentin, sertraline
Vorherige Impfungen: -

VAERS 2128674

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: SC
Alter: 52,0
Geschlecht: F
Eingang: 21.02.2022
Impfdatum: 14.02.2022
Beginn: 14.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose Device connection issue

Symptomtext

liquid from the vaccine running down arm / liquid leaked from vaccine needle; liquid from the vaccine running down arm / liquid leaked from vaccine needle; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) and DEVICE CONNECTION ISSUE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Immunocompromised. On 14-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2022, the patient experienced ACCIDENTAL UNDERDOSE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) and DEVICE CONNECTION ISSUE (liquid from the vaccine running down arm / liquid leaked from vaccine needle). At the time of the report, ACCIDENTAL UNDERDOSE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) and DEVICE CONNECTION ISSUE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Pharmacist took the needle out of the patient's arm and said the liquid from the vaccine came running down out of the arm down the chair. Also, pharmacist stuck the needle in, and its like it dripped all the way down the patient's elbow and down to the chair. Pharmacist was not sure how much came out, but said it seems like a lot came out. The patient had not experienced any symptoms. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 14-Feb-2022: Upon internal Review on 17-Feb-2022, significant correction was made to update event verbatim. On 16-Feb-2022: Followup received contains no new information

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Immunocompromised
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2128401

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MN
Alter: 43,0
Geschlecht: F
Eingang: 20.02.2022
Impfdatum: 18.02.2022
Beginn: 18.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Underdose

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2123682

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: OH
Alter: 25,0
Geschlecht: F
Eingang: 18.02.2022
Impfdatum: 17.02.2022
Beginn: 17.02.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2119270

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MI
Alter: 17,0
Geschlecht: F
Eingang: 17.02.2022
Impfdatum: 18.01.2022
Beginn: 18.01.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product administered to patient of inappropriate age

Symptomtext

Patient is 17 years old and received a Moderna vaccine which is only authorized for ages 18 and up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2115363

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: SC
Alter: 52,0
Geschlecht: F
Eingang: 16.02.2022
Impfdatum: 14.02.2022
Beginn: 14.02.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose Device connection issue

Symptomtext

liquid from the vaccine running down arm / liquid leaked from vaccine needle; She stuck the needle in; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) and DEVICE CONNECTION ISSUE (She stuck the needle in) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination. Concurrent medical conditions included Immunocompromised. On 14-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2022, the patient experienced ACCIDENTAL UNDERDOSE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) and DEVICE CONNECTION ISSUE (She stuck the needle in). At the time of the report, ACCIDENTAL UNDERDOSE (liquid from the vaccine running down arm / liquid leaked from vaccine needle) and DEVICE CONNECTION ISSUE (She stuck the needle in) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Pharmacist took the needle out of the patient's arm and said the liquid from the vaccine came running down out of the arm down the chair. Also, pharmacist stuck the needle in, and its like it dripped all the way down the patient's elbow and down to the chair. Pharmacist was not sure how much came out, but said it seems like a lot came out. The patient had not experienced any symptoms. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Immunocompromised
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2105890

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: PA
Alter: 64,0
Geschlecht: F
Eingang: 11.02.2022
Impfdatum: 06.02.2022
Beginn: 07.02.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Muscle spasms Muscle twitching Nervousness Sleep disorder

Symptomtext

By mid-afternoon on Monday 2/7, I was having muscle spasms on the right side of my head above my ear radiating down to the base of my skull. It dawned on my that it was the same side as the vaccine. It lasted for a good 24 hours. Ibuprofen took the edge off but it was still bad enough to keep me up at night and made me very nervous. By Tuesday, 2/8, I could tell that it was lessening and by Tuesday afternoon, I felt much better. I felt a few twinges yesterday, 2/9 but nothing today. 2/10.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Muscle spasms
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2093167

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: CA
Alter: 36,0
Geschlecht: F
Eingang: 07.02.2022
Impfdatum: 03.02.2022
Beginn: 05.02.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dysphagia Mastication disorder Odynophagia Oedema peripheral Swelling Swollen tongue

Symptomtext

Received booster 2/3, on 2/5 that night tongue, neck & underarms swelled up, had a hard time eating, drinking & swallowing without extreme pain. Went to the ER for treatment & received a shot for pain & a shot of steroids for the swelling. I also received steroids to take home for the week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dysphagia
Hospital-Tage: -
Labordaten: None, went the ER on 2/7 for treatment.
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic Acute Sinusitis
Andere Medikamente: HUMS dietary supplements
Allergien: Sulfa
Vorherige Impfungen: After 2nd Pfizer got really sick like the flu for the a week.

VAERS 2092219

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027L21A

gering

Staat: MA
Alter: 68,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 06.02.2022
Beginn: 06.02.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Error: Booster Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -